1	EDITORIALS	NNS	O	editorial	_	0	SENT_1	[p1l984t81r1178b100],

1	8	CD	NUMBER	8	_	0	SENT_2	[p1l237t178r257b199],
2	.	.	O	.	_	0	SENT_2	[p1l237t178r257b199],

1	Nallamothu	NNP	O	Nallamothu	nn	2	SENT_3	[p1l287t175r441b199],
2	BK	NNP	O	BK	_	0	SENT_3	[p1l451t177r494b204],
3	,	,	O	,	_	0	SENT_3	[p1l451t177r494b204],
4	Bradley	NNP	PERSON	Bradley	nn	5	SENT_3	[p1l506t175r601b205],
5	EH	NNP	O	EH	appos	2	SENT_3	[p1l610t177r655b203],
6	,	,	O	,	_	0	SENT_3	[p1l610t177r655b203],
7	Krumholtz	NNP	PERSON	Krumholtz	nn	8	SENT_3	[p1l667t175r808b199],
8	HM	NNS	O	hm	appos	5	SENT_3	[p1l818t177r872b199],
9	.	.	O	.	_	0	SENT_3	[p1l818t177r872b199],

1	Time	NNP	O	Time	nsubj	3	SENT_4	[p1l883t176r949b199],
2	to	TO	O	to	aux	3	SENT_4	[p1l959t180r983b199],
3	treat	VB	O	treat	_	0	SENT_4	[p1l994t180r1061b199],
4	—	CD	NUMBER	—	num	5	SENT_4	[p1l994t180r1061b199],
5	11	CD	NUMBER	11	dobj	3	SENT_4	[p1l1101t178r1135b199],
6	.	.	O	.	_	0	SENT_4	[p1l1101t178r1135b199],

1	mann	NN	O	mann	nn	2	SENT_5	[p1l1204t183r1279b199],
2	F	NN	MISC	f	_	0	SENT_5	[p1l1287t177r1319b204],
3	)	CD	NUMBER	)	dep	2	SENT_5	[p1l1287t177r1319b204],
4	,	,	O	,	_	0	SENT_5	[p1l1287t177r1319b204],
5	Blasini	NNP	PERSON	Blasini	nn	6	SENT_5	[p1l1329t175r1419b199],
6	R	NNP	PERSON	R	appos	3	SENT_5	[p1l1427t177r1453b203],
7	,	,	O	,	_	0	SENT_5	[p1l1427t177r1453b203],
8	Schmitt	NNP	PERSON	Schmitt	nn	9	SENT_5	[p1l1465t175r1567b199],
9	C	NNP	O	C	appos	3	SENT_5	[p1l1575t177r1600b204],
10	,	,	O	,	_	0	SENT_5	[p1l1575t177r1600b204],
11	et	FW	O	et	nn	12	SENT_5	[p1l1611t180r1634b199],
12	al.	FW	O	al.	appos	3	SENT_5	[p1l1641t175r1671b199],
13	.	.	O	.	_	0	SENT_5	[p1l1641t175r1671b199],

1	Effect	NN	O	effect	_	0	SENT_6	[p1l1682t175r1759b199],
2	of	IN	O	of	_	0	SENT_6	[p1l1767t175r1797b199],
3	glycopro	NN	O	glycopro	nn	5	SENT_6	[p1l1800t175r1923b205],
4	—	CD	NUMBER	—	num	5	SENT_6	[p1l1800t175r1923b205],
5	ment	NN	O	ment	prep_of	1	SENT_6	[p1l238t217r303b236],
6	in	IN	O	in	_	0	SENT_6	[p1l314t213r338b235],
7	rimar	NN	O	rimar	nn	10	SENT_6	[p1l367t213r439b236],
8	ercutaneous	JJ	O	ercutaneous	amod	10	SENT_6	[p1l482t217r636b236],
9	coronary	JJ	O	coronary	amod	10	SENT_6	[p1l649t220r763b242],
10	intervention	NN	O	intervention	prep_in	1	SENT_6	[p1l774t213r938b236],
11	.	.	O	.	_	0	SENT_6	[p1l774t213r938b236],

1	N	NN	O	n	nn	2	SENT_7	[p1l951t214r972b236],
2	EnglJ	NN	O	englj	nsubj	6	SENT_7	[p1l984t212r1062b242],
3	tein	NN	O	tein	nn	6	SENT_7	[p1l1100t213r1150b236],
4	Ia	NN	O	ia	nn	6	SENT_7	[p1l1216t214r1240b236],
5	receptor	NN	O	receptor	nn	6	SENT_7	[p1l1249t217r1358b242],
6	blockade	NN	O	blockade	_	0	SENT_7	[p1l1366t212r1481b236],
7	on	IN	O	on	_	0	SENT_7	[p1l1491t220r1523b236],
8	recovery	NN	O	recovery	nn	10	SENT_7	[p1l1532t220r1641b242],
9	ronary	JJ	O	ronary	amod	10	SENT_7	[p1l1714t220r1800b242],
10	ﬂow	NN	O	ﬂow	prep_on	6	SENT_7	[p1l1809t212r1868b236],
11	and	CC	O	and	_	0	SENT_7	[p1l1876t212r1924b236],
12	Med	VBD	O	med	conj_and	6	SENT_7	[p1l237t249r292b273],
13	2	CD	NUMBER	2	dobj	12	SENT_7	[p1l302t251r316b272],
14	;	:	O	;	_	0	SENT_7	[p1l364t251r420b277],
15	357	CD	NUMBER	357	num	17	SENT_7	[p1l364t251r420b277],
16	:	:	O	:	_	0	SENT_7	[p1l364t251r420b277],
17	-8	CD	NUMBER	-8	dep	13	SENT_7	[p1l481t251r512b273],
18	.	.	O	.	_	0	SENT_7	[p1l481t251r512b273],

1	left	RB	O	left	advmod	2	SENT_8	[p1l1100t249r1144b273],
2	ventricular	JJ	O	ventricular	amod	6	SENT_8	[p1l1159t249r1302b273],
3	functi	NN	O	functus	nn	6	SENT_8	[p1l1319t249r1397b273],
4	n	NN	O	n	nn	6	SENT_8	[p1l1415t257r1430b272],
5	fter	NN	O	fter	nn	6	SENT_8	[p1l1463t249r1509b273],
6	placemen	NNS	O	placeman	_	0	SENT_8	[p1l1526t249r1650b279],
7	coronary	JJ	O	coronary	amod	9	SENT_8	[p1l1720t254r1925b279],
8	—	NN	O	—	nn	9	SENT_8	[p1l1720t254r1925b279],
9	artery	NN	O	artery	dep	6	SENT_8	[p1l1720t254r1925b279],
10	9	CD	NUMBER	9	dep	9	SENT_8	[p1l238t289r258b310],
11	.	.	O	.	_	0	SENT_8	[p1l238t289r258b310],

1	Poli	NNP	MISC	Poli	nn	2	SENT_9	[p1l287t286r336b310],
2	A	NNP	MISC	A	_	0	SENT_9	[p1l348t288r374b315],
3	,	,	O	,	_	0	SENT_9	[p1l348t288r374b315],
4	Fetiveau	NNP	PERSON	Fetiveau	nn	5	SENT_9	[p1l388t287r492b310],
5	R	NNP	PERSON	R	appos	2	SENT_9	[p1l505t288r531b315],
6	,	,	O	,	_	0	SENT_9	[p1l505t288r531b315],
7	Vandoni	NNP	PERSON	Vandoni	nn	8	SENT_9	[p1l545t286r651b310],
8	P	NN	PERSON	p	appos	2	SENT_9	[p1l663t288r683b315],
9	,	,	O	,	_	0	SENT_9	[p1l663t288r683b315],
10	et	FW	O	et	nn	11	SENT_9	[p1l698t291r721b310],
11	al.	FW	O	al.	appos	2	SENT_9	[p1l732t286r762b310],
12	.	.	O	.	_	0	SENT_9	[p1l732t286r762b310],

1	Integrated	NNP	O	Integrated	_	0	SENT_10	[p1l776t286r909b316],
2	analysis	NN	O	analysis	dep	1	SENT_10	[p1l922t286r1023b316],
3	of	IN	O	of	_	0	SENT_10	[p1l1037t286r1066b310],
4	stents	NNS	O	stent	prep_of	2	SENT_10	[p1l1101t291r1176b310],
5	in	IN	O	in	_	0	SENT_10	[p1l1195t287r1221b309],
6	acute	JJ	O	acute	amod	8	SENT_10	[p1l1239t291r1306b310],
7	myoc	JJ	O	myoc	amod	8	SENT_10	[p1l1325t294r1393b316],
8	r	NN	O	r	prep_in	4	SENT_10	[p1l1410t294r1421b309],
9	i	FW	O	i	dep	1	SENT_10	[p1l1439t287r1446b309],
10	l	NN	O	l	nn	11	SENT_10	[p1l1464t286r1471b309],
11	infarction	NN	O	infarction	dep	9	SENT_10	[p1l1489t286r1627b310],
12	.	.	O	.	_	0	SENT_10	[p1l1489t286r1627b310],

1	Circulation	NN	O	circulation	_	0	SENT_11	[p1l1647t286r1794b310],
2	1998	CD	DATE	1998	num	1	SENT_11	[p1l1814t288r1922b314],
3	;	:	O	;	_	0	SENT_11	[p1l1814t288r1922b314],
4	98	CD	NUMBER	98	dep	1	SENT_11	[p1l1814t288r1922b314],
5	:	:	O	:	_	0	SENT_11	[p1l1814t288r1922b314],
6	myocardial	JJ	O	myocardial	dep	7	SENT_11	[p1l238t323r380b353],
7	blush	VBP	O	blush	dep	1	SENT_11	[p1l393t323r462b347],
8	and	CC	O	and	cc	15	SENT_11	[p1l474t323r521b347],
9	ST	JJ	O	st	amod	15	SENT_11	[p1l534t325r642b353],
10	—	NN	O	—	nn	15	SENT_11	[p1l534t325r642b353],
11	segm	NN	O	segm	nn	15	SENT_11	[p1l534t325r642b353],
12	n	NN	O	n	nn	15	SENT_11	[p1l657t331r673b346],
13	elevation	NN	O	elevation	nn	15	SENT_11	[p1l694t323r808b347],
14	re	NN	O	re	nn	15	SENT_11	[p1l820t331r844b347],
15	ry	NN	O	ry	dobj	7	SENT_11	[p1l902t331r927b353],
16	after	IN	O	after	_	0	SENT_11	[p1l938t323r998b347],
17	suc	NN	O	suc	prep_after	15	SENT_11	[p1l1010t331r1061b347],
18	—	CD	NUMBER	—	num	17	SENT_11	[p1l1010t331r1061b347],
19	2695-701	CD	NUMBER	2695-701	nsubj	7	SENT_11	[p1l1100t325r1223b347],
20	.	.	O	.	_	0	SENT_11	[p1l1100t325r1223b347],

1	cess	NN	O	cess	nn	3	SENT_12	[p1l238t368r289b384],
2	rimary	JJ	O	rimary	amod	3	SENT_12	[p1l352t361r439b390],
3	angioplasty	NN	O	angioplasty	_	0	SENT_12	[p1l447t360r602b390],
4	:	:	O	:	_	0	SENT_12	[p1l447t360r602b390],
5	re	VB	O	re	dep	3	SENT_12	[p1l612t368r636b384],
6	—	NN	O	—	nn	7	SENT_12	[p1l661t373r669b377],
7	ime	NN	O	ime	dobj	5	SENT_12	[p1l681t361r728b384],
8	grading	VBG	O	grade	partmod	7	SENT_12	[p1l738t360r839b390],
9	microv	NN	O	microv	dobj	8	SENT_12	[p1l881t361r969b384],
10	ular	JJ	O	ular	amod	9	SENT_12	[p1l1011t360r1062b384],
11	12	CD	NUMBER	12	tmod	10	SENT_12	[p1l1101t363r1135b384],
12	.	.	O	.	_	0	SENT_12	[p1l1101t363r1135b384],

1	Abbate	NNP	PERSON	Abbate	nn	2	SENT_13	[p1l1149t360r1238b384],
2	A	NNP	O	A	_	0	SENT_13	[p1l1246t362r1272b389],
3	,	,	O	,	_	0	SENT_13	[p1l1246t362r1272b389],
4	Bussani	NNP	PERSON	Bussani	nn	5	SENT_13	[p1l1282t361r1382b384],
5	R	NNP	PERSON	R	appos	2	SENT_13	[p1l1390t362r1416b389],
6	,	,	O	,	_	0	SENT_13	[p1l1390t362r1416b389],
7	Biondi	NNP	PERSON	Biondi	appos	5	SENT_13	[p1l1426t360r1602b384],
8	.	.	O	.	_	0	SENT_13	[p1l1426t360r1602b384],

1	—	NN	O	—	_	0	SENT_14	[p1l1426t360r1602b384],
2	.	.	O	.	_	0	SENT_14	[p1l1426t360r1602b384],

1	Zoccai	NNP	O	Zoccai	nn	2	SENT_15	[p1l1426t360r1602b384],
2	GG	NNS	O	gg	_	0	SENT_15	[p1l1611t362r1661b389],
3	,	,	O	,	_	0	SENT_15	[p1l1611t362r1661b389],
4	et	FW	O	et	nn	5	SENT_15	[p1l1671t365r1694b384],
5	al.	FW	O	al.	appos	2	SENT_15	[p1l1701t360r1730b384],
6	.	.	O	.	_	0	SENT_15	[p1l1701t360r1730b384],

1	Infarct	JJ	O	infarct	amod	2	SENT_16	[p1l1740t360r1924b384],
2	—	NN	O	—	nsubj	3	SENT_16	[p1l1740t360r1924b384],
3	related	JJ	O	related	_	0	SENT_16	[p1l1740t360r1924b384],
4	reper	NN	O	reper	nn	5	SENT_16	[p1l238t405r304b427],
5	ion	NN	O	ion	dobj	3	SENT_16	[p1l346t398r386b421],
6	and	CC	O	and	_	0	SENT_16	[p1l395t397r442b421],
7	prediction	NN	O	prediction	dobj	3	SENT_16	[p1l452t397r583b427],
8	of	IN	O	of	_	0	SENT_16	[p1l593t397r623b421],
9	early	JJ	O	early	amod	12	SENT_16	[p1l628t397r689b427],
10	and	CC	O	and	_	0	SENT_16	[p1l697t397r744b421],
11	late	JJ	O	late	conj_and	9	SENT_16	[p1l754t397r799b421],
12	recovery	NN	O	recovery	prep_of	5	SENT_16	[p1l809t405r916b427],
13	of	IN	O	of	_	0	SENT_16	[p1l924t397r954b421],
14	ven	FW	O	ven	nn	17	SENT_16	[p1l1008t405r1061b421],
15	—	FW	O	—	nn	17	SENT_16	[p1l1008t405r1061b421],
16	artery	NN	O	artery	nn	17	SENT_16	[p1l1100t402r1176b427],
17	occlusion	NN	O	occlusion	prep_of	5	SENT_16	[p1l1184t397r1312b426],
18	,	,	O	,	_	0	SENT_16	[p1l1184t397r1312b426],
19	tissue	NN	O	tissue	nn	20	SENT_16	[p1l1323t398r1396b421],
20	markers	NNS	O	marker	conj_and	17	SENT_16	[p1l1405t397r1509b421],
21	of	IN	O	of	_	0	SENT_16	[p1l1519t397r1548b421],
22	ischaem	NN	O	ischaem	prep_of	20	SENT_16	[p1l1552t397r1687b425],
23	'	''	O	'	_	0	SENT_16	[p1l1552t397r1687b425],
24	a	DT	O	a	dep	20	SENT_16	[p1l1552t397r1687b425],
25	,	,	O	,	_	0	SENT_16	[p1l1552t397r1687b425],
26	and	CC	O	and	_	0	SENT_16	[p1l1698t397r1745b421],
27	increase	VB	O	increase	prep_of	5	SENT_16	[p1l1753t398r1858b421],
28	a	DT	O	a	det	31	SENT_16	[p1l1884t405r1897b421],
29	—	NN	O	—	nn	31	SENT_16	[p1l1915t410r1923b414],
30	tricular	JJ	O	tricular	amod	31	SENT_16	[p1l238t434r333b458],
31	function	NN	O	function	dobj	27	SENT_16	[p1l342t434r458b458],
32	.	.	O	.	_	0	SENT_16	[p1l342t434r458b458],

1	Circulation	NN	O	circulation	_	0	SENT_17	[p1l470t434r614b458],
2	2002	CD	DATE	2002	num	1	SENT_17	[p1l623t436r826b462],
3	;	:	O	;	_	0	SENT_17	[p1l623t436r826b462],
4	106:313	CD	NUMBER	106:313	number	5	SENT_17	[p1l623t436r826b462],
5	—	CD	NUMBER	—	dep	1	SENT_17	[p1l623t436r826b462],
6	8	CD	NUMBER	8	dep	5	SENT_17	[p1l623t436r826b462],
7	.	.	O	.	_	0	SENT_17	[p1l623t436r826b462],

1	osis	NN	O	osis	_	0	SENT_18	[p1l1143t435r1191b458],
2	in	IN	O	in	_	0	SENT_18	[p1l1202t435r1226b457],
3	the	DT	O	the	det	6	SENT_18	[p1l1236t434r1276b458],
4	peri	JJ	O	peri	amod	6	SENT_18	[p1l1285t434r1432b464],
5	—	NN	O	—	nn	6	SENT_18	[p1l1285t434r1432b464],
6	infarct	NN	O	infarct	prep_in	1	SENT_18	[p1l1285t434r1432b464],
7	viable	JJ	O	viable	amod	8	SENT_18	[p1l1439t434r1513b458],
8	myocardium	NN	O	myocardium	dep	6	SENT_18	[p1l1523t434r1691b464],
9	.	.	O	.	_	0	SENT_18	[p1l1523t434r1691b464],

1	Eur	NNP	O	Eur	nn	3	SENT_19	[p1l1702t436r1747b458],
2	Heart	NNP	O	Heart	nn	3	SENT_19	[p1l1756t436r1845b461],
3	]	NN	O	]	_	0	SENT_19	[p1l1756t436r1845b461],
4	;	:	O	;	_	0	SENT_19	[p1l1918t445r1922b462],
5	10	CD	NUMBER	10	dep	3	SENT_19	[p1l239t474r272b495],
6	.	.	O	.	_	0	SENT_19	[p1l239t474r272b495],

1	Svilaas	JJ	ORGANIZATION	svilaas	amod	2	SENT_20	[p1l288t472r375b495],
2	T	NN	ORGANIZATION	t	_	0	SENT_20	[p1l384t473r407b500],
3	,	,	O	,	_	0	SENT_20	[p1l384t473r407b500],
4	Vlaar	JJ	PERSON	vlaar	amod	6	SENT_20	[p1l417t472r485b495],
5	P	NN	O	p	nn	6	SENT_20	[p1l493t474r523b500],
6	]	NN	O	]	appos	2	SENT_20	[p1l493t474r523b500],
7	,	,	O	,	_	0	SENT_20	[p1l493t474r523b500],
8	van	NNP	PERSON	van	nn	10	SENT_20	[p1l533t479r577b495],
9	der	NNP	PERSON	der	nn	10	SENT_20	[p1l587t472r627b495],
10	Horst	NNP	PERSON	Horst	appos	2	SENT_20	[p1l636t474r708b495],
11	IC	NN	PERSON	ic	dep	10	SENT_20	[p1l716t473r750b499],
12	,	,	O	,	_	0	SENT_20	[p1l716t473r750b499],
13	et	FW	O	et	nn	14	SENT_20	[p1l762t477r785b495],
14	al.	FW	O	al.	appos	2	SENT_20	[p1l792t472r822b495],
15	.	.	O	.	_	0	SENT_20	[p1l792t472r822b495],

1	Thrombus	NN	O	thrombus	nn	2	SENT_21	[p1l832t472r964b495],
2	aspira	NN	O	aspira	_	0	SENT_21	[p1l974t472r1061b501],
3	—	CD	NUMBER	—	number	4	SENT_21	[p1l974t472r1061b501],
4	6	CD	NUMBER	6	dep	2	SENT_21	[p1l1116t473r1137b495],
5	:	:	O	:	_	0	SENT_21	[p1l1116t473r1137b495],
6	039-45	CD	NUMBER	039-45	dep	2	SENT_21	[p1l1155t473r1247b495],
7	.	.	O	.	_	0	SENT_21	[p1l1155t473r1247b495],

1	tion	NN	O	tion	_	0	SENT_22	[p1l238t509r288b532],
2	during	IN	O	during	_	0	SENT_22	[p1l297t509r383b538],
3	primary	JJ	O	primary	amod	6	SENT_22	[p1l389t509r493b538],
4	percutaneous	JJ	O	percutaneous	amod	6	SENT_22	[p1l500t514r672b538],
5	coronary	JJ	O	coronary	amod	6	SENT_22	[p1l681t516r795b538],
6	intervention	NN	O	intervention	prep_during	1	SENT_22	[p1l802t509r965b532],
7	.	.	O	.	_	0	SENT_22	[p1l802t509r965b532],

1	N	NN	O	n	nn	3	SENT_23	[p1l974t511r996b532],
2	Engl	NNP	O	Engl	nn	3	SENT_23	[p1l1004t509r1061b538],
3	Copyright	NNP	O	Copyright	_	0	SENT_23	[p1l1101t513r1199b538],
4	©	CD	NUMBER	©	num	8	SENT_23	[p1l1208t515r1229b535],
5	2008	CD	DATE	2008	num	8	SENT_23	[p1l1239t514r1291b532],
6	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	8	SENT_23	[p1l1300t513r1448b532],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_23	[p1l1457t513r1538b532],
8	Society	NNP	ORGANIZATION	Society	dep	3	SENT_23	[p1l1546t513r1622b537],
9	.	.	O	.	_	0	SENT_23	[p1l1546t513r1622b537],

1	J	NN	O	j	nsubj	2	SENT_24	[p1l235t548r246b573],
2	Med	VBD	O	med	_	0	SENT_24	[p1l254t546r309b569],
3	2008	CD	DATE	2008	dobj	2	SENT_24	[p1l319t547r532b574],
4	;	:	O	;	_	0	SENT_24	[p1l319t547r532b574],
5	358:557	CD	NUMBER	358:557	num	6	SENT_24	[p1l319t547r532b574],
6	-67	CD	NUMBER	-67	dep	3	SENT_24	[p1l319t547r532b574],
7	.	.	O	.	_	0	SENT_24	[p1l319t547r532b574],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_25	[p1l497t731r982b794],
2	Biomarkers	NNS	O	biomarker	_	0	SENT_25	[p1l1002t731r1295b779],
3	for	IN	O	for	_	0	SENT_25	[p1l1312t730r1386b779],
4	Prediction	NN	O	prediction	prep_for	2	SENT_25	[p1l1406t731r1665b779],
5	of	IN	O	of	_	0	SENT_25	[p1l637t802r697b851],
6	Severe	JJ	O	severe	amod	13	SENT_25	[p1l704t807r876b851],
7	Adverse	JJ	O	adverse	amod	13	SENT_25	[p1l892t803r1101b851],
8	Drug	NN	O	drug	nn	13	SENT_25	[p1l1122t807r1251b866],
9	Reactions	NNS	O	reaction	nn	13	SENT_25	[p1l1272t804r1523b851],
10	Magnus	NNP	PERSON	Magnus	nn	13	SENT_25	[p1l680t887r815b925],
11	lngelman-Sundberg	NNP	PERSON	lngelman-Sundberg	nn	13	SENT_25	[p1l833t884r1178b925],
12	,	,	O	,	_	0	SENT_25	[p1l833t884r1178b925],
13	Ph.D.	NNP	O	Ph.D.	prep_of	2	SENT_25	[p1l1197t884r1296b920],
14	,	,	O	,	_	0	SENT_25	[p1l1197t884r1296b920],
15	B.	NNP	O	B.	nn	16	SENT_25	[p1l1315t884r1483b915],
16	Sc	NNP	O	Sc	appos	13	SENT_25	[p1l1315t884r1483b915],
17	.	.	O	.	_	0	SENT_25	[p1l1315t884r1483b915],

1	Med	NNP	O	Med	_	0	SENT_26	[p1l1315t884r1483b915],
2	.	.	O	.	_	0	SENT_26	[p1l1315t884r1483b915],

1	The	DT	O	the	det	3	SENT_27	[p1l7t1104r168b1183],
2	accumulating	VBG	O	accumulate	amod	3	SENT_27	[p1l199t1104r790b1205],
3	knowledge	NN	O	knowledge	nsubjpass	10	SENT_27	[p1l818t1104r1285b1205],
4	of	IN	O	of	_	0	SENT_27	[p1l1317t1104r1418b1183],
5	human	JJ	O	human	amod	7	SENT_27	[p1l1431t1104r1735b1183],
6	genomic	JJ	O	genomic	amod	7	SENT_27	[p1l1766t1105r2136b1205],
7	variation	NN	O	variation	prep_of	3	SENT_27	[p1l6t1233r398b1311],
8	is	VBZ	O	be	aux	10	SENT_27	[p1l444t1233r511b1311],
9	being	VBG	O	be	auxpass	10	SENT_27	[p1l560t1232r807b1333],
10	used	VBN	O	use	_	0	SENT_27	[p1l850t1232r1050b1311],
11	for	IN	O	for	_	0	SENT_27	[p1l1097t1232r1223b1311],
12	the	DT	O	the	det	13	SENT_27	[p1l1267t1232r1401b1311],
13	development	NN	O	development	prep_for	10	SENT_27	[p1l1450t1232r2010b1333],
14	of	IN	O	of	_	0	SENT_27	[p1l2052t1232r2153b1311],
15	personalized	JJ	O	personalized	amod	16	SENT_27	[p1l9t1360r579b1461],
16	medicine	NN	O	medicine	prep_of	13	SENT_27	[p1l640t1360r1065b1456],
17	,	,	O	,	_	0	SENT_27	[p1l640t1360r1065b1456],
18	with	IN	O	with	_	0	SENT_27	[p1l1127t1360r1326b1439],
19	the	DT	O	the	det	20	SENT_27	[p1l1388t1360r1523b1439],
20	aims	NNS	O	aim	prep_with	10	SENT_27	[p1l1584t1361r1793b1439],
21	of	IN	O	of	_	0	SENT_27	[p1l1857t1360r1958b1439],
22	decreasing	VBG	O	decrease	prepc_of	20	SENT_27	[p1l2002t1360r2134b1439, p1l11t1489r380b1589],
23	the	DT	O	the	det	24	SENT_27	[p1l422t1488r558b1567],
24	number	NN	O	number	dobj	22	SENT_27	[p1l603t1488r947b1567],
25	of	IN	O	of	_	0	SENT_27	[p1l989t1488r1090b1567],
26	adverse	JJ	O	adverse	amod	28	SENT_27	[p1l1117t1488r1439b1567],
27	drug	NN	O	drug	nn	28	SENT_27	[p1l1485t1488r1692b1589],
28	reactions	NNS	O	reaction	prep_of	24	SENT_27	[p1l1734t1489r2134b1567],
29	and	CC	O	and	_	0	SENT_27	[p1l10t1616r169b1695],
30	increasing	VBG	O	increase	conj_and	22	SENT_27	[p1l216t1617r676b1717],
31	the	DT	O	the	det	32	SENT_27	[p1l720t1616r856b1695],
32	efficacy	NN	O	efficacy	dobj	30	SENT_27	[p1l904t1616r1248b1717],
33	of	IN	O	of	_	0	SENT_27	[p1l1292t1616r1393b1695],
34	drug	NN	O	drug	nn	35	SENT_27	[p1l1423t1616r1630b1717],
35	treatment	NN	O	treatment	prep_of	32	SENT_27	[p1l1675t1633r2130b1695],
36	.	.	O	.	_	0	SENT_27	[p1l1675t1633r2130b1695],

1	Considerable	JJ	O	considerable	amod	3	SENT_28	[p1l10t1744r568b1823],
2	pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_28	[p1l600t1744r1411b1845],
3	research	NN	O	research	nsubj	5	SENT_28	[p1l1442t1744r1806b1823],
4	has	VBZ	O	have	aux	5	SENT_28	[p1l1838t1744r1982b1823],
5	focused	VBN	O	focus	_	0	SENT_28	[p1l2016t1744r2134b1823, p1l11t1872r258b1951],
6	on	IN	O	on	_	0	SENT_28	[p1l304t1898r411b1951],
7	understanding	VBG	O	understand	prepc_on	5	SENT_28	[p1l457t1872r1107b1973],
8	the	DT	O	the	det	10	SENT_28	[p1l1150t1872r1285b1951],
9	molecular	JJ	O	molecular	amod	10	SENT_28	[p1l1331t1872r1773b1951],
10	mechanisms	NNS	O	mechanism	dobj	7	SENT_28	[p1l1817t1872r2134b1951, p1l10t2001r270b2079],
11	behind	IN	O	behind	_	0	SENT_28	[p1l316t2000r620b2079],
12	adverse	JJ	O	adverse	amod	14	SENT_28	[p1l662t2000r984b2079],
13	drug	NN	O	drug	nn	14	SENT_28	[p1l1028t2000r1235b2101],
14	reactions	NNS	O	reaction	prep_behind	10	SENT_28	[p1l1273t2001r1673b2079],
15	and	CC	O	and	_	0	SENT_28	[p1l1717t2000r1877b2079],
16	finding	VBG	O	find	prepc_on	5	SENT_28	[p1l1919t2000r2134b2079, p1l10t2129r150b2229],
17	biomarkers	NNS	O	biomarker	dobj	16	SENT_28	[p1l185t2128r672b2208],
18	that	WDT	O	that	nsubj	19	SENT_28	[p1l712t2128r885b2207],
19	identify	VBP	O	identify	rcmod	17	SENT_28	[p1l917t2128r1250b2229],
20	people	NNS	O	people	dobj	19	SENT_28	[p1l1282t2128r1565b2229],
21	at	IN	O	at	_	0	SENT_28	[p1l1603t2145r1682b2207],
22	risk	NN	O	risk	prep_at	19	SENT_28	[p1l1715t2128r1898b2208],
23	.	.	O	.	_	0	SENT_28	[p1l1715t2128r1898b2208],

1	Serious	JJ	O	serious	dep	101	SENT_29	[p1l142t2257r451b2335],
2	adverse	JJ	O	adverse	dep	101	SENT_29	[p1l529t2256r844b2335],
3	drug	NN	O	drug	dep	101	SENT_29	[p1l921t2256r1125b2357],
4	reactions	NNS	O	reaction	dep	101	SENT_29	[p1l1198t2257r1589b2335],
5	have	VBP	O	have	dep	101	SENT_29	[p1l1667t2256r1856b2335],
6	been	VBN	O	be	dep	101	SENT_29	[p1l1934t2256r2135b2335],
7	shown	VBN	O	show	dep	101	SENT_29	[p1l12t2384r294b2463],
8	to	TO	O	to	dep	101	SENT_29	[p1l340t2401r422b2463],
9	cause	VB	O	cause	dep	101	SENT_29	[p1l470t2411r704b2463],
10	or	CC	O	or	dep	101	SENT_29	[p1l750t2410r839b2463],
11	contribute	VB	O	contribute	dep	101	SENT_29	[p1l883t2384r1325b2463],
12	to	TO	O	to	dep	101	SENT_29	[p1l1372t2401r1454b2463],
13	6	CD	NUMBER	6	dep	101	SENT_29	[p1l1502t2390r1549b2463],
14	to	TO	O	to	dep	101	SENT_29	[p1l1596t2401r1677b2463],
15	7	CD	PERCENT	7	dep	101	SENT_29	[p1l1725t2389r1859b2463],
16	%	NN	PERCENT	%	dep	101	SENT_29	[p1l1725t2389r1859b2463],
17	of	IN	O	of	dep	101	SENT_29	[p1l1905t2384r2005b2463],
18	all	DT	O	all	dep	101	SENT_29	[p1l2032t2384r2136b2463],
19	hospitalizations	NNS	O	hospitalization	dep	101	SENT_29	[p1l10t2512r728b2613],
20	,	,	O	,	_	0	SENT_29	[p1l10t2512r728b2613],
21	a	DT	O	a	dep	101	SENT_29	[p1l774t2539r819b2591],
22	2-day	JJ	DURATION	2-day	dep	101	SENT_29	[p1l858t2512r1090b2613],
23	increase	NN	O	increase	dep	101	SENT_29	[p1l1125t2513r1478b2591],
24	in	IN	O	in	dep	101	SENT_29	[p1l1519t2513r1602b2590],
25	the	DT	O	the	dep	101	SENT_29	[p1l1644t2512r1776b2591],
26	average	JJ	O	average	dep	101	SENT_29	[p1l1817t2538r2135b2613],
27	length	NN	O	length	dep	101	SENT_29	[p1l9t2640r292b2741],
28	of	IN	O	of	dep	101	SENT_29	[p1l346t2640r447b2719],
29	hospitalization	NN	O	hospitalization	dep	101	SENT_29	[p1l483t2640r1174b2741],
30	,	,	O	,	_	0	SENT_29	[p1l483t2640r1174b2741],
31	and	CC	O	and	dep	101	SENT_29	[p1l1233t2640r1393b2719],
32	100,000	CD	NUMBER	100,000	dep	101	SENT_29	[p1l1450t2646r1793b2736],
33	deaths	NNS	O	death	dep	101	SENT_29	[p1l1848t2640r2133b2719],
34	annually	RB	SET	annually	dep	101	SENT_29	[p1l10t2768r392b2869],
35	in	IN	O	in	dep	101	SENT_29	[p1l436t2769r520b2846],
36	the	DT	O	the	dep	101	SENT_29	[p1l570t2768r705b2847],
37	United	NNP	LOCATION	United	dep	101	SENT_29	[p1l755t2768r1047b2847],
38	States	NNPS	LOCATION	States	dep	101	SENT_29	[p1l1099t2774r1353b2847],
39	—	NN	O	—	dep	101	SENT_29	[p1l1401t2813r1509b2821],
40	and	CC	O	and	dep	101	SENT_29	[p1l1553t2768r1713b2847],
41	may	MD	O	may	dep	101	SENT_29	[p1l1763t2794r1958b2869],
42	,	,	O	,	_	0	SENT_29	[p1l1763t2794r1958b2869],
43	ac	IN	O	ac	dep	101	SENT_29	[p1l2012t2795r2134b2847],
44	—	CD	NUMBER	—	dep	101	SENT_29	[p1l2012t2795r2134b2847],
45	cording	NN	O	cording	dep	101	SENT_29	[p1l11t2896r345b2997],
46	to	TO	O	to	dep	101	SENT_29	[p1l386t2913r468b2975],
47	some	DT	O	some	dep	101	SENT_29	[p1l515t2922r739b2975],
48	estimates	NNS	O	estimate	dep	101	SENT_29	[p1l785t2897r1218b2992],
49	,	,	O	,	_	0	SENT_29	[p1l785t2897r1218b2992],
50	cost	NN	O	cost	dep	101	SENT_29	[p1l1268t2913r1444b2975],
51	about	IN	O	about	dep	101	SENT_29	[p1l1482t2896r1727b2975],
52	as	RB	O	as	dep	101	SENT_29	[p1l1765t2923r1851b2975],
53	much	JJ	O	much	dep	101	SENT_29	[p1l1897t2896r2135b2975],
54	as	IN	O	as	dep	101	SENT_29	[p1l10t3051r95b3103],
55	the	DT	O	the	dep	101	SENT_29	[p1l139t3024r272b3103],
56	drug	NN	O	drug	dep	101	SENT_29	[p1l316t3024r519b3125],
57	treatment	NN	O	treatment	dep	101	SENT_29	[p1l559t3041r983b3103],
58	itself	PRP	O	itself	dep	101	SENT_29	[p1l1020t3024r1294b3103],
59	}	VBD	O	}	dep	101	SENT_29	[p1l1020t3024r1294b3103],
60	During	IN	O	during	dep	101	SENT_29	[p1l1334t3025r1645b3125],
61	the	DT	O	the	dep	101	SENT_29	[p1l1684t3024r1817b3103],
62	period	NN	O	period	dep	101	SENT_29	[p1l1858t3024r2136b3125],
63	1998-2005	CD	DATE	1998-2005	dep	101	SENT_29	[p1l14t3158r489b3248],
64	,	,	O	,	_	0	SENT_29	[p1l14t3158r489b3248],
65	the	DT	O	the	dep	101	SENT_29	[p1l527t3152r657b3231],
66	numbers	NNS	O	number	dep	101	SENT_29	[p1l689t3152r1061b3231],
67	of	IN	O	of	dep	101	SENT_29	[p1l1095t3152r1194b3231],
68	reported	VBN	O	report	dep	101	SENT_29	[p1l1206t3152r1566b3253],
69	adverse	JJ	O	adverse	dep	101	SENT_29	[p1l1596t3152r1905b3231],
70	drug	NN	O	drug	dep	101	SENT_29	[p1l1937t3152r2139b3253],
71	reactions	NNS	O	reaction	dep	101	SENT_29	[p1l10t3282r409b3360],
72	and	CC	O	and	dep	101	SENT_29	[p1l460t3281r620b3360],
73	deaths	NNS	O	death	dep	101	SENT_29	[p1l670t3281r954b3360],
74	related	VBN	O	relate	dep	101	SENT_29	[p1l1006t3281r1304b3360],
75	to	TO	O	to	dep	101	SENT_29	[p1l1353t3298r1436b3360],
76	such	JJ	O	such	dep	101	SENT_29	[p1l1488t3281r1684b3360],
77	reactions	NNS	O	reaction	dep	101	SENT_29	[p1l1733t3282r2133b3360],
78	have	VBP	O	have	dep	101	SENT_29	[p1l10t3409r203b3488],
79	increased	VBN	O	increase	dep	101	SENT_29	[p1l254t3409r686b3505],
80	,	,	O	,	_	0	SENT_29	[p1l254t3409r686b3505],
81	both	CC	O	both	dep	101	SENT_29	[p1l742t3409r940b3488],
82	by	IN	O	by	dep	101	SENT_29	[p1l990t3409r1088b3510],
83	a	DT	O	a	dep	101	SENT_29	[p1l1132t3436r1177b3488],
84	factor	NN	O	factor	dep	101	SENT_29	[p1l1224t3409r1476b3488],
85	of	IN	O	of	dep	101	SENT_29	[p1l1523t3409r1623b3488],
86	about	IN	O	about	dep	101	SENT_29	[p1l1653t3409r1898b3488],
87	2.6.2	CD	NUMBER	2.6.2	dep	101	SENT_29	[p1l1942t3415r2135b3488],
88	Adverse	JJ	O	adverse	dep	101	SENT_29	[p1l6t3537r342b3616],
89	drug	NN	O	drug	dep	101	SENT_29	[p1l379t3537r583b3638],
90	reactions	NNS	O	reaction	dep	101	SENT_29	[p1l616t3538r1006b3616],
91	are	VBP	O	be	dep	101	SENT_29	[p1l1043t3563r1173b3616],
92	also	RB	O	also	dep	101	SENT_29	[p1l1207t3537r1379b3616],
93	a	DT	O	a	dep	101	SENT_29	[p1l1416t3564r1461b3616],
94	major	JJ	O	major	dep	101	SENT_29	[p1l1494t3538r1745b3638],
95	problem	NN	O	problem	dep	101	SENT_29	[p1l1776t3537r2135b3638],
96	during	IN	O	during	dep	101	SENT_29	[p1l11t3665r301b3766],
97	the	DT	O	the	dep	101	SENT_29	[p1l342t3665r475b3744],
98	development	NN	O	development	dep	101	SENT_29	[p1l521t3665r1071b3766],
99	of	IN	O	of	dep	101	SENT_29	[p1l1111t3665r1211b3744],
100	a	DT	O	a	dep	101	SENT_29	[p1l1237t3692r1281b3744],
101	drug	NN	O	drug	_	0	SENT_29	[p1l1325t3665r1548b3766],
102	.	.	O	.	_	0	SENT_29	[p1l1325t3665r1548b3766],

1	In	IN	O	in	_	0	SENT_30	[p1l1597t3673r1686b3743],
2	total	NN	O	total	pobj	1	SENT_30	[p1l1732t3665r1952b3761],
3	,	,	O	,	_	0	SENT_30	[p1l1732t3665r1952b3761],
4	approximately	RB	O	approximately	advmod	2	SENT_30	[p1l2001t3691r2134b3766, p2l9t20r525b121],

1	4	CD	NUMBER	4	num	2	SENT_31	[p2l573t26r706b99],
2	°	CD	NUMBER	°	_	0	SENT_31	[p2l573t26r706b99],
3	/	:	O	/	punct	2	SENT_31	[p2l573t26r706b99],
4	o	NN	O	o	nsubjpass	11	SENT_31	[p2l573t26r706b99],
5	of	IN	O	of	_	0	SENT_31	[p2l760t20r860b99],
6	all	DT	O	all	det	9	SENT_31	[p2l896t20r1001b99],
7	new	JJ	O	new	amod	9	SENT_31	[p2l1054t46r1231b99],
8	medical	JJ	O	medical	amod	9	SENT_31	[p2l1281t20r1621b99],
9	agents	NNS	O	agent	prep_of	4	SENT_31	[p2l1675t37r1950b121],
10	are	VBP	O	be	auxpass	11	SENT_31	[p2l2006t47r2135b99],
11	withdrawn	VBN	O	withdraw	dep	2	SENT_31	[p2l6t148r487b228],
12	from	IN	O	from	_	0	SENT_31	[p2l539t148r753b227],
13	the	DT	O	the	det	14	SENT_31	[p2l806t148r941b227],
14	market	NN	O	market	prep_from	11	SENT_31	[p2l994t148r1307b227],
15	owing	VBG	O	owe	partmod	14	SENT_31	[p2l1355t149r1629b249],
16	to	TO	O	to	_	0	SENT_31	[p2l1678t165r1761b227],
17	adverse	JJ	O	adverse	amod	19	SENT_31	[p2l1813t148r2135b227],
18	drug	NN	O	drug	nn	19	SENT_31	[p2l11t276r215b377],
19	reactions	NNS	O	reaction	prep_to	15	SENT_31	[p2l263t277r719b355],
20	}	VBP	O	}	rcmod	19	SENT_31	[p2l263t277r719b355],
21	During	IN	O	during	_	0	SENT_31	[p2l770t277r1081b377],
22	the	DT	O	the	det	23	SENT_31	[p2l1130t276r1262b355],
23	period	NN	O	period	prep_during	31	SENT_31	[p2l1313t276r1591b377],
24	1995-2005	CD	DATE	1995-2005	num	23	SENT_31	[p2l1645t282r2130b372],
25	,	,	O	,	_	0	SENT_31	[p2l1645t282r2130b372],
26	at	IN	O	at	quantmod	28	SENT_31	[p2l10t421r90b483],
27	least	JJS	O	least	mwe	26	SENT_31	[p2l129t404r332b483],
28	34	CD	NUMBER	34	num	29	SENT_31	[p2l373t410r475b483],
29	drugs	NNS	O	drug	nsubj	31	SENT_31	[p2l520t404r769b505],
30	were	VBD	O	be	cop	31	SENT_31	[p2l812t430r1016b483],
31	Withdrawn	NNP	O	Withdrawn	ccomp	20	SENT_31	[p2l1058t404r1563b500],
32	,	,	O	,	_	0	SENT_31	[p2l1058t404r1563b500],
33	mainly	RB	O	mainly	advmod	31	SENT_31	[p2l1614t404r1919b505],
34	as	IN	O	as	mark	42	SENT_31	[p2l1959t431r2046b483],
35	a	DT	O	a	det	36	SENT_31	[p2l2092t431r2137b483],
36	result	NN	O	result	nsubj	42	SENT_31	[p2l10t532r249b611],
37	of	IN	O	of	_	0	SENT_31	[p2l280t532r378b611],
38	hepatotoxic	JJ	O	hepatotoxic	amod	41	SENT_31	[p2l395t532r886b633],
39	or	CC	O	or	_	0	SENT_31	[p2l922t558r1009b611],
40	cardiotoxic	JJ	O	cardiotoxic	amod	41	SENT_31	[p2l1042t532r1512b611],
41	effects	NNS	O	effect	prep_of	36	SENT_31	[p2l1547t532r1822b611],
42	—	VBP	O	—	advcl	15	SENT_31	[p2l1856t577r1963b585],
43	notably	RB	O	notably	advmod	42	SENT_31	[p2l1995t558r2134b611, p2l11t660r227b761],
44	,	,	O	,	_	0	SENT_31	[p2l1995t558r2134b611, p2l11t660r227b761],
45	cerivastatin	NN	O	cerivastatin	nn	52	SENT_31	[p2l272t661r778b756],
46	,	,	O	,	_	0	SENT_31	[p2l272t661r778b756],
47	nefazodone	NN	O	nefazodone	dep	52	SENT_31	[p2l822t660r1335b756],
48	,	,	O	,	_	0	SENT_31	[p2l822t660r1335b756],
49	rofecoxib	NN	O	rofecoxib	dep	52	SENT_31	[p2l1379t660r1772b739],
50	(	CD	NUMBER	(	num	52	SENT_31	[p2l1817t661r2130b756],
51	Vioxx	NNP	O	Vioxx	nn	52	SENT_31	[p2l1817t661r2130b756],
52	)	NN	O	)	prep_from	11	SENT_31	[p2l1817t661r2130b756],
53	,	,	O	,	_	0	SENT_31	[p2l1817t661r2130b756],
54	terfenadine	NN	O	terfenadine	appos	52	SENT_31	[p2l11t788r526b884],
55	,	,	O	,	_	0	SENT_31	[p2l11t788r526b884],
56	and	CC	O	and	_	0	SENT_31	[p2l569t788r727b867],
57	troglitazone	NN	O	troglitazone	nn	58	SENT_31	[p2l765t788r1356b889],
58	.3	NN	NUMBER	.3	prep_from	11	SENT_31	[p2l765t788r1356b889],

1	The	DT	O	the	det	2	SENT_32	[p2l136t916r297b995],
2	search	NN	O	search	nsubj	24	SENT_32	[p2l334t916r611b995],
3	for	IN	O	for	_	0	SENT_32	[p2l645t916r769b995],
4	pharmacogenomic	JJ	O	pharmacogenomic	amod	5	SENT_32	[p2l800t916r1611b1017],
5	biomarkers	NNS	O	biomarker	prep_for	2	SENT_32	[p2l1646t916r2134b996],
6	that	WDT	O	that	nsubjpass	9	SENT_32	[p2l11t1044r177b1123],
7	could	MD	O	could	aux	9	SENT_32	[p2l206t1044r431b1123],
8	be	VB	O	be	auxpass	9	SENT_32	[p2l466t1044r559b1123],
9	used	VBN	O	use	rcmod	5	SENT_32	[p2l594t1044r784b1123],
10	to	TO	O	to	aux	11	SENT_32	[p2l817t1061r897b1123],
11	identify	VB	O	identify	xcomp	9	SENT_32	[p2l931t1044r1250b1145],
12	patients	NNS	O	patient	dobj	11	SENT_32	[p2l1277t1045r1604b1145],
13	at	IN	O	at	_	0	SENT_32	[p2l1639t1061r1715b1123],
14	increased	VBN	O	increase	amod	15	SENT_32	[p2l1743t1044r2135b1123],
15	risk	NN	O	risk	prep_at	11	SENT_32	[p2l10t1172r168b1252],
16	for	IN	O	for	_	0	SENT_32	[p2l192t1172r311b1251],
17	drug	NN	O	drug	nn	18	SENT_32	[p2l338t1172r845b1273],
18	—	NN	O	—	prep_for	15	SENT_32	[p2l338t1172r845b1273],
19	related	JJ	O	related	amod	21	SENT_32	[p2l338t1172r845b1273],
20	toxic	JJ	O	toxic	amod	21	SENT_32	[p2l874t1173r1071b1251],
21	effects	NNS	O	effect	dep	18	SENT_32	[p2l1100t1172r1369b1251],
22	has	VBZ	O	have	aux	24	SENT_32	[p2l1400t1172r1540b1251],
23	often	RB	O	often	advmod	24	SENT_32	[p2l1572t1172r1786b1251],
24	focused	VBN	O	focus	_	0	SENT_32	[p2l1816t1172r2135b1251],
25	on	IN	O	on	_	0	SENT_32	[p2l11t1326r116b1379],
26	variation	NN	O	variation	nsubj	29	SENT_32	[p2l154t1301r529b1379],
27	Within	IN	O	within	_	0	SENT_32	[p2l567t1300r847b1379],
28	genes	NNS	O	gene	prep_within	29	SENT_32	[p2l889t1326r1127b1401],
29	encoding	VBG	O	encode	prepc_on	24	SENT_32	[p2l1172t1300r1566b1401],
30	drug	NN	O	drug	nn	33	SENT_32	[p2l1606t1300r2134b1401],
31	—	NN	O	—	nn	33	SENT_32	[p2l1606t1300r2134b1401],
32	metab	NN	O	metab	nn	33	SENT_32	[p2l1606t1300r2134b1401],
33	—	NN	O	—	dobj	29	SENT_32	[p2l1606t1300r2134b1401],
34	olizing	VBG	O	olize	xcomp	29	SENT_32	[p2l11t1428r312b1529],
35	enzymes	NNS	O	enzyme	dobj	34	SENT_32	[p2l352t1454r750b1529],
36	.	.	O	.	_	0	SENT_32	[p2l352t1454r750b1529],

1	Altered	JJ	O	altered	amod	3	SENT_33	[p2l795t1428r1109b1507],
2	enzymatic	JJ	O	enzymatic	amod	3	SENT_33	[p2l1152t1429r1595b1529],
3	activity	NN	O	activity	nsubj	17	SENT_33	[p2l1636t1429r1947b1529],
4	can	MD	O	can	aux	5	SENT_33	[p2l1986t1454r2135b1507],
5	lead	VB	O	lead	_	0	SENT_33	[p2l9t1556r186b1635],
6	to	TO	O	to	_	0	SENT_33	[p2l228t1573r311b1635],
7	elevated	JJ	O	elevated	amod	8	SENT_33	[p2l355t1556r705b1635],
8	levels	NNS	O	level	prep_to	5	SENT_33	[p2l746t1556r982b1635],
9	of	IN	O	of	_	0	SENT_33	[p2l1027t1556r1128b1635],
10	the	DT	O	the	det	12	SENT_33	[p2l1152t1556r1286b1635],
11	substrate	NN	O	substrate	nn	12	SENT_33	[p2l1330t1556r1730b1635],
12	drug	NN	O	drug	prep_of	8	SENT_33	[p2l1773t1556r2000b1657],
13	,	,	O	,	_	0	SENT_33	[p2l1773t1556r2000b1657],
14	or	CC	O	or	_	0	SENT_33	[p2l2048t1582r2138b1635],
15	alternatively	RB	O	alternatively	advmod	5	SENT_33	[p2l10t1684r537b1785],
16	,	,	O	,	_	0	SENT_33	[p2l10t1684r537b1785],
17	increased	VBD	O	increase	conj_or	5	SENT_33	[p2l578t1684r979b1763],
18	amounts	NNS	O	amount	dobj	17	SENT_33	[p2l1015t1701r1384b1763],
19	of	IN	O	of	_	0	SENT_33	[p2l1423t1684r1523b1763],
20	a	DT	O	a	det	22	SENT_33	[p2l1539t1711r1584b1763],
21	reactive	JJ	O	reactive	amod	22	SENT_33	[p2l1618t1685r1937b1763],
22	metabolite	NN	O	metabolite	prep_of	18	SENT_33	[p2l1974t1710r2134b1763, p2l11t1812r350b1906],
23	,	,	O	,	_	0	SENT_33	[p2l1974t1710r2134b1763, p2l11t1812r350b1906],
24	either	DT	O	either	nsubj	28	SENT_33	[p2l392t1812r634b1891],
25	of	IN	O	of	_	0	SENT_33	[p2l668t1812r767b1891],
26	which	WDT	O	which	prep_of	24	SENT_33	[p2l780t1812r1038b1892],
27	could	MD	O	could	aux	28	SENT_33	[p2l1075t1812r1305b1891],
28	have	VB	O	have	rcmod	22	SENT_33	[p2l1341t1812r1528b1891],
29	toxic	JJ	O	toxic	amod	30	SENT_33	[p2l1564t1813r1766b1891],
30	effects	NNS	O	effect	dobj	28	SENT_33	[p2l1801t1812r2106b1891],
31	.	.	O	.	_	0	SENT_33	[p2l1801t1812r2106b1891],

1	For	IN	O	for	_	0	SENT_34	[p2l105t2056r211b2109],
2	immune	JJ	O	immune	amod	3	SENT_34	[p2l236t2050r830b2109],
3	—	NN	O	—	prep_for	12	SENT_34	[p2l236t2050r830b2109],
4	mediated	VBN	O	mediate	partmod	3	SENT_34	[p2l236t2050r830b2109],
5	toxic	JJ	O	toxic	amod	6	SENT_34	[p2l858t2051r1011b2109],
6	effects	NNS	O	effect	dobj	4	SENT_34	[p2l1039t2050r1267b2121],
7	,	,	O	,	_	0	SENT_34	[p2l1039t2050r1267b2121],
8	much	JJ	O	much	amod	9	SENT_34	[p2l1299t2050r1476b2109],
9	focus	NN	O	focus	nsubjpass	12	SENT_34	[p2l1504t2050r1591b2109, p2l11t2165r113b2204],
10	has	VBZ	O	have	aux	12	SENT_34	[p2l144t2145r251b2203],
11	been	VBN	O	be	auxpass	12	SENT_34	[p2l283t2145r433b2204],
12	placed	VBN	O	place	_	0	SENT_34	[p2l461t2145r667b2220],
13	on	IN	O	on	_	0	SENT_34	[p2l697t2164r776b2204],
14	the	DT	O	the	det	16	SENT_34	[p2l806t2145r905b2204],
15	major	JJ	O	major	amod	16	SENT_34	[p2l934t2145r1591b2220],
16	—	NN	O	—	prep_on	12	SENT_34	[p2l934t2145r1591b2220],
17	histocompati	NNS	O	histocompatus	nsubj	18	SENT_34	[p2l934t2145r1591b2220],
18	—	VBP	O	—	rcmod	16	SENT_34	[p2l934t2145r1591b2220],
19	bility-complex	JJ	O	bility-complex	amod	22	SENT_34	[p2l11t2240r460b2315],
20	class	NN	O	class	nn	22	SENT_34	[p2l485t2240r634b2298],
21	1	CD	NUMBER	1	num	22	SENT_34	[p2l661t2246r684b2298],
22	genes	NNS	O	gene	dobj	18	SENT_34	[p2l710t2259r905b2315],
23	.	.	O	.	_	0	SENT_34	[p2l710t2259r905b2315],

1	A	DT	O	a	det	2	SENT_35	[p2l933t2246r982b2298],
2	review	NN	O	review	nsubj	6	SENT_35	[p2l1007t2241r1212b2299],
3	of	IN	O	of	_	0	SENT_35	[p2l1236t2240r1310b2299],
4	pharmacogenomic	JJ	O	pharmacogenomic	amod	5	SENT_35	[p2l1322t2240r1591b2315, p2l11t2336r360b2410],
5	biomarkers	NNS	O	biomarker	prep_of	2	SENT_35	[p2l411t2335r773b2394],
6	reveals	VBZ	O	reveal	_	0	SENT_35	[p2l826t2335r1043b2394],
7	only	RB	O	only	advmod	10	SENT_35	[p2l1096t2335r1234b2410],
8	a	DT	O	a	det	10	SENT_35	[p2l1280t2355r1313b2393],
9	limited	JJ	O	limited	amod	10	SENT_35	[p2l1362t2335r1592b2394],
10	number	NN	O	number	dobj	6	SENT_35	[p2l10t2430r262b2489],
11	of	IN	O	of	_	0	SENT_35	[p2l287t2430r361b2489],
12	potentially	RB	O	potentially	advmod	13	SENT_35	[p2l373t2430r721b2505],
13	useful	JJ	O	useful	amod	29	SENT_35	[p2l744t2430r941b2489],
14	examples	NNS	O	example	nsubj	15	SENT_35	[p2l968t2430r1264b2505],
15	(	VBP	O	(	ccomp	13	SENT_35	[p2l1296t2430r1489b2498],
16	Table	NNP	O	Table	nsubj	18	SENT_35	[p2l1296t2430r1489b2498],
17	1	CD	NUMBER	1	number	18	SENT_35	[p2l1518t2435r1588b2501],
18	)	CD	NUMBER	)	xcomp	15	SENT_35	[p2l1518t2435r1588b2501],
19	,	,	O	,	_	0	SENT_35	[p2l1518t2435r1588b2501],
20	with	IN	O	with	_	0	SENT_35	[p2l7t2525r150b2584],
21	the	DT	O	the	det	23	SENT_35	[p2l178t2525r276b2584],
22	highest	JJS	O	highest	amod	23	SENT_35	[p2l304t2525r539b2600],
23	specificity	NN	O	specificity	prep_with	18	SENT_35	[p2l565t2525r885b2600],
24	seen	VBN	O	see	partmod	23	SENT_35	[p2l911t2544r1049b2584],
25	among	IN	O	among	_	0	SENT_35	[p2l1077t2544r1297b2600],
26	the	DT	O	the	det	27	SENT_35	[p2l1324t2525r1421b2584],
27	HLA	NN	O	hlum	prep_among	24	SENT_35	[p2l1449t2531r1594b2583],
28	allelic	JJ	O	allelic	amod	29	SENT_35	[p2l10t2620r203b2679],
29	variants	NNS	O	variant	prep_of	10	SENT_35	[p2l242t2621r523b2679],
30	.	.	O	.	_	0	SENT_35	[p2l242t2621r523b2679],

1	Thus	RB	O	thus	advmod	6	SENT_36	[p2l567t2620r746b2691],
2	,	,	O	,	_	0	SENT_36	[p2l567t2620r746b2691],
3	many	JJ	O	many	amod	5	SENT_36	[p2l793t2639r973b2695],
4	more	JJR	O	more	amod	5	SENT_36	[p2l1012t2639r1178b2679],
5	biomarkers	NNS	O	biomarker	nsubj	6	SENT_36	[p2l1221t2620r1591b2679],
6	remain	VBP	O	remain	_	0	SENT_36	[p2l10t2716r242b2774],
7	to	TO	O	to	aux	9	SENT_36	[p2l286t2727r347b2774],
8	be	VB	O	be	auxpass	9	SENT_36	[p2l392t2715r465b2774],
9	identified	VBN	O	identify	xcomp	6	SENT_36	[p2l508t2715r845b2774],
10	.	.	O	.	_	0	SENT_36	[p2l508t2715r845b2774],

1	Unfortunately	RB	O	unfortunately	advmod	13	SENT_37	[p2l892t2715r1365b2790],
2	,	,	O	,	_	0	SENT_37	[p2l892t2715r1365b2790],
3	much	RB	O	much	nsubjpass	13	SENT_37	[p2l1413t2715r1592b2774],
4	of	IN	O	of	_	0	SENT_37	[p2l11t2810r86b2869],
5	the	DT	O	the	det	7	SENT_37	[p2l114t2810r213b2869],
6	existing	VBG	O	exist	amod	7	SENT_37	[p2l254t2811r510b2885],
7	research	NN	O	research	prep_of	3	SENT_37	[p2l548t2810r818b2869],
8	in	IN	O	in	_	0	SENT_37	[p2l857t2811r919b2868],
9	this	DT	O	this	det	10	SENT_37	[p2l959t2810r1079b2868],
10	area	NN	O	area	prep_in	7	SENT_37	[p2l1120t2829r1254b2869],
11	has	VBZ	O	have	aux	13	SENT_37	[p2l1293t2810r1400b2868],
12	been	VBN	O	be	auxpass	13	SENT_37	[p2l1442t2810r1592b2869],
13	hampered	VBN	O	hamper	_	0	SENT_37	[p2l10t2905r327b2980],
14	by	IN	O	by	_	0	SENT_37	[p2l355t2905r427b2980],
15	limitations	NNS	O	limitation	agent	13	SENT_37	[p2l450t2905r794b2964],
16	in	IN	O	in	_	0	SENT_37	[p2l822t2906r884b2963],
17	study	NN	O	study	nn	18	SENT_37	[p2l912t2905r1080b2980],
18	design	NN	O	design	prep_in	15	SENT_37	[p2l1105t2905r1327b2980],
19	,	,	O	,	_	0	SENT_37	[p2l1105t2905r1327b2980],
20	such	JJ	O	such	_	0	SENT_37	[p2l1359t2905r1501b2964],
21	as	IN	O	as	_	0	SENT_37	[p2l1528t2925r1591b2963],
22	poorly	RB	O	poorly	advmod	23	SENT_37	[p2l9t3000r215b3075],
23	defined	VBN	O	define	prepc_such_as	15	SENT_37	[p2l242t3000r485b3059],
24	case	NN	O	case	nn	27	SENT_37	[p2l516t3020r650b3059],
25	and	CC	O	and	_	0	SENT_37	[p2l679t3000r797b3059],
26	control	NN	O	control	nn	27	SENT_37	[p2l827t3000r1056b3059],
27	groups	NNS	O	group	dobj	23	SENT_37	[p2l1085t3019r1324b3075],
28	,	,	O	,	_	0	SENT_37	[p2l1085t3019r1324b3075],
29	the	DT	O	the	det	30	SENT_37	[p2l1358t3000r1458b3059],
30	use	NN	O	use	dobj	23	SENT_37	[p2l1488t3020r1592b3059],
31	of	IN	O	of	_	0	SENT_37	[p2l11t3095r85b3154],
32	retrospective	NN	O	retrospective	nn	36	SENT_37	[p2l113t3096r525b3170],
33	and	CC	O	and	_	0	SENT_37	[p2l567t3095r685b3154],
34	nonblind	JJ	O	nonblind	conj_and	32	SENT_37	[p2l726t3095r1018b3154],
35	study	NN	O	study	nn	36	SENT_37	[p2l1061t3095r1232b3170],
36	protocols	NNS	O	protocol	prep_of	30	SENT_37	[p2l1270t3095r1588b3170],
37	,	,	O	,	_	0	SENT_37	[p2l1270t3095r1588b3170],
38	and	CC	O	and	_	0	SENT_37	[p2l10t3190r129b3249],
39	nonoptimal	JJ	O	nonoptimal	amod	40	SENT_37	[p2l167t3190r551b3265],
40	selection	NN	O	selection	dobj	23	SENT_37	[p2l590t3190r879b3249],
41	of	IN	O	of	_	0	SENT_37	[p2l918t3190r993b3249],
42	gene	NN	O	gene	nn	43	SENT_37	[p2l1018t3209r1168b3265],
43	variants	NNS	O	variant	prep_of	40	SENT_37	[p2l1203t3191r1484b3249],
44	.	.	O	.	_	0	SENT_37	[p2l1203t3191r1484b3249],

1	In	IN	O	in	dep	5	SENT_38	[p2l1526t3196r1593b3248],
2	addition	NN	O	addition	pobj	1	SENT_38	[p2l10t3285r293b3356],
3	,	,	O	,	_	0	SENT_38	[p2l10t3285r293b3356],
4	polygenic	JJ	O	polygenic	amod	5	SENT_38	[p2l329t3285r636b3360],
5	influences	NNS	O	influence	_	0	SENT_38	[p2l669t3285r1002b3344],
6	on	IN	O	on	_	0	SENT_38	[p2l1038t3304r1117b3344],
7	many	JJ	O	many	amod	10	SENT_38	[p2l1150t3304r1328b3360],
8	adverse	JJ	O	adverse	amod	10	SENT_38	[p2l1357t3285r1592b3344],
9	drug	NN	O	drug	nn	10	SENT_38	[p2l11t3380r163b3455],
10	reactions	NNS	O	reaction	prep_on	5	SENT_38	[p2l186t3381r495b3451],
11	,	,	O	,	_	0	SENT_38	[p2l186t3381r495b3451],
12	instances	NNS	O	instance	appos	5	SENT_38	[p2l524t3381r825b3439],
13	of	IN	O	of	_	0	SENT_38	[p2l852t3380r927b3439],
14	treatment	NN	O	treatment	prep_of	12	SENT_38	[p2l939t3392r1255b3439],
15	with	IN	O	with	_	0	SENT_38	[p2l1273t3380r1419b3439],
16	multiple	JJ	O	multiple	amod	17	SENT_38	[p2l1444t3380r1591b3439, p2l10t3475r149b3550],
17	drugs	NNS	O	drug	prep_with	14	SENT_38	[p2l176t3475r376b3550],
18	,	,	O	,	_	0	SENT_38	[p2l176t3475r376b3550],
19	and	CC	O	and	_	0	SENT_38	[p2l406t3475r524b3534],
20	variation	NN	O	variation	conj_and	12	SENT_38	[p2l547t3476r832b3534],
21	in	IN	O	in	_	0	SENT_38	[p2l858t3476r921b3533],
22	the	DT	O	the	det	23	SENT_38	[p2l947t3475r1046b3534],
23	severity	NN	O	severity	prep_in	20	SENT_38	[p2l1074t3476r1317b3550],
24	of	IN	O	of	_	0	SENT_38	[p2l1340t3475r1415b3534],
25	cliniTable	JJ	O	clinitable	prep_of	23	SENT_38	[p2l1428t3475r1591b3533, p3l59t98r200b146],

1	1	LS	NUMBER	1	_	0	SENT_39	[p3l220t103r262b146],
2	.	.	O	.	_	0	SENT_39	[p3l220t103r262b146],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_40	[p3l285t98r781b161],
2	Biomarkers	NNS	O	biomarker	_	0	SENT_40	[p3l801t98r1101b146],
3	as	IN	O	as	_	0	SENT_40	[p3l1120t114r1175b146],
4	Predictors	NNS	O	predictor	prep_as	2	SENT_40	[p3l1198t98r1465b146],
5	of	IN	O	of	_	0	SENT_40	[p3l1484t97r1544b146],
6	Adverse	JJ	O	adverse	amod	8	SENT_40	[p3l1549t98r1764b146],
7	Drug	NN	O	drug	nn	8	SENT_40	[p3l1784t103r1916b161],
8	Reactions	NNS	O	reaction	prep_of	2	SENT_40	[p3l64t179r337b226],
9	.	.	O	.	_	0	SENT_40	[p3l64t179r337b226],

1	Percent	NN	O	percent	_	0	SENT_41	[p3l1624t309r1818b353],
2	of	IN	O	of	_	0	SENT_41	[p3l1836t305r1896b353],
3	Patients	NNS	O	patient	nn	4	SENT_41	[p3l1908t306r2116b353],
4	Speciﬁcity	NN	O	speciﬁcity	prep_of	1	SENT_41	[p3l1219t377r1497b440],
5	with	IN	O	with	_	0	SENT_41	[p3l1656t377r1767b425],
6	an	DT	O	a	det	8	SENT_41	[p3l1789t393r1848b425],
7	Adverse	JJ	O	adverse	amod	8	SENT_41	[p3l1868t377r2079b425],
8	Gene	NN	O	gene	prep_with	4	SENT_41	[p3l60t453r200b497],
9	or	CC	O	or	_	0	SENT_41	[p3l220t465r275b497],
10	Allele	NNP	O	Allele	nn	12	SENT_41	[p3l292t450r439b497],
11	Relevant	NNP	O	Relevant	nn	12	SENT_41	[p3l669t450r895b497],
12	Drug	NNP	O	Drug	prep_of	1	SENT_41	[p3l917t454r1049b512],
13	of	IN	O	of	_	0	SENT_41	[p3l1185t449r1245b497],
14	Biomarker	NNP	O	Biomarker	nn	15	SENT_41	[p3l1258t450r1532b497],
15	Reaction	NNP	O	Reaction	prep_of	12	SENT_41	[p3l1631t451r1853b497],
16	to	TO	O	to	_	0	SENT_41	[p3l1873t457r1924b497],
17	Drug	NNP	O	Drug	prep_to	15	SENT_41	[p3l1947t452r2109b512],
18	‘’	CD	NUMBER	‘’	number	19	SENT_41	[p3l1947t452r2109b512],
19	‘	CD	NUMBER	‘	num	28	SENT_41	[p3l1947t452r2109b512],
20	TPMT	NN	O	tpmt	nn	28	SENT_41	[p3l63t565r224b608],
21	(	NN	O	(	nn	28	SENT_41	[p3l243t564r468b624],
22	mutant	JJ	O	mutant	amod	24	SENT_41	[p3l243t564r468b624],
23	)	NN	O	)	nn	24	SENT_41	[p3l243t564r468b624],
24	6-Mercaptopurines	NNS	O	6-mercaptopurine	dep	28	SENT_41	[p3l607t564r1096b623],
25	Very	RB	O	very	dep	24	SENT_41	[p3l1157t565r1271b623],
26	good	JJ	O	good	amod	28	SENT_41	[p3l1292t560r1420b624],
27	1-10	CD	NUMBER	1-10	num	28	SENT_41	[p3l1820t563r1941b609],
28	UGT1A1	NN	O	ugt1a1	dep	1	SENT_41	[p3l64t675r379b720],
29	*	CD	NUMBER	*	number	30	SENT_41	[p3l64t675r379b720],
30	28	CD	NUMBER	28	num	31	SENT_41	[p3l64t675r379b720],
31	lrinotecan	NN	O	lrinotecan	npadvmod	32	SENT_41	[p3l610t676r868b720],
32	Good	JJ	O	good	amod	28	SENT_41	[p3l1160t672r1300b720],
33	30-40	CD	NUMBER	30-40	dep	28	SENT_41	[p3l1785t675r1941b720],

1	C	NN	O	c	nn	2	SENT_42	[p3l63t786r100b831],
2	YPZC	NN	O	ypzc	_	0	SENT_42	[p3l104t786r242b831],
3	9	CD	NUMBER	9	dep	2	SENT_42	[p3l246t787r273b831],
4	and	CC	O	and	prep	3	SENT_42	[p3l289t783r381b831],
5	Warfarin	NNP	O	Warfarin	dep	4	SENT_42	[p3l604t782r866b845],
6	'	POS	O	'	_	0	SENT_42	[p3l604t782r866b845],
7	i	FW	O	i	dep	5	SENT_42	[p3l604t782r866b845],
8	'	''	O	'	_	0	SENT_42	[p3l604t782r866b845],
9	Good	JJ	O	good	amod	10	SENT_42	[p3l1160t782r1300b831],
10	5-40	NN	O	5-40	dep	3	SENT_42	[p3l1817t785r1941b831],

1	VKORC1	NN	O	vkorc1	_	0	SENT_43	[p3l160t858r381b903],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_44	[p3l63t978r278b1022],
2	(	CD	NUMBER	(	num	4	SENT_44	[p3l301t978r526b1037],
3	mutant	JJ	O	mutant	amod	4	SENT_44	[p3l301t978r526b1037],
4	)	NN	O	)	dep	1	SENT_44	[p3l301t978r526b1037],
5	Tricyclic	JJ	MISC	tricyclic	amod	6	SENT_44	[p3l604t973r817b1037],
6	anti-	JJ	O	anti-	amod	9	SENT_44	[p3l836t978r950b1021],
7	Relatively	RB	O	relatively	advmod	8	SENT_44	[p3l1163t973r1405b1037],
8	good	JJ	O	good	amod	9	SENT_44	[p3l1424t973r1551b1037],
9	5-7	NN	O	5-7	dep	4	SENT_44	[p3l1817t978r1908b1021],

1	depressants	NNS	O	depressant	_	0	SENT_45	[p3l702t1045r1019b1108],

1	H	NN	O	h	nn	2	SENT_46	[p3l65t1161r101b1204],
2	LA-B	NN	O	la-b	dep	13	SENT_46	[p3l115t1159r292b1204],
3	*	CD	NUMBER	*	dep	2	SENT_46	[p3l115t1159r292b1204],
4	5	CD	NUMBER	5	number	5	SENT_46	[p3l115t1159r292b1204],
5	701	CD	NUMBER	701	num	9	SENT_46	[p3l303t1159r389b1204],
6	Abacavir	NNP	O	Abacavir	nn	9	SENT_46	[p3l604t1156r831b1204],
7	Very	RB	O	very	advmod	8	SENT_46	[p3l1157t1161r1271b1219],
8	good	JJ	O	good	amod	9	SENT_46	[p3l1292t1156r1420b1220],
9	5-8	NN	O	5-8	dep	3	SENT_46	[p3l1817t1159r1907b1205],
10	H	NN	O	h	nn	11	SENT_46	[p3l65t1272r101b1315],
11	LA-B	NN	O	la-b	dep	13	SENT_46	[p3l115t1270r391b1316],
12	*	CD	NUMBER	*	num	13	SENT_46	[p3l115t1270r391b1316],
13	1502	CD	DATE	1502	dep	18	SENT_46	[p3l115t1270r391b1316],
14	Carbamazepine	NNP	O	Carbamazepine	dep	13	SENT_46	[p3l607t1267r1017b1330],
15	Very	RB	O	very	rcmod	14	SENT_46	[p3l1157t1272r1271b1330],
16	good	JJ	O	good	dep	15	SENT_46	[p3l1292t1267r1420b1331],
17	10	CD	NUMBER	10	num	18	SENT_46	[p3l1842t1270r1899b1316],
18	HLA-DRB1	NN	O	hla-drb1	dep	23	SENT_46	[p3l65t1381r443b1426],
19	*	CD	NUMBER	*	number	20	SENT_46	[p3l65t1381r443b1426],
20	07	CD	NUMBER	07	dep	18	SENT_46	[p3l65t1381r443b1426],
21	Ximelagatran	NNP	O	Ximelagatran	nn	22	SENT_46	[p3l604t1378r952b1442],
22	Good	NNP	O	Good	dep	20	SENT_46	[p3l1160t1378r1300b1426],
23	5-7	CD	NUMBER	5-7	_	0	SENT_46	[p3l1817t1383r1908b1426],

1	and	CC	O	and	dep	2	SENT_47	[p3l158t1450r250b1498],
2	DQA1	NN	O	dqa1	_	0	SENT_47	[p3l276t1453r528b1512],
3	*	CD	NUMBER	*	num	4	SENT_47	[p3l276t1453r528b1512],
4	02	NN	NUMBER	02	dep	2	SENT_47	[p3l276t1453r528b1512],

1	*	NN	O	*	nn	2	SENT_48	[p3l9t1618r38b1646],
2	Percentages	NNS	O	percentage	nsubj	3	SENT_48	[p3l62t1618r375b1677],
3	are	VBP	O	be	_	0	SENT_48	[p3l399t1630r476b1662],
4	of	IN	O	of	_	0	SENT_48	[p3l498t1613r555b1662],
5	affected	JJ	O	affected	amod	6	SENT_48	[p3l569t1613r770b1662],
6	whites	NNS	O	whites	prep_of	3	SENT_48	[p3l793t1613r961b1662],
7	except	IN	O	except	_	0	SENT_48	[p3l984t1623r1150b1676],
8	that	DT	O	that	prep_except	6	SENT_48	[p3l1170t1613r1272b1662],
9	for	IN	O	for	_	0	SENT_48	[p3l1292t1613r1365b1662],
10	HLA-B	NN	O	hla-b	prep_for	8	SENT_48	[p3l1389t1616r1729b1670],
11	"	''	O	"	punct	10	SENT_48	[p3l1389t1616r1729b1670],
12	'	''	O	'	_	0	SENT_48	[p3l1389t1616r1729b1670],
13	~	FW	O	~	nn	15	SENT_48	[p3l1389t1616r1729b1670],
14	‘	FW	O	‘	dep	15	SENT_48	[p3l1389t1616r1729b1670],
15	1502	CD	DATE	1502	advmod	3	SENT_48	[p3l1389t1616r1729b1670],
16	,	,	O	,	_	0	SENT_48	[p3l1389t1616r1729b1670],
17	which	WDT	O	which	nsubj	20	SENT_48	[p3l1752t1613r1902b1662],
18	is	VBZ	O	be	cop	20	SENT_48	[p3l1930t1618r1966b1662],
19	the	DT	O	the	det	20	SENT_48	[p3l1987t1613r2069b1662],
20	percentage	NN	O	percentage	ccomp	3	SENT_48	[p3l61t1695r347b1749],
21	of	IN	O	of	_	0	SENT_48	[p3l369t1685r426b1734],
22	affected	VBN	O	affect	amod	23	SENT_48	[p3l439t1685r641b1734],
23	Asians	NNPS	MISC	Asians	prep_of	20	SENT_48	[p3l664t1689r852b1734],
24	.	.	O	.	_	0	SENT_48	[p3l664t1689r852b1734],

1	1	CD	NUMBER	1	nn	4	SENT_49	[p3l11t1773r41b1832],
2	'	''	O	'	_	0	SENT_49	[p3l11t1773r41b1832],
3	Carriage	NN	O	carriage	nn	4	SENT_49	[p3l59t1773r275b1832],
4	ofthe	NN	O	ofthe	nsubj	9	SENT_49	[p3l297t1768r447b1817],
5	CYPZC9	NN	O	cypzc9	nn	8	SENT_49	[p3l471t1773r681b1817],
6	and	CC	O	and	_	0	SENT_49	[p3l700t1769r792b1817],
7	VKORC1	NN	O	vkorc1	conj_and	5	SENT_49	[p3l820t1773r1040b1817],
8	alleles	NNS	O	allele	nsubj	9	SENT_49	[p3l1067t1769r1225b1817],
9	affects	VBZ	O	affect	_	0	SENT_49	[p3l1250t1768r1416b1817],
10	warfarin	NN	O	warfarin	nn	11	SENT_49	[p3l1438t1768r1648b1817],
11	dosing	NN	O	dosing	dobj	9	SENT_49	[p3l1674t1769r1864b1832],
12	.	.	O	.	_	0	SENT_49	[p3l1674t1769r1864b1832],

1	N	NN	O	n	nn	3	SENT_50	[p3l516t1961r530b1976],
2	ENGLJ	NN	O	englj	nn	3	SENT_50	[p3l544t1961r622b1983],
3	MED	NN	O	med	_	0	SENT_50	[p3l637t1961r689b1976],
4	358	CD	NUMBER	358	num	6	SENT_50	[p3l699t1955r762b1983],
5	;	:	O	;	_	0	SENT_50	[p3l699t1955r762b1983],
6	6	CD	NUMBER	6	dep	3	SENT_50	[p3l699t1955r762b1983],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_50	[p3l796t1961r997b1983],
8	FEBRUARY	NNP	DATE	FEBRUARY	dep	6	SENT_50	[p3l1034t1961r1155b1977],
9	7	CD	DATE	7	num	8	SENT_50	[p3l1165t1961r1184b1982],
10	,	,	DATE	,	_	0	SENT_50	[p3l1165t1961r1184b1982],
11	2008	CD	DATE	2008	num	8	SENT_50	[p3l1195t1955r1258b1977],
12	637	CD	NUMBER	637	dep	3	SENT_50	[p3l1959t1950r2016b1974],

1	The	DT	O	the	det	4	SENT_51	[p3l702t1994r753b2018],
2	New	NNP	O	New	nn	4	SENT_51	[p3l762t1995r824b2018],
3	England	NNP	O	England	nn	4	SENT_51	[p3l833t1994r944b2025],
4	Journal	NNP	O	Journal	_	0	SENT_51	[p3l952t1994r1050b2018],
5	of	IN	O	of	_	0	SENT_51	[p3l1059t1994r1088b2018],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_51	[p3l1095t1994r1220b2018],

1	The	DT	O	the	det	3	SENT_52	[p3l672t2182r717b2203],
2	NEW	NNP	O	NEW	nn	3	SENT_52	[p3l736t2184r821b2203],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_52	[p3l840t2184r1029b2203],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_52	[p3l1048t2184r1228b2210],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_52	[p3l1247t2182r1487b2209],

1	cally	RB	O	cally	advmod	2	SENT_53	[p3l12t2404r211b2505],
2	observed	VBN	O	observe	amod	3	SENT_53	[p3l263t2404r644b2483],
3	reactions	NNS	O	reaction	nsubj	4	SENT_53	[p3l700t2405r1090b2483],
4	make	VBP	O	make	_	0	SENT_53	[p3l1148t2404r1381b2484],
5	gene	NN	O	gene	nn	6	SENT_53	[p3l1437t2430r1636b2505],
6	identification	NN	O	identification	nsubj	7	SENT_53	[p3l1691t2404r2133b2483, p3l12t2533r182b2611],
7	difficult	JJ	O	difficult	xcomp	4	SENT_53	[p3l219t2532r594b2611],
8	.	.	O	.	_	0	SENT_53	[p3l219t2532r594b2611],

1	As	IN	O	as	_	0	SENT_54	[p3l632t2540r738b2611],
2	a	DT	O	a	det	3	SENT_54	[p3l776t2559r820b2611],
3	result	NN	O	result	prep_as	24	SENT_54	[p3l854t2532r1119b2628],
4	,	,	O	,	_	0	SENT_54	[p3l854t2532r1119b2628],
5	only	RB	O	only	advmod	8	SENT_54	[p3l1161t2532r1345b2633],
6	a	DT	O	a	det	8	SENT_54	[p3l1377t2559r1421b2611],
7	limited	JJ	O	limited	amod	8	SENT_54	[p3l1454t2532r1763b2611],
8	number	NN	O	number	nsubjpass	24	SENT_54	[p3l1799t2532r2137b2611],
9	of	IN	O	of	_	0	SENT_54	[p3l12t2660r113b2739],
10	reports	NNS	O	report	prep_of	8	SENT_54	[p3l137t2677r444b2761],
11	of	IN	O	of	_	0	SENT_54	[p3l490t2660r590b2739],
12	a	DT	O	a	det	14	SENT_54	[p3l614t2687r659b2739],
13	positive	JJ	O	positive	amod	14	SENT_54	[p3l699t2661r1030b2761],
14	association	NN	O	association	prep_of	10	SENT_54	[p3l1074t2661r1558b2739],
15	between	IN	O	between	_	0	SENT_54	[p3l1601t2660r1959b2739],
16	genetic	JJ	O	genetic	amod	17	SENT_54	[p3l2002t2687r2133b2761, p3l12t2789r219b2867],
17	characteristics	NNS	O	characteristic	prep_between	14	SENT_54	[p3l265t2788r886b2867],
18	and	CC	O	and	_	0	SENT_54	[p3l933t2788r1091b2867],
19	adverse	JJ	O	adverse	amod	21	SENT_54	[p3l1134t2788r1449b2867],
20	drug	NN	O	drug	nn	21	SENT_54	[p3l1495t2788r1700b2889],
21	reactions	NNS	O	reaction	prep_between	14	SENT_54	[p3l1742t2789r2132b2867],
22	have	VBP	O	have	aux	24	SENT_54	[p3l12t2916r198b2995],
23	been	VBN	O	be	auxpass	24	SENT_54	[p3l236t2916r434b2995],
24	reproduced	VBN	O	reproduce	_	0	SENT_54	[p3l471t2916r1011b3017],
25	.4	CD	NUMBER	.4	dobj	24	SENT_54	[p3l471t2916r1011b3017],
26	There	EX	O	there	expl	27	SENT_54	[p3l1044t2916r1284b2995],
27	is	VBZ	O	be	rcmod	25	SENT_54	[p3l1321t2917r1386b2995],
28	therefore	RB	O	therefore	advmod	27	SENT_54	[p3l1425t2916r1806b2995],
29	a	DT	O	a	det	31	SENT_54	[p3l1842t2943r1887b2995],
30	great	JJ	O	great	amod	31	SENT_54	[p3l1922t2933r2139b3017],
31	need	NN	O	need	nsubj	27	SENT_54	[p3l12t3044r213b3123],
32	for	IN	O	for	_	0	SENT_54	[p3l258t3044r382b3123],
33	large	JJ	O	large	prep_for	31	SENT_54	[p3l423t3044r661b3145],
34	,	,	O	,	_	0	SENT_54	[p3l423t3044r661b3145],
35	randomized	VBN	O	randomize	partmod	33	SENT_54	[p3l711t3044r1256b3140],
36	,	,	O	,	_	0	SENT_54	[p3l711t3044r1256b3140],
37	double	JJ	O	double	amod	44	SENT_54	[p3l1307t3044r1878b3140],
38	—	RB	O	—	advmod	39	SENT_54	[p3l1307t3044r1878b3140],
39	blind	JJ	O	blind	amod	44	SENT_54	[p3l1307t3044r1878b3140],
40	,	,	O	,	_	0	SENT_54	[p3l1307t3044r1878b3140],
41	wellcontrolled	JJ	O	wellcontrolled	dep	39	SENT_54	[p3l1925t3044r2132b3124, p3l12t3172r484b3268],
42	,	,	O	,	_	0	SENT_54	[p3l1925t3044r2132b3124, p3l12t3172r484b3268],
43	prospective	JJ	O	prospective	amod	44	SENT_54	[p3l547t3173r1047b3273],
44	studies	NNS	O	study	nsubj	52	SENT_54	[p3l1107t3172r1414b3251],
45	in	IN	O	in	_	0	SENT_54	[p3l1474t3173r1559b3250],
46	the	DT	O	the	det	47	SENT_54	[p3l1618t3172r1752b3251],
47	area	NN	O	area	prep_in	44	SENT_54	[p3l1810t3198r1994b3251],
48	of	IN	O	of	_	0	SENT_54	[p3l2051t3172r2152b3251],
49	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	47	SENT_54	[p3l11t3300r879b3401],
50	to	TO	O	to	aux	52	SENT_54	[p3l932t3317r1014b3379],
51	clearly	RB	O	clearly	advmod	52	SENT_54	[p3l1067t3300r1352b3401],
52	demonstrate	VB	O	demonstrate	xcomp	35	SENT_54	[p3l1399t3300r1947b3379],
53	the	DT	O	the	det	54	SENT_54	[p3l1999t3300r2134b3379],
54	Value	NN	O	value	dobj	52	SENT_54	[p3l7t3428r229b3507],
55	of	IN	O	of	_	0	SENT_54	[p3l270t3428r370b3507],
56	prospective	JJ	O	prospective	amod	57	SENT_54	[p3l389t3429r878b3529],
57	genotyping	NN	O	genotyping	prep_of	54	SENT_54	[p3l917t3429r1408b3529],
58	in	IN	O	in	_	0	SENT_54	[p3l1444t3429r1527b3506],
59	clinical	JJ	O	clinical	amod	60	SENT_54	[p3l1567t3428r1880b3507],
60	practice	NN	O	practice	prep_in	57	SENT_54	[p3l1918t3454r2133b3529, p3l12t3557r185b3635],
61	.	.	O	.	_	0	SENT_54	[p3l1918t3454r2133b3529, p3l12t3557r185b3635],

1	There	EX	O	there	expl	2	SENT_55	[p3l221t3556r466b3635],
2	are	VBP	O	be	_	0	SENT_55	[p3l500t3583r652b3652],
3	,	,	O	,	_	0	SENT_55	[p3l500t3583r652b3652],
4	however	RB	O	however	advmod	2	SENT_55	[p3l692t3556r1066b3652],
5	,	,	O	,	_	0	SENT_55	[p3l692t3556r1066b3652],
6	considerable	JJ	O	considerable	amod	7	SENT_55	[p3l1107t3556r1644b3635],
7	challenges	NNS	O	challenge	nsubj	2	SENT_55	[p3l1680t3556r2132b3657],
8	in	IN	O	in	_	0	SENT_55	[p3l11t3685r95b3762],
9	designing	VBG	O	design	prepc_in	7	SENT_55	[p3l133t3684r561b3785],
10	and	CC	O	and	_	0	SENT_55	[p3l595t3684r752b3763],
11	financing	VBG	O	finance	prepc_in	7	SENT_55	[p3l790t3684r1212b3785],
12	such	JJ	O	such	amod	13	SENT_55	[p3l1248t3684r1441b3763],
13	studies	NNS	O	study	dobj	9	SENT_55	[p3l1481t3684r1805b3763],
14	.	.	O	.	_	0	SENT_55	[p3l1481t3684r1805b3763],

1	Abacavir	NNP	O	Abacavir	nsubjpass	27	SENT_56	[p4l137t21r541b117],
2	,	,	O	,	_	0	SENT_56	[p4l137t21r541b117],
3	a	DT	O	a	det	8	SENT_56	[p4l602t48r646b100],
4	guanosine	NN	O	guanosine	nn	8	SENT_56	[p4l701t22r1156b122],
5	reVerse	NN	O	reverse	nn	8	SENT_56	[p4l1213t22r2134b122],
6	—	CD	NUMBER	—	num	8	SENT_56	[p4l1213t22r2134b122],
7	transcriptase	NN	O	transcriptase	nn	8	SENT_56	[p4l1213t22r2134b122],
8	inhibitor	NN	O	inhibitor	appos	1	SENT_56	[p4l11t149r390b228],
9	and	CC	O	and	_	0	SENT_56	[p4l443t149r599b228],
10	an	DT	O	a	det	13	SENT_56	[p4l656t175r758b228],
11	important	JJ	O	important	amod	13	SENT_56	[p4l814t150r1247b250],
12	antiretroviral	JJ	O	antiretroviral	amod	13	SENT_56	[p4l1298t149r1858b229],
13	treatment	NN	O	treatment	appos	1	SENT_56	[p4l1915t166r2133b228, p4l12t294r229b356],
14	against	IN	O	against	_	0	SENT_56	[p4l259t278r568b378],
15	infection	NN	O	infection	prep_against	13	SENT_56	[p4l598t277r976b356],
16	with	IN	O	with	_	0	SENT_56	[p4l1008t277r1199b357],
17	the	DT	O	the	det	20	SENT_56	[p4l1235t277r1365b356],
18	human	JJ	O	human	amod	20	SENT_56	[p4l1401t277r1701b356],
19	immunodeficiency	NN	O	immunodeficiency	nn	20	SENT_56	[p4l1735t278r2133b356, p4l12t405r458b506],
20	virus	NN	O	virus	prep_with	15	SENT_56	[p4l484t406r701b484],
21	(	CD	NUMBER	(	num	23	SENT_56	[p4l743t412r1007b501],
22	HIV	NN	MISC	hiv	nn	23	SENT_56	[p4l743t412r1007b501],
23	)	NN	O	)	dep	13	SENT_56	[p4l743t412r1007b501],
24	,	,	O	,	_	0	SENT_56	[p4l743t412r1007b501],
25	has	VBZ	O	have	aux	27	SENT_56	[p4l1048t405r1194b484],
26	been	VBN	O	be	auxpass	27	SENT_56	[p4l1232t405r1437b484],
27	used	VBN	O	use	_	0	SENT_56	[p4l1472t405r1672b484],
28	by	IN	O	by	_	0	SENT_56	[p4l1708t405r1806b506],
29	almost	RB	O	almost	quantmod	31	SENT_56	[p4l1836t405r2139b484],
30	1	CD	NUMBER	1	number	31	SENT_56	[p4l15t539r59b611],
31	million	CD	NUMBER	million	num	32	SENT_56	[p4l102t533r417b612],
32	patients	NNS	O	patient	agent	27	SENT_56	[p4l457t534r798b634],
33	infected	VBN	O	infect	partmod	32	SENT_56	[p4l840t533r1188b612],
34	with	IN	O	with	_	0	SENT_56	[p4l1224t533r1420b613],
35	HIV	NN	MISC	hiv	prep_with	33	SENT_56	[p4l1460t541r1635b612],
36	during	IN	O	during	_	0	SENT_56	[p4l1673t533r1963b634],
37	the	DT	DATE	the	det	39	SENT_56	[p4l2001t533r2133b612],
38	past	JJ	DATE	past	amod	39	SENT_56	[p4l11t678r185b762],
39	decade	NN	DATE	decade	prep_during	33	SENT_56	[p4l214t661r551b740],
40	.5	CD	NUMBER	.5	nsubj	55	SENT_56	[p4l214t661r551b740],
41	In	IN	O	in	_	0	SENT_56	[p4l587t669r674b739],
42	white	JJ	O	white	amod	43	SENT_56	[p4l703t661r933b741],
43	populations	NNS	O	population	prep_in	40	SENT_56	[p4l966t661r1480b762],
44	,	,	O	,	_	0	SENT_56	[p4l966t661r1480b762],
45	between	IN	O	between	quantmod	49	SENT_56	[p4l1521t661r1866b740],
46	5	CD	NUMBER	5	number	49	SENT_56	[p4l1902t669r1944b740],
47	and	CC	O	and	_	0	SENT_56	[p4l1981t661r2134b740],
48	8	CD	PERCENT	8	appos	43	SENT_56	[p4l12t794r146b868],
49	%	NN	PERCENT	%	appos	43	SENT_56	[p4l12t794r146b868],
50	of	IN	O	of	_	0	SENT_56	[p4l185t789r285b868],
51	patients	NNS	O	patient	prep_of	49	SENT_56	[p4l305t790r646b890],
52	receiving	VBG	O	receive	partmod	51	SENT_56	[p4l687t790r1078b890],
53	abacavir	NN	O	abacavir	dobj	52	SENT_56	[p4l1113t789r1469b869],
54	will	MD	O	will	aux	55	SENT_56	[p4l1501t789r1665b869],
55	have	VB	O	have	rcmod	39	SENT_56	[p4l1703t789r1893b868],
56	a	DT	O	a	det	59	SENT_56	[p4l1932t816r1976b868],
57	serious	JJ	O	serious	amod	59	SENT_56	[p4l2015t816r2133b868, p4l12t918r229b996],
58	hypersensitivity	NN	O	hypersensitivity	nn	59	SENT_56	[p4l273t917r970b1018],
59	reaction	NN	O	reaction	dobj	55	SENT_56	[p4l1006t918r1363b996],
60	characterized	VBN	O	characterize	partmod	59	SENT_56	[p4l1404t917r1999b996],
61	by	IN	O	by	_	0	SENT_56	[p4l2040t917r2138b1018],
62	fever	NN	O	fever	agent	60	SENT_56	[p4l12t1045r230b1141],
63	,	,	O	,	_	0	SENT_56	[p4l12t1045r230b1141],
64	rash	NN	O	rash	agent	60	SENT_56	[p4l273t1045r474b1141],
65	,	,	O	,	_	0	SENT_56	[p4l273t1045r474b1141],
66	and	CC	O	and	_	0	SENT_56	[p4l515t1045r671b1124],
67	symptoms	NNS	O	symptom	agent	60	SENT_56	[p4l709t1062r1144b1146],
68	in	IN	O	in	_	0	SENT_56	[p4l1182t1046r1264b1123],
69	the	DT	O	the	det	71	SENT_56	[p4l1301t1045r1431b1124],
70	gastrointestinal	JJ	O	gastrointestinal	amod	71	SENT_56	[p4l1468t1045r2134b1146],
71	tract	NN	O	tract	prep_in	60	SENT_56	[p4l12t1190r230b1269],
72	,	,	O	,	_	0	SENT_56	[p4l12t1190r230b1269],
73	other	JJ	O	other	amod	75	SENT_56	[p4l275t1173r503b1252],
74	organ	NN	O	organ	nn	75	SENT_56	[p4l538t1199r787b1274],
75	systems	NNS	O	system	prep_in	60	SENT_56	[p4l827t1190r1185b1274],
76	,	,	O	,	_	0	SENT_56	[p4l827t1190r1185b1274],
77	or	CC	O	or	_	0	SENT_56	[p4l1230t1199r1318b1252],
78	both	DT	O	both	prep_in	60	SENT_56	[p4l1354t1173r1574b1252],
79	.	.	O	.	_	0	SENT_56	[p4l1354t1173r1574b1252],

1	In	IN	O	in	_	0	SENT_57	[p4l140t1309r229b1379],
2	2002	CD	DATE	2002	prep_in	7	SENT_57	[p4l265t1307r494b1397],
3	,	,	O	,	_	0	SENT_57	[p4l265t1307r494b1397],
4	a	DT	O	a	det	6	SENT_57	[p4l536t1328r580b1380],
5	major	JJ	O	major	amod	6	SENT_57	[p4l615t1302r865b1402],
6	discovery	NN	O	discovery	nsubj	7	SENT_57	[p4l900t1301r1303b1402],
7	was	VBD	O	be	_	0	SENT_57	[p4l1332t1328r1494b1381],
8	that	IN	O	that	complm	19	SENT_57	[p4l1534t1301r1706b1380],
9	the	DT	O	the	det	10	SENT_57	[p4l1738t1301r1871b1380],
10	HLA	NN	O	hlum	nsubjpass	19	SENT_57	[p4l1907t1309r2133b1379],
11	—	NN	O	—	nn	12	SENT_57	[p4l1907t1309r2133b1379],
12	B	NN	O	b	dep	10	SENT_57	[p4l11t1429r314b1508],
13	*	CD	NUMBER	*	number	14	SENT_57	[p4l11t1429r314b1508],
14	5701	CD	NUMBER	5701	dep	10	SENT_57	[p4l11t1429r314b1508],
15	gene	NN	O	gene	nn	16	SENT_57	[p4l351t1455r547b1530],
16	variant	NN	O	variant	dep	14	SENT_57	[p4l580t1430r877b1508],
17	is	VBZ	O	be	auxpass	19	SENT_57	[p4l908t1430r973b1508],
18	highly	RB	O	highly	advmod	19	SENT_57	[p4l1012t1429r1279b1530],
19	associated	VBN	O	associate	ccomp	7	SENT_57	[p4l1311t1429r1746b1508],
20	with	IN	O	with	_	0	SENT_57	[p4l1778t1429r1970b1508],
21	hypersensitivity	NN	O	hypersensitivity	nn	22	SENT_57	[p4l2007t1429r2133b1530, p4l11t1558r575b1658],
22	reactions	NNS	O	reaction	prep_with	19	SENT_57	[p4l612t1558r994b1636],
23	to	TO	O	to	aux	24	SENT_57	[p4l1039t1574r1119b1636],
24	abacavir	VB	O	abacavir	xcomp	19	SENT_57	[p4l1162t1557r1624b1636],
25	.6	CD	NUMBER	.6	number	26	SENT_57	[p4l1162t1557r1624b1636],
26	’	CD	NUMBER	’	num	27	SENT_57	[p4l1162t1557r1624b1636],
27	7	CD	NUMBER	7	dobj	24	SENT_57	[p4l1162t1557r1624b1636],
28	The	DT	O	the	det	29	SENT_57	[p4l1663t1557r1822b1636],
29	identification	NN	O	identification	tmod	24	SENT_57	[p4l1863t1557r2133b1636, p4l12t1685r337b1764],
30	of	IN	O	of	_	0	SENT_57	[p4l386t1685r484b1764],
31	the	DT	O	the	det	32	SENT_57	[p4l517t1685r650b1764],
32	HLA	NN	O	hlum	prep_of	29	SENT_57	[p4l700t1685r1238b1764],
33	.	.	O	.	_	0	SENT_57	[p4l700t1685r1238b1764],

1	—	NN	O	—	_	0	SENT_58	[p4l700t1685r1238b1764],
2	.	.	O	.	_	0	SENT_58	[p4l700t1685r1238b1764],

1	B	NN	O	b	nsubj	7	SENT_59	[p4l700t1685r1238b1764],
2	*	CD	NUMBER	*	num	1	SENT_59	[p4l700t1685r1238b1764],
3	5701	CD	NUMBER	5701	num	4	SENT_59	[p4l700t1685r1238b1764],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_59	[p4l1287t1685r1923b1786],
5	was	VBD	O	be	cop	7	SENT_59	[p4l1969t1712r2132b1764],
6	the	DT	O	the	det	7	SENT_59	[p4l12t1813r147b1892],
7	result	NN	O	result	_	0	SENT_59	[p4l198t1813r447b1892],
8	of	IN	O	of	_	0	SENT_59	[p4l492t1813r593b1892],
9	microcytotoxicity	NN	O	microcytotoxicity	nn	10	SENT_59	[p4l625t1814r1397b1914],
10	studies	NNS	O	study	prep_of	7	SENT_59	[p4l1444t1813r1750b1892],
11	and	CC	O	and	_	0	SENT_59	[p4l1802t1813r1961b1892],
12	sequence	NN	O	sequence	nn	13	SENT_59	[p4l2013t1840r2133b1892, p4l12t1967r300b2042],
13	analysis	NN	O	analysis	conj_and	7	SENT_59	[p4l336t1941r660b2042],
14	of	IN	O	of	_	0	SENT_59	[p4l699t1941r797b2020],
15	the	DT	O	the	det	16	SENT_59	[p4l815t1941r944b2020],
16	HLA	NN	O	hlum	prep_of	13	SENT_59	[p4l979t1949r1280b2037],
17	.	.	O	.	_	0	SENT_59	[p4l979t1949r1280b2037],

1	—	NN	O	—	_	0	SENT_60	[p4l979t1949r1280b2037],
2	.	.	O	.	_	0	SENT_60	[p4l979t1949r1280b2037],

1	A	DT	O	a	_	0	SENT_61	[p4l979t1949r1280b2037],
2	,	,	O	,	_	0	SENT_61	[p4l979t1949r1280b2037],
3	HLA	NN	O	hlum	appos	1	SENT_61	[p4l1321t1948r1619b2037],
4	.	.	O	.	_	0	SENT_61	[p4l1321t1948r1619b2037],

1	—	NN	O	—	_	0	SENT_62	[p4l1321t1948r1619b2037],
2	.	.	O	.	_	0	SENT_62	[p4l1321t1948r1619b2037],

1	B	NN	O	b	_	0	SENT_63	[p4l1321t1948r1619b2037],
2	,	,	O	,	_	0	SENT_63	[p4l1321t1948r1619b2037],
3	and	CC	O	and	_	0	SENT_63	[p4l1660t1941r1814b2020],
4	HLA	NN	O	hlum	conj_and	1	SENT_63	[p4l1849t1947r2132b2020],
5	.	.	O	.	_	0	SENT_63	[p4l1849t1947r2132b2020],

1	—	NN	O	—	_	0	SENT_64	[p4l1849t1947r2132b2020],
2	.	.	O	.	_	0	SENT_64	[p4l1849t1947r2132b2020],

1	C	NN	O	c	nn	2	SENT_65	[p4l1849t1947r2132b2020],
2	genes	NNS	O	gene	_	0	SENT_65	[p4l12t2095r278b2170],
3	.	.	O	.	_	0	SENT_65	[p4l12t2095r278b2170],

1	These	DT	O	these	det	2	SENT_66	[p4l328t2069r580b2148],
2	findings	NNS	O	finding	nsubj	3	SENT_66	[p4l628t2069r993b2170],
3	encouraged	VBD	O	encourage	_	0	SENT_66	[p4l1043t2069r1541b2170],
4	clinicians	NNS	O	clinician	dobj	3	SENT_66	[p4l1589t2069r2001b2148],
5	in	IN	O	in	_	0	SENT_66	[p4l2050t2070r2134b2147],
6	Australia	NNP	LOCATION	Australia	prep_in	3	SENT_66	[p4l8t2197r402b2276],
7	to	TO	O	to	aux	8	SENT_66	[p4l456t2214r537b2276],
8	carry	VB	O	carry	xcomp	3	SENT_66	[p4l594t2223r815b2298],
9	out	RP	O	out	prt	8	SENT_66	[p4l866t2214r1004b2276],
10	prospective	JJ	O	prospective	amod	11	SENT_66	[p4l1053t2198r1542b2298],
11	HLA	NN	O	hlum	dobj	8	SENT_66	[p4l1596t2197r2133b2276],
12	.	.	O	.	_	0	SENT_66	[p4l1596t2197r2133b2276],

1	—	NN	O	—	_	0	SENT_67	[p4l1596t2197r2133b2276],
2	.	.	O	.	_	0	SENT_67	[p4l1596t2197r2133b2276],

1	B	NN	O	b	_	0	SENT_68	[p4l1596t2197r2133b2276],
2	*	CD	NUMBER	*	number	3	SENT_68	[p4l1596t2197r2133b2276],
3	5701	CD	NUMBER	5701	num	4	SENT_68	[p4l1596t2197r2133b2276],
4	genotyping	NN	O	genotyping	dep	1	SENT_68	[p4l12t2326r513b2426],
5	between	IN	O	between	_	0	SENT_68	[p4l554t2325r918b2404],
6	2002	CD	DATE	2002	prep_between	4	SENT_68	[p4l962t2331r1169b2404],
7	and	CC	DATE	and	_	0	SENT_68	[p4l1214t2325r1374b2404],
8	2005	CD	DATE	2005	prep_between	4	SENT_68	[p4l1418t2331r1650b2421],
9	,	,	O	,	_	0	SENT_68	[p4l1418t2331r1650b2421],
10	which	WDT	O	which	nsubj	11	SENT_68	[p4l1696t2325r1963b2404],
11	led	VBD	O	lead	rcmod	1	SENT_68	[p4l2006t2325r2134b2404],
12	to	TO	O	to	_	0	SENT_68	[p4l12t2470r95b2532],
13	a	DT	O	a	det	15	SENT_68	[p4l141t2480r185b2532],
14	drastic	JJ	O	drastic	amod	15	SENT_68	[p4l229t2453r526b2532],
15	reduction	NN	O	reduction	prep_to	11	SENT_68	[p4l571t2453r989b2532],
16	in	IN	O	in	_	0	SENT_68	[p4l1033t2454r1118b2531],
17	the	DT	O	the	det	18	SENT_68	[p4l1163t2453r1298b2532],
18	number	NN	O	number	prep_in	11	SENT_68	[p4l1343t2453r1686b2532],
19	of	IN	O	of	_	0	SENT_68	[p4l1729t2453r1830b2532],
20	hypersensitivity	NN	O	hypersensitivity	nn	21	SENT_68	[p4l1857t2453r2133b2554, p4l13t2582r447b2682],
21	reactions	NNS	O	reaction	prep_of	18	SENT_68	[p4l505t2582r895b2660],
22	associated	VBN	O	associate	partmod	1	SENT_68	[p4l958t2581r1403b2660],
23	with	IN	O	with	_	0	SENT_68	[p4l1461t2581r1656b2661],
24	abacavir	NN	O	abacavir	prep_with	22	SENT_68	[p4l1717t2581r2134b2677],
25	,8	CD	NUMBER	,8	num	24	SENT_68	[p4l1717t2581r2134b2677],
26	with	IN	O	with	_	0	SENT_68	[p4l7t2709r199b2788],
27	no	DT	O	no	det	29	SENT_68	[p4l233t2735r336b2788],
28	hypersensitivity	NN	O	hypersensitivity	nn	29	SENT_68	[p4l371t2709r1035b2810],
29	reactions	NNS	O	reaction	prep_with	22	SENT_68	[p4l1064t2710r1445b2788],
30	reported	VBN	O	report	partmod	29	SENT_68	[p4l1480t2709r1839b2810],
31	in	IN	O	in	_	0	SENT_68	[p4l1871t2710r1954b2787],
32	148	CD	NUMBER	148	num	33	SENT_68	[p4l1990t2715r2132b2788],
33	HLA	NN	O	hlum	prep_in	30	SENT_68	[p4l11t2837r977b2938],
34	.	.	O	.	_	0	SENT_68	[p4l11t2837r977b2938],

1	—	NN	O	—	_	0	SENT_69	[p4l11t2837r977b2938],
2	.	.	O	.	_	0	SENT_69	[p4l11t2837r977b2938],

1	B	NN	O	b	_	0	SENT_70	[p4l11t2837r977b2938],
2	*	CD	NUMBER	*	number	3	SENT_70	[p4l11t2837r977b2938],
3	5701	CD	NUMBER	5701	num	1	SENT_70	[p4l11t2837r977b2938],
4	.	.	O	.	_	0	SENT_70	[p4l11t2837r977b2938],

1	—	NN	O	—	_	0	SENT_71	[p4l11t2837r977b2938],
2	.	.	O	.	_	0	SENT_71	[p4l11t2837r977b2938],

1	negative	JJ	O	negative	amod	2	SENT_72	[p4l11t2837r977b2938],
2	patients	NNS	O	patient	_	0	SENT_72	[p4l1032t2838r1407b2938],
3	.	.	O	.	_	0	SENT_72	[p4l1032t2838r1407b2938],

1	Similar	JJ	O	similar	amod	2	SENT_73	[p4l1470t2837r1790b2916],
2	results	NNS	O	result	nsubjpass	5	SENT_73	[p4l1842t2837r2132b2916],
3	were	VBD	O	be	auxpass	5	SENT_73	[p4l7t2991r209b3044],
4	later	RB	O	later	advmod	5	SENT_73	[p4l250t2965r443b3044],
5	obtained	VBN	O	obtain	_	0	SENT_73	[p4l483t2965r861b3044],
6	in	IN	O	in	_	0	SENT_73	[p4l902t2966r986b3043],
7	the	DT	O	the	det	9	SENT_73	[p4l1028t2965r1160b3044],
8	United	NNP	LOCATION	United	nn	9	SENT_73	[p4l1202t2965r1489b3044],
9	Kingdom	NNP	LOCATION	Kingdom	prep_in	5	SENT_73	[p4l1531t2965r1934b3066],
10	and	CC	O	and	_	0	SENT_73	[p4l1976t2965r2134b3044],
11	France	NNP	LOCATION	France	conj_and	9	SENT_73	[p4l11t3101r319b3172],
12	.	.	O	.	_	0	SENT_73	[p4l11t3101r319b3172],

1	This	DT	O	this	det	2	SENT_74	[p4l360t3093r548b3172],
2	relationship	NN	O	relationship	_	0	SENT_74	[p4l589t3093r1105b3194],
3	between	IN	O	between	_	0	SENT_74	[p4l1146t3093r1503b3172],
4	HLA	NN	O	hlum	prep_between	2	SENT_74	[p4l1542t3100r1825b3172],
5	.	.	O	.	_	0	SENT_74	[p4l1542t3100r1825b3172],

1	—	NN	O	—	_	0	SENT_75	[p4l1542t3100r1825b3172],
2	.	.	O	.	_	0	SENT_75	[p4l1542t3100r1825b3172],

1	B	NN	O	b	nn	2	SENT_76	[p4l1542t3100r1825b3172],
2	alleles	NNS	O	allele	nsubj	8	SENT_76	[p4l1866t3093r2132b3172],
3	and	CC	O	and	_	0	SENT_76	[p4l11t3221r169b3300],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_76	[p4l209t3221r891b3322],
5	reactions	NNS	O	reaction	conj_and	2	SENT_76	[p4l927t3222r1318b3300],
6	is	VBZ	O	be	cop	8	SENT_76	[p4l1360t3222r1426b3300],
7	less	RBR	O	less	advmod	8	SENT_76	[p4l1467t3221r1623b3300],
8	clear	JJ	O	clear	_	0	SENT_76	[p4l1667t3221r1872b3300],
9	within	IN	O	within	_	0	SENT_76	[p4l1905t3221r2133b3301, p4l11t3350r94b3427],
10	black	JJ	O	black	amod	11	SENT_76	[p4l129t3349r354b3429],
11	populations	NNS	O	population	prep_within	8	SENT_76	[p4l383t3349r909b3450],
12	,	,	O	,	_	0	SENT_76	[p4l383t3349r909b3450],
13	for	IN	O	for	_	0	SENT_76	[p4l950t3349r1071b3428],
14	unknown	JJ	O	unknown	amod	15	SENT_76	[p4l1103t3349r1511b3429],
15	reasons	NNS	O	reason	prep_for	8	SENT_76	[p4l1546t3355r1927b3428],
16	.9	CD	NUMBER	.9	tmod	8	SENT_76	[p4l1546t3355r1927b3428],
17	Furthermore	RB	O	furthermore	advmod	16	SENT_76	[p4l1962t3357r2133b3428, p4l12t3477r425b3573],
18	,	,	O	,	_	0	SENT_76	[p4l1962t3357r2133b3428, p4l12t3477r425b3573],
19	in	IN	O	in	_	0	SENT_76	[p4l468t3478r550b3555],
20	Asian	JJ	LOCATION	asian	amod	21	SENT_76	[p4l586t3478r826b3556],
21	populations	NNS	O	population	prep_in	8	SENT_76	[p4l863t3477r1389b3578],
22	,	,	O	,	_	0	SENT_76	[p4l863t3477r1389b3578],
23	the	DT	O	the	det	24	SENT_76	[p4l1434t3477r1564b3556],
24	frequency	NN	O	frequency	attr	8	SENT_76	[p4l1604t3477r2018b3578],
25	of	IN	O	of	_	0	SENT_76	[p4l2054t3477r2152b3556],
26	HLA	NN	O	hlum	prep_of	24	SENT_76	[p4l11t3605r539b3684],
27	.	.	O	.	_	0	SENT_76	[p4l11t3605r539b3684],

1	—	NN	O	—	_	0	SENT_77	[p4l11t3605r539b3684],
2	.	.	O	.	_	0	SENT_77	[p4l11t3605r539b3684],

1	B	NN	O	b	nsubj	6	SENT_78	[p4l11t3605r539b3684],
2	*	CD	NUMBER	*	num	3	SENT_78	[p4l11t3605r539b3684],
3	5701	CD	NUMBER	5701	dep	1	SENT_78	[p4l11t3605r539b3684],
4	is	VBZ	O	be	cop	6	SENT_78	[p4l577t3606r642b3684],
5	very	RB	O	very	advmod	6	SENT_78	[p4l679t3631r853b3706],
6	low	JJ	O	low	_	0	SENT_78	[p4l885t3605r1052b3701],
7	,	,	O	,	_	0	SENT_78	[p4l885t3605r1052b3701],
8	thus	RB	O	thus	advmod	9	SENT_78	[p4l1096t3605r1275b3684],
9	restricting	VBG	O	restrict	xcomp	6	SENT_78	[p4l1316t3606r1756b3706],
10	the	DT	O	the	det	11	SENT_78	[p4l1792t3605r1923b3684],
11	usefulness	NN	O	usefulness	dobj	9	SENT_78	[p4l1961t3632r2133b3684, p5l12t20r314b99],

1	of	IN	O	of	_	0	SENT_79	[p5l349t20r448b99],
2	this	DT	O	this	det	4	SENT_79	[p5l462t20r618b99],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	4	SENT_79	[p5l651t20r1385b121],
4	biomarker	NN	O	biomarker	pobj	1	SENT_79	[p5l1417t20r1855b100],
5	mainly	RB	O	mainly	advmod	1	SENT_79	[p5l1884t21r2133b99, p5l11t148r82b249],
6	to	TO	O	to	_	0	SENT_79	[p5l114t165r194b227],
7	whites	NNS	O	whites	prep_to	1	SENT_79	[p5l230t148r536b227],
8	.	.	O	.	_	0	SENT_79	[p5l230t148r536b227],

1	Molecular	JJ	O	molecular	amod	2	SENT_80	[p5l138t277r573b356],
2	studies	NNS	O	study	nsubj	4	SENT_80	[p5l612t277r911b356],
3	have	VBP	O	have	aux	4	SENT_80	[p5l954t277r1143b356],
4	revealed	VBN	O	reveal	_	0	SENT_80	[p5l1183t277r1534b356],
5	that	IN	O	that	complm	8	SENT_80	[p5l1574t277r1747b356],
6	abacavir	NN	O	abacavir	nsubjpass	8	SENT_80	[p5l1780t277r2137b356],
7	is	VBZ	O	be	auxpass	8	SENT_80	[p5l11t406r77b484],
8	metabolized	VBN	O	metabolize	ccomp	4	SENT_80	[p5l119t405r653b484],
9	by	IN	O	by	_	0	SENT_80	[p5l693t405r790b506],
10	class	NN	O	class	nn	13	SENT_80	[p5l826t405r1030b484],
11	I	CD	NUMBER	i	num	13	SENT_80	[p5l1071t413r1101b483],
12	alcohol	NN	O	alcohol	nn	13	SENT_80	[p5l1139t405r1451b484],
13	dehydrogenase	NN	O	dehydrogenase	agent	8	SENT_80	[p5l1491t405r2134b506],
14	to	TO	O	to	aux	15	SENT_80	[p5l12t550r95b612],
15	form	VB	O	form	xcomp	8	SENT_80	[p5l165t533r378b612],
16	aldehydes	NNS	O	aldehyde	dobj	15	SENT_80	[p5l447t533r873b634],
17	and	CC	O	and	_	0	SENT_80	[p5l943t533r1102b612],
18	acids	NNS	O	acid	conj_and	16	SENT_80	[p5l1171t533r1387b612],
19	that	WDT	O	that	nsubj	21	SENT_80	[p5l1459t533r1635b612],
20	covalently	RB	O	covalently	advmod	21	SENT_80	[p5l1699t533r2139b634],
21	bind	VBP	O	bind	rcmod	16	SENT_80	[p5l12t661r207b740],
22	to	TO	O	to	_	0	SENT_80	[p5l257t678r340b740],
23	cellular	JJ	O	cellular	amod	24	SENT_80	[p5l392t661r713b740],
24	proteins	NNS	O	protein	prep_to	21	SENT_80	[p5l756t662r1110b762],
25	and	CC	O	and	_	0	SENT_80	[p5l1159t661r1316b740],
26	peptides	NNS	O	peptide	prep_to	21	SENT_80	[p5l1362t661r1826b762],
27	.1	CD	NUMBER	.1	number	28	SENT_80	[p5l1362t661r1826b762],
28	°	CD	NUMBER	°	num	30	SENT_80	[p5l1362t661r1826b762],
29	Initial	JJ	O	initial	amod	30	SENT_80	[p5l1872t661r2134b740],
30	studies	NNS	O	study	dobj	21	SENT_80	[p5l13t789r307b868],
31	showed	VBD	O	show	partmod	30	SENT_80	[p5l345t789r662b869],
32	that	IN	O	that	complm	36	SENT_80	[p5l697t789r866b868],
33	ex	FW	O	ex	nn	36	SENT_80	[p5l896t816r987b868],
34	Vivo	FW	O	vivo	nn	36	SENT_80	[p5l1014t790r1179b868],
35	stimulation	NN	O	stimulation	nn	36	SENT_80	[p5l1217t789r1702b868],
36	ofWhole	NN	O	ofwhole	dep	31	SENT_80	[p5l1738t789r2133b868],
37	—	CD	NUMBER	—	dep	36	SENT_80	[p5l1738t789r2133b868],

1	blood	NN	O	blood	nn	2	SENT_81	[p5l12t917r246b996],
2	specimens	NNS	O	specimen	nsubj	5	SENT_81	[p5l281t918r711b1018],
3	with	IN	O	with	_	0	SENT_81	[p5l742t917r932b996],
4	abacavir	NN	O	abacavir	prep_with	2	SENT_81	[p5l964t917r1305b996],
5	leads	VBZ	O	lead	_	0	SENT_81	[p5l1334t917r1541b996],
6	to	TO	O	to	_	0	SENT_81	[p5l1577t934r1657b996],
7	the	DT	O	the	det	8	SENT_81	[p5l1691t917r1820b996],
8	release	NN	O	release	prep_to	5	SENT_81	[p5l1854t917r2134b996],
9	of	IN	O	of	_	0	SENT_81	[p5l12t1045r113b1124],
10	tumor	NN	O	tumor	prep_of	8	SENT_81	[p5l147t1062r419b1124],
11	necrosis	NN	O	necrosis	nn	13	SENT_81	[p5l467t1046r825b1124],
12	factor	NN	O	factor	nn	13	SENT_81	[p5l879t1045r1135b1124],
13	CV	NN	O	cv	nsubj	23	SENT_81	[p5l1182t1074r1240b1122],
14	and	CC	O	and	_	0	SENT_81	[p5l1293t1045r1453b1124],
15	interferonq	NN	O	interferonq	nsubj	23	SENT_81	[p5l1504t1045r2134b1144],
16	/	:	O	/	punct	20	SENT_81	[p5l1504t1045r2134b1144],
17	.11	CD	NUMBER	.11	num	20	SENT_81	[p5l1504t1045r2134b1144],
18	More	JJR	O	more	quantmod	17	SENT_81	[p5l9t1181r230b1252],
19	recent	JJ	O	recent	amod	20	SENT_81	[p5l269t1190r533b1252],
20	Work	NN	O	work	dep	13	SENT_81	[p5l561t1173r782b1253],
21	in	IN	O	in	_	0	SENT_81	[p5l814t1174r897b1251],
22	progress	NN	O	progress	prep_in	20	SENT_81	[p5l933t1199r1305b1274],
23	suggests	VBZ	O	suggest	rcmod	8	SENT_81	[p5l1346t1190r1712b1274],
24	that	IN	O	that	complm	26	SENT_81	[p5l1752t1173r1925b1252],
25	abacavir	NN	O	abacavir	nsubj	26	SENT_81	[p5l1956t1173r2133b1252, p5l12t1302r214b1380],
26	triggers	VBZ	O	trigger	ccomp	23	SENT_81	[p5l248t1302r575b1402],
27	cytokine	NN	O	cytokine	nn	28	SENT_81	[p5l615t1301r973b1402],
28	release	NN	O	release	dobj	26	SENT_81	[p5l1010t1301r1297b1380],
29	from	IN	O	from	_	0	SENT_81	[p5l1334t1301r1542b1380],
30	CD8	NN	O	cd8	nn	33	SENT_81	[p5l1579t1307r1819b1380],
31	+	CC	O	+	_	0	SENT_81	[p5l1579t1307r1819b1380],
32	T	NN	O	t	conj_+	30	SENT_81	[p5l1853t1307r1915b1379],
33	cells	NNS	O	cell	prep_from	26	SENT_81	[p5l1949t1301r2133b1380],
34	in	IN	O	in	_	0	SENT_81	[p5l11t1430r96b1507],
35	blood	NN	O	blood	prep_in	33	SENT_81	[p5l159t1429r406b1508],
36	in	IN	O	in	_	0	SENT_81	[p5l469t1430r553b1507],
37	a	DT	O	a	det	38	SENT_81	[p5l615t1456r660b1508],
38	response	NN	O	response	prep_in	35	SENT_81	[p5l721t1455r1109b1530],
39	specifically	RB	O	specifically	advmod	40	SENT_81	[p5l1174t1429r1674b1530],
40	involving	VBG	O	involve	xcomp	26	SENT_81	[p5l1731t1429r2137b1530],
41	HLA	NN	O	hlum	dobj	40	SENT_81	[p5l11t1557r562b1636],
42	.	.	O	.	_	0	SENT_81	[p5l11t1557r562b1636],

1	—	NN	O	—	_	0	SENT_82	[p5l11t1557r562b1636],
2	.	.	O	.	_	0	SENT_82	[p5l11t1557r562b1636],

1	B	NN	O	b	_	0	SENT_83	[p5l11t1557r562b1636],
2	*	CD	NUMBER	*	number	3	SENT_83	[p5l11t1557r562b1636],
3	5701	CD	DATE	5701	dep	1	SENT_83	[p5l11t1557r562b1636],
4	and	CC	O	and	_	0	SENT_83	[p5l612t1557r772b1636],
5	a	DT	O	a	det	8	SENT_83	[p5l821t1584r865b1636],
6	proposed	VBN	O	propose	amod	8	SENT_83	[p5l912t1557r1323b1658],
7	endogenous	JJ	O	endogenous	amod	8	SENT_83	[p5l1373t1557r1902b1658],
8	peptide	NN	O	peptide	conj_and	1	SENT_83	[p5l1952t1583r2147b1658, p5l12t1685r275b1764],
9	.	.	O	.	_	0	SENT_83	[p5l1952t1583r2147b1658, p5l12t1685r275b1764],

1	”	NN	O	”	nsubj	4	SENT_84	[p5l1952t1583r2147b1658, p5l12t1685r275b1764],
2	These	DT	O	these	det	3	SENT_84	[p5l308t1685r561b1764],
3	studies	NNS	O	study	dep	1	SENT_84	[p5l600t1685r902b1764],
4	hold	VBP	O	hold	_	0	SENT_84	[p5l941t1685r1131b1764],
5	the	DT	O	the	det	6	SENT_84	[p5l1169t1685r1302b1764],
6	promise	NN	O	promise	dobj	4	SENT_84	[p5l1338t1686r1691b1786],
7	of	IN	O	of	_	0	SENT_84	[p5l1729t1685r1830b1764],
8	a	DT	O	a	det	11	SENT_84	[p5l1847t1712r1892b1764],
9	more	RBR	O	more	advmod	10	SENT_84	[p5l1927t1711r2148b1764],
10	extensive	JJ	O	extensive	amod	11	SENT_84	[p5l12t1814r403b1892],
11	understanding	NN	O	understanding	prep_of	6	SENT_84	[p5l445t1813r1086b1914],
12	of	IN	O	of	_	0	SENT_84	[p5l1125t1813r1225b1892],
13	the	DT	O	the	det	17	SENT_84	[p5l1248t1813r1382b1892],
14	genetic	JJ	O	genetic	amod	17	SENT_84	[p5l1423t1814r1734b1914],
15	and	CC	O	and	_	0	SENT_84	[p5l1774t1813r1933b1892],
16	molecular	JJ	O	molecular	conj_and	14	SENT_84	[p5l1975t1839r2147b1892, p5l11t1941r313b2020],
17	basis	NN	O	basis	prep_of	11	SENT_84	[p5l364t1941r581b2020],
18	of	IN	O	of	_	0	SENT_84	[p5l637t1941r738b2020],
19	this	DT	O	this	det	20	SENT_84	[p5l774t1941r938b2020],
20	reaction	NN	O	reaction	prep_of	17	SENT_84	[p5l993t1942r1351b2020],
21	and	CC	O	and	_	0	SENT_84	[p5l1404t1941r1565b2020],
22	the	DT	O	the	det	24	SENT_84	[p5l1618t1941r1754b2020],
23	specific	JJ	O	specific	amod	24	SENT_84	[p5l1809t1941r2148b2042],
24	role	NN	O	role	prep_of	6	SENT_84	[p5l12t2069r172b2148],
25	the	DT	O	the	det	26	SENT_84	[p5l212t2069r345b2148],
26	HLA	NN	O	hlum	dep	24	SENT_84	[p5l383t2069r924b2148],
27	.	.	O	.	_	0	SENT_84	[p5l383t2069r924b2148],

1	—	NN	O	—	_	0	SENT_85	[p5l383t2069r924b2148],
2	.	.	O	.	_	0	SENT_85	[p5l383t2069r924b2148],

1	B	NN	O	b	nsubj	10	SENT_86	[p5l383t2069r924b2148],
2	*	CD	NUMBER	*	num	1	SENT_86	[p5l383t2069r924b2148],
3	5701	CD	NUMBER	5701	num	4	SENT_86	[p5l383t2069r924b2148],
4	polymorphism	NN	O	polymorphism	nsubj	6	SENT_86	[p5l961t2069r1602b2170],
5	may	MD	O	may	aux	6	SENT_86	[p5l1640t2095r1821b2170],
6	play	VB	O	play	rcmod	1	SENT_86	[p5l1853t2069r2030b2170],
7	in	IN	O	in	_	0	SENT_86	[p5l2063t2070r2148b2147],
8	abacavir	NN	O	abacavir	nn	9	SENT_86	[p5l11t2197r786b2277],
9	—	NN	O	—	prep_in	6	SENT_86	[p5l11t2197r786b2277],
10	mediated	VBD	O	mediate	_	0	SENT_86	[p5l11t2197r786b2277],
11	hypersensitivity	NN	O	hypersensitivity	nn	12	SENT_86	[p5l817t2197r1486b2298],
12	reactions	NNS	O	reaction	dobj	10	SENT_86	[p5l1513t2198r1921b2276],
13	.	.	O	.	_	0	SENT_86	[p5l1513t2198r1921b2276],

1	That	DT	O	that	det	2	SENT_87	[p5l1954t2197r2153b2276],
2	role	NN	O	role	nsubj	4	SENT_87	[p5l12t2325r176b2404],
3	might	MD	O	might	aux	4	SENT_87	[p5l219t2325r485b2426],
4	explain	VB	O	explain	_	0	SENT_87	[p5l524t2325r846b2426],
5	the	DT	O	the	det	7	SENT_87	[p5l889t2325r1025b2404],
6	high	JJ	O	high	amod	7	SENT_87	[p5l1068t2325r1268b2426],
7	selectivity	NN	O	selectivity	dobj	4	SENT_87	[p5l1313t2325r1752b2426],
8	of	IN	O	of	_	0	SENT_87	[p5l1791t2325r1892b2404],
9	HLA	NN	O	hlum	nn	11	SENT_87	[p5l1916t2333r2147b2403],
10	—	NN	O	—	nn	11	SENT_87	[p5l1916t2333r2147b2403],
11	B	NN	O	b	prep_of	7	SENT_87	[p5l11t2453r328b2532],
12	*	CD	NUMBER	*	number	13	SENT_87	[p5l11t2453r328b2532],
13	5701	CD	NUMBER	5701	npadvmod	4	SENT_87	[p5l11t2453r328b2532],
14	as	IN	O	as	_	0	SENT_87	[p5l368t2480r454b2532],
15	a	DT	O	a	det	17	SENT_87	[p5l494t2480r538b2532],
16	pharmacogenomic	JJ	O	pharmacogenomic	amod	17	SENT_87	[p5l573t2453r1389b2554],
17	biomarker	NN	O	biomarker	prep_as	4	SENT_87	[p5l1427t2453r1894b2533],
18	.	.	O	.	_	0	SENT_87	[p5l1427t2453r1894b2533],

1	In	IN	O	in	_	0	SENT_88	[p5l140t2589r230b2659],
2	this	DT	O	this	det	3	SENT_88	[p5l293t2581r454b2660],
3	issue	NN	O	issue	prep_in	19	SENT_88	[p5l517t2582r730b2660],
4	of	IN	O	of	_	0	SENT_88	[p5l794t2581r894b2660],
5	the	DT	O	the	det	6	SENT_88	[p5l939t2581r1072b2660],
6	journal	NN	O	journal	prep_of	3	SENT_88	[p5l1119t2581r1433b2682],
7	,	,	O	,	_	0	SENT_88	[p5l1119t2581r1433b2682],
8	Mallal	NNP	O	Mallal	appos	6	SENT_88	[p5l1498t2581r1774b2660],
9	et	FW	O	et	nn	10	SENT_88	[p5l1837t2598r1915b2660],
10	al.	FW	O	al.	dep	8	SENT_88	[p5l1971t2581r2147b2660],
11	13	CD	NUMBER	13	number	12	SENT_88	[p5l1971t2581r2147b2660],
12	present	JJ	DATE	present	amod	10	SENT_88	[p5l11t2726r332b2810],
13	the	DT	O	the	det	14	SENT_88	[p5l372t2709r505b2788],
14	results	NNS	O	result	nsubjpass	19	SENT_88	[p5l549t2709r834b2788],
15	of	IN	O	of	_	0	SENT_88	[p5l881t2709r981b2788],
16	What	WP	O	what	prep_of	14	SENT_88	[p5l1002t2709r1218b2788],
17	has	VBZ	O	have	aux	19	SENT_88	[p5l1257t2709r1403b2788],
18	been	VBN	O	be	auxpass	19	SENT_88	[p5l1449t2709r1652b2788],
19	strived	VBN	O	strive	_	0	SENT_88	[p5l1697t2709r1983b2788],
20	for	IN	O	for	dep	19	SENT_88	[p5l2027t2709r2151b2788],
21	in	IN	O	in	_	0	SENT_88	[p5l11t2838r95b2915],
22	the	DT	O	the	det	23	SENT_88	[p5l138t2837r272b2916],
23	field	NN	O	field	prep_in	19	SENT_88	[p5l315t2837r510b2916],
24	of	IN	O	of	_	0	SENT_88	[p5l553t2837r654b2916],
25	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	23	SENT_88	[p5l677t2837r1559b2938],
26	:	:	O	:	_	0	SENT_88	[p5l677t2837r1559b2938],
27	a	DT	O	a	det	29	SENT_88	[p5l1605t2864r1650b2916],
28	very	RB	O	very	advmod	29	SENT_88	[p5l1687t2863r1866b2938],
29	large	JJ	O	large	dep	23	SENT_88	[p5l1903t2837r2142b2938],
30	,	,	O	,	_	0	SENT_88	[p5l1903t2837r2142b2938],
31	randomized	VBN	O	randomize	dep	29	SENT_88	[p5l12t2965r538b3061],
32	,	,	O	,	_	0	SENT_88	[p5l12t2965r538b3061],
33	double	JJ	O	double	amod	29	SENT_88	[p5l587t2965r1135b3061],
34	—	RB	O	—	advmod	35	SENT_88	[p5l587t2965r1135b3061],
35	blind	JJ	O	blind	amod	29	SENT_88	[p5l587t2965r1135b3061],
36	,	,	O	,	_	0	SENT_88	[p5l587t2965r1135b3061],
37	prospective	JJ	O	prospective	amod	38	SENT_88	[p5l1182t2966r1653b3066],
38	study	NN	O	study	appos	23	SENT_88	[p5l1697t2965r1920b3066],
39	evaluating	VBG	O	evaluate	partmod	38	SENT_88	[p5l1959t2965r2147b3044, p5l12t3094r282b3194],
40	the	DT	O	the	det	42	SENT_88	[p5l313t3093r447b3172],
41	clinical	JJ	O	clinical	amod	42	SENT_88	[p5l486t3093r802b3172],
42	utility	NN	O	utility	dobj	39	SENT_88	[p5l839t3093r1099b3194],
43	of	IN	O	of	_	0	SENT_88	[p5l1133t3093r1234b3172],
44	a	DT	O	a	det	46	SENT_88	[p5l1253t3120r1298b3172],
45	pharmacogenomic	JJ	O	pharmacogenomic	amod	46	SENT_88	[p5l1333t3093r2148b3194],
46	biomarker	NN	O	biomarker	prep_of	42	SENT_88	[p5l12t3221r471b3301],
47	.	.	O	.	_	0	SENT_88	[p5l12t3221r471b3301],

1	Patients	NNS	O	patient	_	0	SENT_89	[p5l512t3222r846b3300],
2	from	IN	O	from	_	0	SENT_89	[p5l885t3221r1094b3300],
3	265	CD	NUMBER	265	num	4	SENT_89	[p5l1130t3227r1275b3300],
4	centers	NNS	O	center	prep_from	1	SENT_89	[p5l1316t3238r1614b3300],
5	in	IN	O	in	_	0	SENT_89	[p5l1653t3222r1735b3299],
6	19	CD	NUMBER	19	num	7	SENT_89	[p5l1776t3227r1871b3300],
7	countries	NNS	O	country	prep_in	1	SENT_89	[p5l1910t3247r2147b3300, p5l12t3350r194b3428],

1	were	VBD	O	be	auxpass	3	SENT_90	[p5l229t3375r428b3428],
2	randomly	RB	O	randomly	advmod	3	SENT_90	[p5l464t3349r874b3450],
3	assigned	VBN	O	assign	_	0	SENT_90	[p5l905t3349r1274b3450],
4	to	TO	O	to	_	0	SENT_90	[p5l1310t3366r1391b3428],
5	one	CD	TIME	one	prep_to	3	SENT_90	[p5l1430t3375r1579b3428],
6	of	IN	TIME	of	_	0	SENT_90	[p5l1617t3349r1716b3428],
7	two	CD	TIME	two	num	9	SENT_90	[p5l1734t3366r1890b3428],
8	treatment	NN	O	treatment	nn	9	SENT_90	[p5l1927t3366r2147b3428, p5l12t3494r231b3556],
9	groups	NNS	O	group	prep_of	5	SENT_90	[p5l259t3503r581b3578],
10	.	.	O	.	_	0	SENT_90	[p5l259t3503r581b3578],

1	One	CD	NUMBER	one	num	2	SENT_91	[p5l621t3483r794b3556],
2	group	NN	O	group	nsubj	6	SENT_91	[p5l829t3503r1082b3578],
3	of	IN	O	of	_	0	SENT_91	[p5l1119t3477r1220b3556],
4	847	CD	NUMBER	847	num	5	SENT_91	[p5l1236t3483r1386b3556],
5	patients	NNS	O	patient	prep_of	2	SENT_91	[p5l1421t3478r1764b3578],
6	received	VBD	O	receive	_	0	SENT_91	[p5l1801t3477r2148b3556],
7	abacavir	NN	O	abacavir	dobj	6	SENT_91	[p5l11t3605r363b3685],
8	without	IN	O	without	_	0	SENT_91	[p5l392t3605r728b3685],
9	prospective	JJ	O	prospective	amod	10	SENT_91	[p5l758t3606r1240b3706],
10	HLA	NN	O	hlum	prep_without	6	SENT_91	[p5l1277t3605r1808b3684],
11	.	.	O	.	_	0	SENT_91	[p5l1277t3605r1808b3684],

1	—	NN	O	—	_	0	SENT_92	[p5l1277t3605r1808b3684],
2	.	.	O	.	_	0	SENT_92	[p5l1277t3605r1808b3684],

1	B	NN	O	b	_	0	SENT_93	[p5l1277t3605r1808b3684],
2	*	CD	NUMBER	*	number	3	SENT_93	[p5l1277t3605r1808b3684],
3	5701	CD	NUMBER	5701	num	4	SENT_93	[p5l1277t3605r1808b3684],
4	screening	NN	O	screening	dep	1	SENT_93	[p5l1848t3631r2147b3684, p6l11t21r168b121],
5	;	:	O	;	_	0	SENT_93	[p5l1848t3631r2147b3684, p6l11t21r168b121],

1	the	DT	O	the	det	3	SENT_94	[p6l208t20r342b99],
2	other	JJ	O	other	amod	3	SENT_94	[p6l381t20r610b99],
3	group	NN	O	group	nsubj	7	SENT_94	[p6l644t46r898b121],
4	of	IN	O	of	_	0	SENT_94	[p6l938t20r1038b99],
5	803	CD	NUMBER	803	num	6	SENT_94	[p6l1057t26r1205b99],
6	patients	NNS	O	patient	prep_of	3	SENT_94	[p6l1245t21r1589b121],
7	received	VBD	O	receive	_	0	SENT_94	[p6l1628t20r1977b99],
8	the	DT	O	the	det	9	SENT_94	[p6l2014t20r2148b99],
9	drug	NN	O	drug	dobj	7	SENT_94	[p6l12t148r211b249],
10	only	RB	O	only	advmod	14	SENT_94	[p6l246t148r425b249],
11	after	IN	O	after	dep	14	SENT_94	[p6l457t148r652b227],
12	prospective	JJ	O	prospective	amod	13	SENT_94	[p6l685t149r1156b249],
13	screening	NN	O	screening	nsubj	14	SENT_94	[p6l1195t149r1599b249],
14	showed	VBD	O	show	dep	7	SENT_94	[p6l1634t148r1948b227],
15	that	IN	O	that	complm	18	SENT_94	[p6l1985t148r2153b227],
16	they	PRP	O	they	nsubj	18	SENT_94	[p6l12t276r196b377],
17	were	VBD	O	be	cop	18	SENT_94	[p6l225t302r428b355],
18	negative	JJ	O	negative	ccomp	14	SENT_94	[p6l467t277r822b377],
19	for	IN	O	for	_	0	SENT_94	[p6l860t276r985b355],
20	HLA	NN	O	hlum	prep_for	18	SENT_94	[p6l1019t276r1583b355],
21	.	.	O	.	_	0	SENT_94	[p6l1019t276r1583b355],

1	—	NN	O	—	_	0	SENT_95	[p6l1019t276r1583b355],
2	.	.	O	.	_	0	SENT_95	[p6l1019t276r1583b355],

1	B	NN	O	b	_	0	SENT_96	[p6l1019t276r1583b355],
2	*	CD	NUMBER	*	number	3	SENT_96	[p6l1019t276r1583b355],
3	5701	CD	NUMBER	5701	num	1	SENT_96	[p6l1019t276r1583b355],
4	.	.	O	.	_	0	SENT_96	[p6l1019t276r1583b355],

1	No	DT	O	no	det	5	SENT_97	[p6l139t412r264b483],
2	immunologically	RB	O	immunologically	advmod	3	SENT_97	[p6l305t404r1033b505],
3	confirmed	VBN	O	confirm	amod	5	SENT_97	[p6l1070t404r1517b483],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_97	[p6l1558t404r2147b505, p6l11t533r117b633],
5	reactions	NNS	O	reaction	nsubjpass	7	SENT_97	[p6l144t533r528b611],
6	were	VBD	O	be	auxpass	7	SENT_97	[p6l557t559r756b612],
7	reported	VBN	O	report	_	0	SENT_97	[p6l788t532r1149b633],
8	in	IN	O	in	_	0	SENT_97	[p6l1179t533r1263b610],
9	patients	NNS	O	patient	prep_in	7	SENT_97	[p6l1292t533r1628b633],
10	who	WP	O	who	nsubj	11	SENT_97	[p6l1657t532r1839b611],
11	underwent	VBD	O	undergo	rcmod	9	SENT_97	[p6l1871t532r2147b611, p6l7t677r216b739],
12	prospective	JJ	O	prospective	amod	13	SENT_97	[p6l246t661r738b761],
13	genotyping	NN	O	genotyping	dobj	11	SENT_97	[p6l777t661r1270b761],
14	and	CC	O	and	_	0	SENT_97	[p6l1304t660r1464b739],
15	were	VBD	O	be	cop	17	SENT_97	[p6l1496t686r1699b739],
16	not	RB	O	not	neg	17	SENT_97	[p6l1738t677r1882b739],
17	carriers	NNS	O	carrier	conj_and	11	SENT_97	[p6l1915t661r2147b739, p6l12t814r134b867],
18	of	IN	O	of	_	0	SENT_97	[p6l173t788r274b867],
19	HLA	NN	O	hlum	prep_of	17	SENT_97	[p6l290t788r855b884],
20	.	.	O	.	_	0	SENT_97	[p6l290t788r855b884],

1	—	NN	O	—	_	0	SENT_98	[p6l290t788r855b884],
2	.	.	O	.	_	0	SENT_98	[p6l290t788r855b884],

1	B	NN	O	b	_	0	SENT_99	[p6l290t788r855b884],
2	*	CD	NUMBER	*	number	3	SENT_99	[p6l290t788r855b884],
3	5701	CD	NUMBER	5701	dep	1	SENT_99	[p6l290t788r855b884],
4	;	:	O	;	_	0	SENT_99	[p6l290t788r855b884],
5	all	DT	O	all	det	6	SENT_99	[p6l895t788r1000b867],
6	hypersensitivity	NN	O	hypersensitivity	dep	1	SENT_99	[p6l1036t788r1721b889],
7	reactions	NNS	O	reaction	nsubj	8	SENT_99	[p6l1753t789r2145b867],
8	occurred	VBD	O	occur	rcmod	6	SENT_99	[p6l12t916r402b995],
9	in	IN	O	in	_	0	SENT_99	[p6l456t917r541b994],
10	carriers	NNS	O	carrier	prep_in	8	SENT_99	[p6l598t917r933b995],
11	of	IN	O	of	_	0	SENT_99	[p6l991t916r1093b995],
12	HLA	NN	O	hlum	prep_of	10	SENT_99	[p6l1130t916r1704b995],
13	.	.	O	.	_	0	SENT_99	[p6l1130t916r1704b995],

1	—	NN	O	—	_	0	SENT_100	[p6l1130t916r1704b995],
2	.	.	O	.	_	0	SENT_100	[p6l1130t916r1704b995],

1	B	NN	O	b	_	0	SENT_101	[p6l1130t916r1704b995],
2	*	CD	NUMBER	*	number	3	SENT_101	[p6l1130t916r1704b995],
3	5701	CD	NUMBER	5701	num	1	SENT_101	[p6l1130t916r1704b995],
4	.	.	O	.	_	0	SENT_101	[p6l1130t916r1704b995],

1	ApproXi	NN	O	approxus	nn	2	SENT_102	[p6l1762t917r2147b1017],
2	—	NN	O	—	_	0	SENT_102	[p6l1762t917r2147b1017],
3	mately	RB	O	mately	advmod	5	SENT_102	[p6l12t1044r301b1145],
4	50	CD	PERCENT	50	num	5	SENT_102	[p6l342t1049r528b1123],
5	%	NN	PERCENT	%	dep	2	SENT_102	[p6l342t1049r528b1123],
6	of	IN	O	of	_	0	SENT_102	[p6l572t1044r672b1123],
7	HLA	NN	O	hlum	prep_of	5	SENT_102	[p6l697t1044r1238b1123],
8	.	.	O	.	_	0	SENT_102	[p6l697t1044r1238b1123],

1	—	NN	O	—	_	0	SENT_103	[p6l697t1044r1238b1123],
2	.	.	O	.	_	0	SENT_103	[p6l697t1044r1238b1123],

1	B	NN	O	b	nsubj	23	SENT_104	[p6l697t1044r1238b1123],
2	*	CD	NUMBER	*	number	3	SENT_104	[p6l697t1044r1238b1123],
3	5701	CD	NUMBER	5701	num	4	SENT_104	[p6l697t1044r1238b1123],
4	carriers	NNS	O	carrier	npadvmod	1	SENT_104	[p6l1283t1045r1610b1123],
5	in	IN	O	in	_	0	SENT_104	[p6l1656t1045r1739b1122],
6	the	DT	O	the	det	8	SENT_104	[p6l1784t1044r1917b1123],
7	control	NN	O	control	nn	8	SENT_104	[p6l1962t1070r2147b1123, p6l12t1172r167b1251],
8	group	NN	O	group	prep_in	1	SENT_104	[p6l213t1198r471b1273],
9	(	CD	PERCENT	(	number	10	SENT_104	[p6l525t1178r771b1263],
10	2.7	CD	PERCENT	2.7	dep	11	SENT_104	[p6l525t1178r771b1263],
11	%	NN	PERCENT	%	dep	8	SENT_104	[p6l525t1178r771b1263],
12	of	IN	O	of	_	0	SENT_104	[p6l818t1172r920b1251],
13	the	DT	O	the	det	14	SENT_104	[p6l949t1172r1085b1251],
14	patients	NNS	O	patient	prep_of	8	SENT_104	[p6l1131t1173r1482b1273],
15	who	WP	O	who	nsubjpass	18	SENT_104	[p6l1527t1172r1713b1252],
16	could	MD	O	could	aux	18	SENT_104	[p6l1762t1172r2002b1251],
17	be	VB	O	be	auxpass	18	SENT_104	[p6l2050t1172r2148b1251],
18	evaluated	VBN	O	evaluate	rcmod	1	SENT_104	[p6l12t1301r446b1393],
19	)	NN	O	)	dobj	18	SENT_104	[p6l12t1301r446b1393],
20	who	WP	O	who	nsubj	21	SENT_104	[p6l491t1301r675b1381],
21	received	VBD	O	receive	rcmod	19	SENT_104	[p6l720t1301r1068b1380],
22	abacavir	NN	O	abacavir	dobj	21	SENT_104	[p6l1111t1301r1470b1381],
23	had	VBD	O	have	_	0	SENT_104	[p6l1510t1301r1668b1380],
24	an	DT	O	a	det	28	SENT_104	[p6l1711t1327r1814b1380],
25	immunologically	RB	O	immunologically	advmod	26	SENT_104	[p6l1857t1302r2147b1380, p6l12t1429r490b1530],
26	confirmed	VBN	O	confirm	amod	28	SENT_104	[p6l534t1429r991b1508],
27	hypersensitivity	NN	O	hypersensitivity	nn	28	SENT_104	[p6l1039t1429r1724b1530],
28	reaction	NN	O	reaction	dobj	23	SENT_104	[p6l1768t1430r2142b1508],
29	.	.	O	.	_	0	SENT_104	[p6l1768t1430r2142b1508],

1	The	DT	O	the	det	4	SENT_105	[p6l8t1557r169b1636],
2	relatively	RB	O	relatively	advmod	4	SENT_105	[p6l208t1557r587b1658],
3	high	JJ	O	high	amod	4	SENT_105	[p6l622t1557r815b1658],
4	incidence	NN	O	incidence	_	0	SENT_105	[p6l853t1557r1253b1636],
5	of	IN	O	of	_	0	SENT_105	[p6l1293t1557r1392b1636],
6	no	DT	O	no	det	8	SENT_105	[p6l1413t1583r1518b1636],
7	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_105	[p6l1558t1557r2147b1658, p6l11t1686r120b1786],
8	reaction	NN	O	reaction	prep_of	4	SENT_105	[p6l167t1686r517b1764],
9	among	IN	O	among	_	0	SENT_105	[p6l569t1711r872b1786],
10	HLA	NN	O	hlum	prep_among	4	SENT_105	[p6l919t1685r1460b1764],
11	.	.	O	.	_	0	SENT_105	[p6l919t1685r1460b1764],

1	—	NN	O	—	_	0	SENT_106	[p6l919t1685r1460b1764],
2	.	.	O	.	_	0	SENT_106	[p6l919t1685r1460b1764],

1	B	NN	O	b	nsubjpass	7	SENT_107	[p6l919t1685r1460b1764],
2	*	CD	NUMBER	*	num	1	SENT_107	[p6l919t1685r1460b1764],
3	5701	CD	NUMBER	5701	num	4	SENT_107	[p6l919t1685r1460b1764],
4	carriers	NNS	O	carrier	dep	1	SENT_107	[p6l1514t1686r1841b1764],
5	might	MD	O	might	aux	7	SENT_107	[p6l1895t1685r2153b1786],
6	be	VB	O	be	auxpass	7	SENT_107	[p6l12t1813r108b1892],
7	explained	VBN	O	explain	_	0	SENT_107	[p6l159t1813r568b1914],
8	by	IN	O	by	_	0	SENT_107	[p6l619t1813r716b1914],
9	a	DT	O	a	det	11	SENT_107	[p6l760t1840r805b1892],
10	reduced	VBN	O	reduce	amod	11	SENT_107	[p6l853t1813r1186b1892],
11	capacity	NN	O	capacity	agent	7	SENT_107	[p6l1236t1814r1579b1914],
12	to	TO	O	to	aux	13	SENT_107	[p6l1626t1830r1706b1892],
13	form	VB	O	form	infmod	11	SENT_107	[p6l1757t1813r1966b1892],
14	the	DT	O	the	det	17	SENT_107	[p6l2016t1813r2148b1892],
15	active	JJ	O	active	amod	17	SENT_107	[p6l11t1942r243b2020],
16	peptide	NN	O	peptide	nn	17	SENT_107	[p6l278t1941r589b2042],
17	conjugate	NN	O	conjugate	dobj	13	SENT_107	[p6l626t1942r1024b2042],
18	or	CC	O	or	_	0	SENT_107	[p6l1061t1967r1148b2020],
19	mechanisms	NNS	O	mechanism	dobj	13	SENT_107	[p6l1182t1941r1710b2020],
20	of	IN	O	of	_	0	SENT_107	[p6l1749t1941r1848b2020],
21	immunologic	JJ	O	immunologic	amod	22	SENT_107	[p6l1865t1942r2147b2020, p6l12t2069r331b2170],
22	tolerance	NN	O	tolerance	prep_of	19	SENT_107	[p6l369t2069r764b2148],
23	that	WDT	O	that	nsubj	24	SENT_107	[p6l803t2069r977b2148],
24	remain	VBP	O	remain	rcmod	19	SENT_107	[p6l1009t2070r1317b2148],
25	to	TO	O	to	aux	27	SENT_107	[p6l1356t2086r1438b2148],
26	be	VB	O	be	auxpass	27	SENT_107	[p6l1478t2069r1574b2148],
27	understood	VBN	O	understand	xcomp	24	SENT_107	[p6l1613t2069r2132b2148],
28	.	.	O	.	_	0	SENT_107	[p6l1613t2069r2132b2148],

1	Is	VBZ	O	be	cop	3	SENT_108	[p6l140t2205r212b2276],
2	it	PRP	O	it	nsubj	3	SENT_108	[p6l258t2198r318b2276],
3	appropriate	JJ	O	appropriate	_	0	SENT_108	[p6l356t2198r854b2298],
4	to	TO	O	to	aux	5	SENT_108	[p6l899t2214r981b2276],
5	use	VB	O	use	dep	3	SENT_108	[p6l1027t2224r1168b2276],
6	HLA	NN	O	hlum	dobj	5	SENT_108	[p6l1212t2197r1753b2276],
7	.	.	O	.	_	0	SENT_108	[p6l1212t2197r1753b2276],

1	—	NN	O	—	_	0	SENT_109	[p6l1212t2197r1753b2276],
2	.	.	O	.	_	0	SENT_109	[p6l1212t2197r1753b2276],

1	B	NN	O	b	_	0	SENT_110	[p6l1212t2197r1753b2276],
2	*	CD	NUMBER	*	number	3	SENT_110	[p6l1212t2197r1753b2276],
3	5701	CD	NUMBER	5701	dep	1	SENT_110	[p6l1212t2197r1753b2276],
4	as	IN	O	as	_	0	SENT_110	[p6l1797t2224r1883b2276],
5	a	DT	O	a	det	7	SENT_110	[p6l1929t2224r1974b2276],
6	genetic	JJ	O	genetic	amod	7	SENT_110	[p6l2016t2224r2147b2298, p6l12t2327r220b2405],
7	biomarker	NN	O	biomarker	prep_as	3	SENT_110	[p6l260t2326r709b2406],
8	in	IN	O	in	_	0	SENT_110	[p6l744t2327r828b2404],
9	routine	JJ	O	routine	amod	11	SENT_110	[p6l867t2327r1179b2405],
10	clinical	JJ	O	clinical	amod	11	SENT_110	[p6l1219t2326r1534b2405],
11	practice	NN	O	practice	prep_in	7	SENT_110	[p6l1571t2323r1949b2427],
12	?	.	O	?	_	0	SENT_110	[p6l1571t2323r1949b2427],

1	The	DT	O	the	det	2	SENT_111	[p6l1985t2326r2148b2405],
2	answer	NN	O	answer	nsubj	9	SENT_111	[p6l11t2480r338b2550],
3	,	,	O	,	_	0	SENT_111	[p6l11t2480r338b2550],
4	in	IN	O	in	_	0	SENT_111	[p6l389t2455r473b2532],
5	my	PRP$	O	my	poss	6	SENT_111	[p6l518t2480r649b2555],
6	opinion	NN	O	opinion	prep_in	2	SENT_111	[p6l690t2455r1048b2555],
7	,	,	O	,	_	0	SENT_111	[p6l690t2455r1048b2555],
8	is	VBZ	O	be	cop	9	SENT_111	[p6l1099t2455r1164b2533],
9	yes	RB	O	yes	_	0	SENT_111	[p6l1208t2481r1364b2555],
10	.	.	O	.	_	0	SENT_111	[p6l1208t2481r1364b2555],

1	Only	RB	O	only	quantmod	2	SENT_112	[p6l1415t2454r1621b2555],
2	14	CD	NUMBER	14	num	3	SENT_112	[p6l1665t2460r1757b2533],
3	patients	NNS	O	patient	nsubj	5	SENT_112	[p6l1801t2455r2145b2555],
4	would	MD	O	would	aux	5	SENT_112	[p6l7t2582r275b2661],
5	have	VB	O	have	_	0	SENT_112	[p6l324t2582r515b2661],
6	to	TO	O	to	aux	8	SENT_112	[p6l564t2599r646b2661],
7	be	VB	O	be	auxpass	8	SENT_112	[p6l696t2582r794b2661],
8	screened	VBN	O	screen	xcomp	5	SENT_112	[p6l844t2582r1220b2661],
9	to	TO	O	to	aux	10	SENT_112	[p6l1269t2599r1351b2661],
10	prevent	VB	O	prevent	xcomp	8	SENT_112	[p6l1400t2599r1721b2683],
11	one	CD	NUMBER	one	num	12	SENT_112	[p6l1765t2608r1917b2661],
12	case	NN	O	case	nsubj	16	SENT_112	[p6l1967t2609r2148b2661],
13	of	IN	O	of	_	0	SENT_112	[p6l12t2710r114b2789],
14	abacavir	NN	O	abacavir	nn	15	SENT_112	[p6l168t2710r916b2789],
15	—	NN	O	—	prep_of	12	SENT_112	[p6l168t2710r916b2789],
16	induced	VBD	O	induce	ccomp	10	SENT_112	[p6l168t2710r916b2789],
17	hypersensitivity	NN	O	hypersensitivity	nn	18	SENT_112	[p6l990t2710r1691b2811],
18	reaction	NN	O	reaction	dobj	16	SENT_112	[p6l1759t2711r2142b2789],
19	.	.	O	.	_	0	SENT_112	[p6l1759t2711r2142b2789],

1	Such	JJ	O	such	amod	2	SENT_113	[p6l14t2838r220b2917],
2	analyses	NNS	O	analysis	nsubjpass	6	SENT_113	[p6l260t2838r621b2939],
3	have	VBP	O	have	aux	6	SENT_113	[p6l662t2838r853b2917],
4	thus	RB	O	thus	advmod	6	SENT_113	[p6l893t2838r1077b2917],
5	been	VBN	O	be	auxpass	6	SENT_113	[p6l1119t2838r1322b2917],
6	shown	VBN	O	show	ccomp	19	SENT_113	[p6l1362t2838r1646b2917],
7	to	TO	O	to	aux	9	SENT_113	[p6l1686t2855r1768b2917],
8	be	VB	O	be	cop	9	SENT_113	[p6l1809t2838r1906b2917],
9	costeffective	JJ	O	costeffective	xcomp	6	SENT_113	[p6l1946t2855r2146b2917, p6l12t2966r474b3062],
10	,	,	O	,	_	0	SENT_113	[p6l1946t2855r2146b2917, p6l12t2966r474b3062],
11	“	NN	O	“	nsubj	19	SENT_113	[p6l1946t2855r2146b2917, p6l12t2966r474b3062],
12	and	CC	O	and	_	0	SENT_113	[p6l528t2966r686b3045],
13	the	DT	O	the	det	14	SENT_113	[p6l743t2966r876b3045],
14	data	NNS	O	datum	nsubj	19	SENT_113	[p6l932t2966r1116b3045],
15	of	IN	O	of	_	0	SENT_113	[p6l1171t2966r1272b3045],
16	Mallal	NNP	O	Mallal	prep_of	14	SENT_113	[p6l1305t2966r1582b3045],
17	et	FW	O	et	nn	18	SENT_113	[p6l1637t2983r1715b3045],
18	al.	FW	O	al.	dep	14	SENT_113	[p6l1765t2966r1862b3045],
19	show	VBP	O	show	_	0	SENT_113	[p6l1925t2966r2152b3046],
20	that	IN	O	that	complm	21	SENT_113	[p6l12t3095r186b3174],
21	screening	VBG	O	screen	ccomp	19	SENT_113	[p6l235t3096r656b3196],
22	for	IN	O	for	_	0	SENT_113	[p6l706t3095r830b3174],
23	HLA	NN	O	hlum	prep_for	21	SENT_113	[p6l879t3095r1420b3174],
24	.	.	O	.	_	0	SENT_113	[p6l879t3095r1420b3174],

1	—	NN	O	—	_	0	SENT_114	[p6l879t3095r1420b3174],
2	.	.	O	.	_	0	SENT_114	[p6l879t3095r1420b3174],

1	B	NN	O	b	nsubj	5	SENT_115	[p6l879t3095r1420b3174],
2	*	CD	NUMBER	*	num	3	SENT_115	[p6l879t3095r1420b3174],
3	5701	NN	NUMBER	5701	dep	1	SENT_115	[p6l879t3095r1420b3174],
4	can	MD	O	can	aux	5	SENT_115	[p6l1475t3121r1625b3174],
5	reduce	VB	O	reduce	_	0	SENT_115	[p6l1678t3095r1960b3174],
6	the	DT	O	the	det	7	SENT_115	[p6l2014t3095r2147b3174],
7	incidence	NN	O	incidence	dobj	5	SENT_115	[p6l11t3223r419b3302],
8	of	IN	O	of	_	0	SENT_115	[p6l468t3223r568b3302],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_115	[p6l597t3223r1282b3324],
10	reaction	NN	O	reaction	prep_of	7	SENT_115	[p6l1325t3224r1676b3302],
11	to	TO	O	to	aux	13	SENT_115	[p6l1723t3240r1805b3302],
12	almost	RB	O	almost	advmod	13	SENT_115	[p6l1854t3223r2153b3302],
13	nil	VB	O	nil	xcomp	5	SENT_115	[p6l12t3351r150b3430],
14	.	.	O	.	_	0	SENT_115	[p6l12t3351r150b3430],

1	Patients	NNS	O	patient	_	0	SENT_116	[p6l216t3352r558b3430],
2	who	WP	O	who	nsubj	3	SENT_116	[p6l617t3351r800b3430],
3	carry	VBP	O	carry	rcmod	1	SENT_116	[p6l865t3377r1087b3452],
4	HLA	NN	O	hlum	dobj	3	SENT_116	[p6l1144t3351r1685b3430],
5	.	.	O	.	_	0	SENT_116	[p6l1144t3351r1685b3430],

1	—	NN	O	—	_	0	SENT_117	[p6l1144t3351r1685b3430],
2	.	.	O	.	_	0	SENT_117	[p6l1144t3351r1685b3430],

1	B	NN	O	b	nn	8	SENT_118	[p6l1144t3351r1685b3430],
2	*	CD	NUMBER	*	num	3	SENT_118	[p6l1144t3351r1685b3430],
3	5701	CD	NUMBER	5701	dep	8	SENT_118	[p6l1144t3351r1685b3430],
4	and	CC	O	and	_	0	SENT_118	[p6l1746t3351r1905b3430],
5	who	WP	O	who	nsubj	7	SENT_118	[p6l1962t3351r2147b3430],
6	should	MD	O	should	aux	7	SENT_118	[p6l13t3479r302b3558],
7	receive	VB	O	receive	dep	8	SENT_118	[p6l344t3480r635b3558],
8	abacavir	NN	O	abacavir	nsubj	21	SENT_118	[p6l676t3479r1052b3575],
9	,	,	O	,	_	0	SENT_118	[p6l676t3479r1052b3575],
10	such	JJ	O	such	_	0	SENT_118	[p6l1101t3479r1296b3558],
11	as	IN	O	as	_	0	SENT_118	[p6l1338t3506r1423b3558],
12	those	DT	O	those	prep_such_as	8	SENT_118	[p6l1467t3479r1700b3558],
13	requiring	VBG	O	require	partmod	12	SENT_118	[p6l1743t3480r2151b3580],
14	deep	JJ	O	deep	amod	18	SENT_118	[p6l12t3607r564b3708],
15	—	NN	O	—	nn	18	SENT_118	[p6l12t3607r564b3708],
16	salvage	NN	O	salvage	nn	18	SENT_118	[p6l12t3607r564b3708],
17	antiretroviral	JJ	O	antiretroviral	amod	18	SENT_118	[p6l600t3607r1177b3686],
18	therapy	NN	O	therapy	dobj	13	SENT_118	[p6l1214t3607r1551b3708],
19	,	,	O	,	_	0	SENT_118	[p6l1214t3607r1551b3708],
20	would	MD	O	would	aux	21	SENT_118	[p6l1589t3607r1857b3687],
21	be	VB	O	be	_	0	SENT_118	[p6l1894t3607r1991b3686],
22	extremely	RB	O	extremely	advmod	21	SENT_118	[p6l2029t3634r2147b3686, p7l12t20r338b121],

1	rare	JJ	O	rare	_	0	SENT_119	[p7l372t46r541b99],
2	because	IN	O	because	mark	6	SENT_119	[p7l580t20r918b99],
3	alternative	JJ	O	alternative	amod	4	SENT_119	[p7l957t20r1411b99],
4	medications	NNS	O	medication	nsubj	6	SENT_119	[p7l1449t20r1977b99],
5	are	VBP	O	be	cop	6	SENT_119	[p7l2018t46r2147b99],
6	available	JJ	O	available	dep	1	SENT_119	[p7l11t148r409b227],
7	.	.	O	.	_	0	SENT_119	[p7l11t148r409b227],

1	If	IN	O	if	mark	8	SENT_120	[p7l451t148r534b226],
2	abacavir	NN	O	abacavir	nn	3	SENT_120	[p7l553t148r912b227],
3	therapy	NN	O	therapy	nsubj	8	SENT_120	[p7l947t148r1271b249],
4	for	IN	O	for	_	0	SENT_120	[p7l1304t148r1429b227],
5	such	JJ	O	such	amod	6	SENT_120	[p7l1465t148r1660b227],
6	patients	NNS	O	patient	prep_for	3	SENT_120	[p7l1696t149r2040b249],
7	is	VBZ	O	be	cop	8	SENT_120	[p7l2079t149r2145b227],
8	unavoidable	JJ	O	unavoidable	advcl	19	SENT_120	[p7l12t276r565b372],
9	,	,	O	,	_	0	SENT_120	[p7l12t276r565b372],
10	however	RB	O	however	advmod	19	SENT_120	[p7l634t276r1018b372],
11	,	,	O	,	_	0	SENT_120	[p7l634t276r1018b372],
12	careful	JJ	O	careful	amod	13	SENT_120	[p7l1088t276r1395b355],
13	monitoring	NN	O	monitoring	nsubjpass	19	SENT_120	[p7l1458t277r1965b377],
14	for	IN	O	for	_	0	SENT_120	[p7l2024t276r2151b355],
15	hypersensitivity	NN	O	hypersensitivity	nn	16	SENT_120	[p7l12t404r713b505],
16	reaction	NN	O	reaction	prep_for	13	SENT_120	[p7l753t405r1111b483],
17	would	MD	O	would	aux	19	SENT_120	[p7l1151t404r1422b484],
18	be	VB	O	be	auxpass	19	SENT_120	[p7l1466t404r1565b483],
19	required	VBN	O	require	_	0	SENT_120	[p7l1609t404r1981b505],
20	for	IN	O	for	_	0	SENT_120	[p7l2024t404r2151b483],
21	6	CD	DURATION	6	num	22	SENT_120	[p7l12t538r59b611],
22	weeks	NNS	NUMBER	week	prep_for	19	SENT_120	[p7l96t532r389b612],
23	.	.	O	.	_	0	SENT_120	[p7l96t532r389b612],

1	The	DT	O	the	det	3	SENT_121	[p7l138t660r298b739],
2	drug	NN	O	drug	nn	3	SENT_121	[p7l349t660r551b761],
3	industry	NN	O	industry	nsubj	7	SENT_121	[p7l596t660r952b761],
4	is	VBZ	O	be	cop	7	SENT_121	[p7l997t661r1062b739],
5	usually	RB	O	usually	advmod	7	SENT_121	[p7l1114t660r1417b761],
6	very	RB	O	very	advmod	7	SENT_121	[p7l1457t687r1633b761],
7	hesitant	JJ	O	hesitant	_	0	SENT_121	[p7l1678t660r2020b739],
8	to	TO	O	to	prep	7	SENT_121	[p7l2065t677r2146b739],

1	638	CD	NUMBER	638	num	4	SENT_122	[p7l149t836r206b860],
2	N	NN	O	n	nn	4	SENT_122	[p7l909t847r922b862],
3	ENGLJ	NN	O	englj	nn	4	SENT_122	[p7l937t847r1015b869],
4	MED	NN	O	med	_	0	SENT_122	[p7l1030t847r1082b862],
5	358	CD	NUMBER	358	num	7	SENT_122	[p7l1092t841r1155b869],
6	;	:	O	;	_	0	SENT_122	[p7l1092t841r1155b869],
7	6	CD	NUMBER	6	dep	4	SENT_122	[p7l1092t841r1155b869],
8	WWW.NEJM.oRG	NNP	O	WWW.NEJM.oRG	nn	9	SENT_122	[p7l1189t847r1390b869],
9	FEBRUARY	NNP	DATE	FEBRUARY	dep	4	SENT_122	[p7l1427t847r1548b863],
10	7	CD	DATE	7	num	9	SENT_122	[p7l1558t847r1577b868],
11	,	,	DATE	,	_	0	SENT_122	[p7l1558t847r1577b868],
12	2008	CD	DATE	2008	num	9	SENT_122	[p7l1588t841r1651b863],

1	The	DT	O	the	det	4	SENT_123	[p7l936t880r987b904],
2	New	NNP	O	New	nn	4	SENT_123	[p7l996t881r1058b904],
3	England	NNP	O	England	nn	4	SENT_123	[p7l1067t880r1178b911],
4	Journal	NNP	O	Journal	_	0	SENT_123	[p7l1187t880r1284b904],
5	of	IN	O	of	_	0	SENT_123	[p7l1294t880r1323b904],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_123	[p7l1330t880r1455b904],

1	EDITORIALS	NNS	O	editorial	_	0	SENT_124	[p7l983t1068r1177b1087],

1	release	NN	O	release	nn	2	SENT_125	[p7l11t1282r300b1361],
2	drugs	NNS	O	drug	nsubj	14	SENT_125	[p7l339t1282r580b1383],
3	requiring	VBG	O	require	partmod	2	SENT_125	[p7l620t1283r1021b1383],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_125	[p7l1054t1282r1794b1383],
5	testing	NN	O	testing	dobj	3	SENT_125	[p7l1832t1283r2144b1383],
6	,	,	O	,	_	0	SENT_125	[p7l1832t1283r2144b1383],
7	because	IN	O	because	_	0	SENT_125	[p7l12t1410r350b1489],
8	the	DT	O	the	det	9	SENT_125	[p7l394t1410r527b1489],
9	basis	NN	O	basis	prep_because	3	SENT_125	[p7l571t1410r783b1489],
10	for	IN	O	for	_	0	SENT_125	[p7l828t1410r952b1489],
11	prescription	NN	O	prescription	prep_for	9	SENT_125	[p7l991t1411r1517b1511],
12	is	VBZ	O	be	cop	14	SENT_125	[p7l1559t1411r1625b1489],
13	more	RBR	O	more	advmod	14	SENT_125	[p7l1670t1436r1891b1489],
14	complex	JJ	O	complex	_	0	SENT_125	[p7l1934t1436r2148b1489, p7l10t1538r188b1639],
15	than	IN	O	than	prep	14	SENT_125	[p7l227t1538r424b1617],
16	for	IN	O	for	pcomp	15	SENT_125	[p7l467t1538r591b1617],
17	drugs	NNS	O	drug	pobj	16	SENT_125	[p7l631t1538r876b1639],
18	not	RB	O	not	neg	19	SENT_125	[p7l920t1555r1064b1617],
19	requiring	VBG	O	require	xcomp	14	SENT_125	[p7l1101t1539r1510b1639],
20	testing	NN	O	testing	dobj	19	SENT_125	[p7l1549t1539r1868b1639],
21	.	.	O	.	_	0	SENT_125	[p7l1549t1539r1868b1639],

1	However	RB	O	however	advmod	10	SENT_126	[p7l1915t1546r2148b1617, p7l12t1692r202b1762],
2	,	,	O	,	_	0	SENT_126	[p7l1915t1546r2148b1617, p7l12t1692r202b1762],
3	the	DT	O	the	det	4	SENT_126	[p7l250t1666r384b1745],
4	rate	NN	O	rate	nsubj	10	SENT_126	[p7l427t1683r588b1745],
5	of	IN	O	of	_	0	SENT_126	[p7l631t1666r731b1745],
6	prescription	NN	O	prescription	prep_of	4	SENT_126	[p7l753t1667r1280b1767],
7	of	IN	O	of	_	0	SENT_126	[p7l1323t1666r1424b1745],
8	abacavir	NN	O	abacavir	prep_of	6	SENT_126	[p7l1446t1666r1806b1745],
9	has	VBZ	O	have	aux	10	SENT_126	[p7l1845t1666r1989b1745],
10	increased	VBN	O	increase	_	0	SENT_126	[p7l2033t1667r2148b1744, p7l12t1794r335b1873],
11	in	IN	O	in	_	0	SENT_126	[p7l366t1795r449b1872],
12	the	DT	O	the	det	14	SENT_126	[p7l482t1794r616b1873],
13	United	NNP	LOCATION	United	nn	14	SENT_126	[p7l648t1794r937b1873],
14	Kingdom	NNP	LOCATION	Kingdom	prep_in	10	SENT_126	[p7l968t1794r1375b1895],
15	since	IN	O	since	_	0	SENT_126	[p7l1408t1795r1625b1873],
16	prospective	JJ	O	prospective	amod	17	SENT_126	[p7l1656t1795r2149b1895],
17	HLA	NN	O	hlum	prep_since	10	SENT_126	[p7l11t1922r552b2001],
18	.	.	O	.	_	0	SENT_126	[p7l11t1922r552b2001],

1	—	NN	O	—	_	0	SENT_127	[p7l11t1922r552b2001],
2	.	.	O	.	_	0	SENT_127	[p7l11t1922r552b2001],

1	B	NN	O	b	nsubjpass	6	SENT_128	[p7l11t1922r552b2001],
2	*	CD	NUMBER	*	num	1	SENT_128	[p7l11t1922r552b2001],
3	5701	CD	NUMBER	5701	num	4	SENT_128	[p7l11t1922r552b2001],
4	genotyping	NN	O	genotyping	dep	1	SENT_128	[p7l588t1923r1082b2023],
5	was	VBD	O	be	auxpass	6	SENT_128	[p7l1110t1949r1273b2002],
6	introduced	VBN	O	introduce	_	0	SENT_128	[p7l1311t1922r1782b2001],
7	(	CD	NUMBER	(	num	8	SENT_128	[p7l1822t1923r2148b2014],
8	Pirmo	NNP	O	Pirmo	dobj	6	SENT_128	[p7l1822t1923r2148b2014],
9	—	CD	NUMBER	—	num	8	SENT_128	[p7l1822t1923r2148b2014],
10	hamed	VBD	O	hame	rcmod	8	SENT_128	[p7l11t2050r302b2129],
11	M	NN	O	m	dobj	10	SENT_128	[p7l337t2058r445b2146],
12	,	,	O	,	_	0	SENT_128	[p7l337t2058r445b2146],
13	University	NNP	ORGANIZATION	University	appos	11	SENT_128	[p7l488t2051r917b2151],
14	of	IN	ORGANIZATION	of	_	0	SENT_128	[p7l952t2050r1051b2129],
15	Liverpool	NNP	ORGANIZATION	Liverpool	prep_of	13	SENT_128	[p7l1069t2050r1489b2151],
16	:	:	O	:	_	0	SENT_128	[p7l1069t2050r1489b2151],
17	personal	JJ	O	personal	amod	19	SENT_128	[p7l1530t2050r1899b2151],
18	communication	NN	O	communication	nn	19	SENT_128	[p7l1937t2076r2148b2129, p7l11t2179r548b2270],
19	)	NN	O	)	dep	11	SENT_128	[p7l1937t2076r2148b2129, p7l11t2179r548b2270],
20	.	.	O	.	_	0	SENT_128	[p7l1937t2076r2148b2129, p7l11t2179r548b2270],

1	Thus	RB	O	thus	advmod	40	SENT_129	[p7l588t2178r826b2274],
2	,	,	O	,	_	0	SENT_129	[p7l588t2178r826b2274],
3	the	DT	O	the	det	4	SENT_129	[p7l872t2178r1006b2257],
4	use	NN	O	use	nsubj	40	SENT_129	[p7l1047t2205r1188b2257],
5	of	IN	O	of	_	0	SENT_129	[p7l1229t2178r1329b2257],
6	validated	VBN	O	validate	prepc_of	4	SENT_129	[p7l1347t2178r1740b2257],
7	pharma	NN	O	pharma	nn	8	SENT_129	[p7l1777t2178r2148b2279],
8	—	NN	O	—	dobj	6	SENT_129	[p7l1777t2178r2148b2279],
9	cogenetic	JJ	O	cogenetic	amod	10	SENT_129	[p7l12t2307r423b2407],
10	biomarkers	NNS	O	biomarker	nsubj	12	SENT_129	[p7l466t2306r955b2386],
11	might	MD	O	might	aux	12	SENT_129	[p7l1000t2306r1263b2407],
12	result	VB	O	result	rcmod	8	SENT_129	[p7l1300t2306r1546b2385],
13	in	IN	O	in	advmod	14	SENT_129	[p7l1582t2307r1667b2384],
14	increased	VBN	O	increase	dep	12	SENT_129	[p7l1708t2306r2144b2402],
15	,	,	O	,	_	0	SENT_129	[p7l1708t2306r2144b2402],
16	rather	RB	O	rather	_	0	SENT_129	[p7l11t2434r273b2513],
17	than	IN	O	than	_	0	SENT_129	[p7l325t2434r523b2513],
18	decreased	VBN	O	decrease	dep	12	SENT_129	[p7l579t2434r1027b2530],
19	,	,	O	,	_	0	SENT_129	[p7l579t2434r1027b2530],
20	use	NN	O	use	dep	12	SENT_129	[p7l1087t2461r1229b2513],
21	of	IN	O	of	_	0	SENT_129	[p7l1285t2434r1385b2513],
22	medication	NN	O	medication	prep_of	20	SENT_129	[p7l1421t2434r1908b2513],
23	and	CC	O	and	_	0	SENT_129	[p7l1962t2434r2144b2530],
24	,	,	O	,	_	0	SENT_129	[p7l1962t2434r2144b2530],
25	in	IN	O	in	dep	12	SENT_129	[p7l11t2564r94b2641],
26	my	PRP$	O	my	poss	27	SENT_129	[p7l132t2589r262b2664],
27	opinion	NN	O	opinion	pobj	25	SENT_129	[p7l296t2564r654b2664],
28	,	,	O	,	_	0	SENT_129	[p7l296t2564r654b2664],
29	the	DT	O	the	det	30	SENT_129	[p7l697t2563r831b2642],
30	development	NN	O	development	nsubj	36	SENT_129	[p7l870t2563r1423b2664],
31	of	IN	O	of	_	0	SENT_129	[p7l1455t2563r1556b2642],
32	pharmacoge	NN	O	pharmacoge	nn	35	SENT_129	[p7l1573t2563r2148b2664],
33	—	NN	O	—	nn	35	SENT_129	[p7l1573t2563r2148b2664],
34	netic	JJ	O	netic	amod	35	SENT_129	[p7l11t2692r220b2770],
35	biomarkers	NNS	O	biomarker	prep_of	30	SENT_129	[p7l267t2691r757b2771],
36	may	MD	O	may	rcmod	8	SENT_129	[p7l807t2717r987b2792],
37	in	IN	O	in	_	0	SENT_129	[p7l1030t2692r1113b2769],
38	many	JJ	O	many	amod	39	SENT_129	[p7l1161t2717r1401b2792],
39	cases	NNS	O	case	prep_in	36	SENT_129	[p7l1445t2718r1669b2770],
40	constitute	VBP	O	constitute	_	0	SENT_129	[p7l1719t2692r2149b2770],
41	an	DT	O	a	det	43	SENT_129	[p7l11t2845r114b2898],
42	integral	JJ	O	integral	amod	43	SENT_129	[p7l151t2819r491b2920],
43	part	NN	O	part	dobj	40	SENT_129	[p7l527t2836r708b2920],
44	of	IN	O	of	_	0	SENT_129	[p7l741t2819r842b2898],
45	drug	NN	O	drug	nn	46	SENT_129	[p7l862t2819r1068b2920],
46	development	NN	O	development	prep_of	43	SENT_129	[p7l1104t2819r1677b2920],
47	.	.	O	.	_	0	SENT_129	[p7l1104t2819r1677b2920],

1	HLA	NN	O	hlum	_	0	SENT_130	[p7l141t2947r682b3026],
2	.	.	O	.	_	0	SENT_130	[p7l141t2947r682b3026],

1	—	NN	O	—	_	0	SENT_131	[p7l141t2947r682b3026],
2	.	.	O	.	_	0	SENT_131	[p7l141t2947r682b3026],

1	B	NN	O	b	_	0	SENT_132	[p7l141t2947r682b3026],
2	*	CD	NUMBER	*	number	3	SENT_132	[p7l141t2947r682b3026],
3	5701	CD	NUMBER	5701	dep	1	SENT_132	[p7l141t2947r682b3026],
4	genotyping	NN	O	genotyping	nsubj	5	SENT_132	[p7l723t2948r1219b3048],
5	appears	VBZ	O	appear	dep	1	SENT_132	[p7l1256t2973r1590b3048],
6	to	TO	O	to	aux	11	SENT_132	[p7l1634t2964r1716b3026],
7	be	VB	O	be	cop	11	SENT_132	[p7l1760t2947r1857b3026],
8	an	DT	O	a	det	11	SENT_132	[p7l1898t2973r2001b3026],
9	effective	JJ	O	effective	amod	10	SENT_132	[p7l2044t2947r2148b3026, p7l11t3075r287b3155],
10	pharmacogenomic	JJ	O	pharmacogenomic	amod	11	SENT_132	[p7l336t3075r1152b3176],
11	test	NN	O	test	xcomp	5	SENT_132	[p7l1201t3092r1356b3154],
12	in	IN	O	in	_	0	SENT_132	[p7l1400t3076r1484b3153],
13	white	JJ	O	white	amod	14	SENT_132	[p7l1529t3075r1769b3154],
14	populations	NNS	O	population	prep_in	11	SENT_132	[p7l1817t3075r2148b3176, p7l12t3204r249b3299],
15	,	,	O	,	_	0	SENT_132	[p7l1817t3075r2148b3176, p7l12t3204r249b3299],
16	with	IN	O	with	_	0	SENT_132	[p7l289t3203r486b3282],
17	high	JJ	O	high	amod	18	SENT_132	[p7l524t3203r721b3304],
18	sensitivity	NN	O	sensitivity	prep_with	1	SENT_132	[p7l761t3204r1198b3304],
19	and	CC	O	and	_	0	SENT_132	[p7l1231t3203r1390b3282],
20	modest	JJ	O	modest	amod	21	SENT_132	[p7l1428t3203r1749b3282],
21	specificity	NN	O	specificity	prep_with	1	SENT_132	[p7l1784t3203r2148b3304, p7l11t3332r132b3432],
22	,	,	O	,	_	0	SENT_132	[p7l1784t3203r2148b3304, p7l11t3332r132b3432],
23	allowing	VBG	O	allow	partmod	1	SENT_132	[p7l186t3331r567b3432],
24	clinicians	NNS	O	clinician	dobj	23	SENT_132	[p7l615t3331r1030b3410],
25	to	TO	O	to	aux	26	SENT_132	[p7l1082t3348r1164b3410],
26	avert	VB	O	avert	xcomp	23	SENT_132	[p7l1214t3348r1424b3410],
27	a	DT	O	a	det	30	SENT_132	[p7l1468t3358r1512b3410],
28	specific	JJ	O	specific	amod	30	SENT_132	[p7l1561t3331r1893b3432],
29	toxic	JJ	O	toxic	amod	30	SENT_132	[p7l1943t3332r2150b3410],
30	effect	NN	O	effect	dobj	26	SENT_132	[p7l12t3459r255b3538],
31	of	IN	O	of	_	0	SENT_132	[p7l299t3459r400b3538],
32	a	DT	O	a	det	33	SENT_132	[p7l429t3486r474b3538],
33	drug	NN	O	drug	prep_of	1	SENT_132	[p7l522t3459r747b3560],
34	.	.	O	.	_	0	SENT_132	[p7l522t3459r747b3560],

1	It	PRP	O	it	nsubj	6	SENT_133	[p7l799t3467r865b3538],
2	is	VBZ	O	be	cop	6	SENT_133	[p7l907t3460r973b3538],
3	also	RB	O	also	advmod	6	SENT_133	[p7l1023t3459r1196b3538],
4	an	DT	O	a	det	6	SENT_133	[p7l1245t3485r1349b3538],
5	important	JJ	O	important	amod	6	SENT_133	[p7l1397t3460r1841b3560],
6	precedent	NN	O	precedent	_	0	SENT_133	[p7l1884t3485r2148b3560, p7l12t3587r202b3666],
7	for	IN	O	for	_	0	SENT_133	[p7l242t3587r366b3666],
8	further	JJ	O	further	amod	10	SENT_133	[p7l408t3587r719b3666],
9	pharmacogenomic	JJ	O	pharmacogenomic	amod	10	SENT_133	[p7l759t3587r1576b3688],
10	research	NN	O	research	prep_for	6	SENT_133	[p7l1620t3587r1985b3666],
11	toward	IN	O	toward	prep	6	SENT_133	[p7l2031t3604r2148b3666, p8l7t20r224b99],

1	safer	JJR	O	safer	_	0	SENT_134	[p8l282t20r510b116],
2	,	,	O	,	_	0	SENT_134	[p8l282t20r510b116],
3	more	RBR	O	more	advmod	4	SENT_134	[p8l573t46r794b99],
4	effective	JJ	O	effective	amod	6	SENT_134	[p8l852t20r1212b99],
5	individualized	JJ	O	individualized	amod	6	SENT_134	[p8l1269t20r1889b99],
6	drug	NN	O	drug	appos	1	SENT_134	[p8l1947t20r2152b121],
7	therapy	NN	O	therapy	dep	6	SENT_134	[p8l12t148r349b249],
8	.	.	O	.	_	0	SENT_134	[p8l12t148r349b249],

1	Dr.	NNP	O	Dr.	nn	2	SENT_135	[p8l96t302r196b357],
2	Ingelman-Sundberg	NNP	PERSON	Ingelman-Sundberg	nsubj	3	SENT_135	[p8l229t297r890b374],
3	reports	VBZ	O	report	_	0	SENT_135	[p8l918t310r1148b373],
4	receiving	VBG	O	receive	xcomp	3	SENT_135	[p8l1182t298r1477b374],
5	grant	NN	O	grant	nn	6	SENT_135	[p8l1505t310r1680b374],
6	support	NN	O	support	dobj	4	SENT_135	[p8l1709t310r1965b373],
7	from	IN	O	from	_	0	SENT_135	[p8l1992t297r2151b357],
8	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	4	SENT_135	[p8l7t388r409b442],
9	for	IN	O	for	_	0	SENT_135	[p8l443t383r538b442],
10	two	CD	NUMBER	two	num	12	SENT_135	[p8l571t396r687b443],
11	research	NN	O	research	nn	12	SENT_135	[p8l723t383r997b442],
12	projects	NNS	O	project	prep_for	8	SENT_135	[p8l1031t384r1307b458],
13	.	.	O	.	_	0	SENT_135	[p8l1031t384r1307b458],

1	No	DT	O	no	det	4	SENT_136	[p8l1345t388r1441b443],
2	other	JJ	O	other	amod	4	SENT_136	[p8l1478t383r1650b442],
3	potential	JJ	O	potential	amod	4	SENT_136	[p8l1682t383r1972b458],
4	conﬂict	NN	O	conﬂict	nsubjpass	12	SENT_136	[p8l2008t402r2149b442, p8l10t470r138b529],
5	of	IN	O	of	_	0	SENT_136	[p8l162t470r239b529],
6	interest	NN	O	interest	prep_of	4	SENT_136	[p8l251t471r499b529],
7	relevant	JJ	O	relevant	amod	6	SENT_136	[p8l523t470r782b530],
8	to	TO	O	to	_	0	SENT_136	[p8l805t483r865b529],
9	this	DT	O	this	det	10	SENT_136	[p8l894t470r1012b529],
10	article	NN	O	article	prep_to	7	SENT_136	[p8l1040t470r1239b529],
11	was	VBD	O	be	auxpass	12	SENT_136	[p8l1263t489r1386b530],
12	reported	VBN	O	report	_	0	SENT_136	[p8l1415t470r1710b545],
13	.	.	O	.	_	0	SENT_136	[p8l1415t470r1710b545],

1	From	IN	O	from	dep	6	SENT_137	[p8l16t652r183b708],
2	the	DT	O	the	det	4	SENT_137	[p8l206t646r312b708],
3	Section	NN	O	section	nn	4	SENT_137	[p8l334t651r583b708],
4	ofPharmacogenetics	NNS	O	ofpharmacogenetic	pobj	1	SENT_137	[p8l609t646r1341b727],
5	,	,	O	,	_	0	SENT_137	[p8l609t646r1341b727],
6	Department	NNP	ORGANIZATION	Department	_	0	SENT_137	[p8l1371t652r1782b726],
7	of	IN	ORGANIZATION	of	_	0	SENT_137	[p8l1802t646r1875b708],
8	Physiology	NNP	ORGANIZATION	Physiology	prep_of	6	SENT_137	[p8l1890t646r2149b727, p8l11t765r129b824],
9	and	CC	ORGANIZATION	and	_	0	SENT_137	[p8l153t743r271b805],
10	Pharmacology	NNP	ORGANIZATION	Pharmacology	conj_and	8	SENT_137	[p8l304t743r800b824],
11	,	,	O	,	_	0	SENT_137	[p8l304t743r800b824],
12	Karolinska	NNP	PERSON	Karolinska	dep	6	SENT_137	[p8l833t743r1178b805],
13	Institutet	NNP	PERSON	Institutet	dep	12	SENT_137	[p8l1209t749r1534b815],
14	,	,	O	,	_	0	SENT_137	[p8l1209t749r1534b815],
15	Stockholm	NNP	LOCATION	Stockholm	dep	6	SENT_137	[p8l1563t743r1942b805],
16	.	.	O	.	_	0	SENT_137	[p8l1563t743r1942b805],

1	1	LS	NUMBER	1	_	0	SENT_138	[p8l13t935r62b986],
2	.	.	O	.	_	0	SENT_138	[p8l13t935r62b986],

1	Eichelbaum	NNP	PERSON	Eichelbaum	nn	2	SENT_139	[p8l139t928r527b988],
2	M	NNP	O	M	_	0	SENT_139	[p8l555t933r639b999],
3	,	,	O	,	_	0	SENT_139	[p8l555t933r639b999],
4	Ingelman	NNP	O	Ingelman	appos	2	SENT_139	[p8l672t928r1340b1003],
5	.	.	O	.	_	0	SENT_139	[p8l672t928r1340b1003],

1	—	NN	O	—	_	0	SENT_140	[p8l672t928r1340b1003],
2	.	.	O	.	_	0	SENT_140	[p8l672t928r1340b1003],

1	Sundberg	NNP	PERSON	Sundberg	nn	2	SENT_141	[p8l672t928r1340b1003],
2	M	NNP	O	M	_	0	SENT_141	[p8l1365t933r1448b999],
3	,	,	O	,	_	0	SENT_141	[p8l1365t933r1448b999],
4	Evans	NNP	PERSON	Evans	nn	5	SENT_141	[p8l1482t933r1671b988],
5	WE	NNP	O	WE	appos	2	SENT_141	[p8l1700t933r1835b987],
6	.	.	O	.	_	0	SENT_141	[p8l1700t933r1835b987],

1	Pharma	NNP	O	Pharma	_	0	SENT_142	[p8l1868t928r2149b986],
2	—	CD	NUMBER	—	num	3	SENT_142	[p8l1868t928r2149b986],
3	cogenomics	NNS	O	cogenomic	dep	1	SENT_142	[p8l11t1025r405b1099],
4	and	CC	O	and	_	0	SENT_142	[p8l447t1024r569b1083],
5	individualized	VBN	O	individualize	dep	1	SENT_142	[p8l610t1024r1086b1083],
6	drug	NN	O	drug	nn	7	SENT_142	[p8l1129t1024r1285b1099],
7	therapy	NN	O	therapy	dobj	5	SENT_142	[p8l1325t1024r1584b1099],
8	.	.	O	.	_	0	SENT_142	[p8l1325t1024r1584b1099],

1	Annu	NNP	PERSON	Annu	nn	2	SENT_143	[p8l1628t1029r1809b1084],
2	Rev	NN	PERSON	rev	nsubj	3	SENT_143	[p8l1850t1029r1971b1086],
3	Med	VBD	O	med	_	0	SENT_143	[p8l2007t1024r2150b1083],
4	2006	CD	DATE	2006	dobj	3	SENT_143	[p8l10t1124r523b1192],
5	;	:	O	;	_	0	SENT_143	[p8l10t1124r523b1192],
6	57:119	CD	NUMBER	57:119	num	7	SENT_143	[p8l10t1124r523b1192],
7	-37	CD	NUMBER	-37	dep	4	SENT_143	[p8l10t1124r523b1192],
8	.	.	O	.	_	0	SENT_143	[p8l10t1124r523b1192],

1	2	LS	NUMBER	2	_	0	SENT_144	[p8l9t1224r62b1275],
2	.	.	O	.	_	0	SENT_144	[p8l9t1224r62b1275],

1	Moore	NNP	PERSON	Moore	nn	3	SENT_145	[p8l138t1222r351b1276],
2	T	NN	O	t	nn	3	SENT_145	[p8l391t1221r478b1288],
3	]	NN	O	]	_	0	SENT_145	[p8l391t1221r478b1288],
4	,	,	O	,	_	0	SENT_145	[p8l391t1221r478b1288],
5	Cohen	NNP	PERSON	Cohen	nn	6	SENT_145	[p8l525t1217r736b1276],
6	MR	NN	PERSON	mr	appos	3	SENT_145	[p8l776t1222r912b1288],
7	,	,	O	,	_	0	SENT_145	[p8l776t1222r912b1288],
8	Furberg	NNP	PERSON	Furberg	nn	9	SENT_145	[p8l958t1217r1221b1292],
9	CD	NNP	O	CD	appos	6	SENT_145	[p8l1261t1221r1377b1276],
10	.	.	O	.	_	0	SENT_145	[p8l1261t1221r1377b1276],

1	Serious	JJ	O	serious	amod	4	SENT_146	[p8l1426t1218r1666b1277],
2	adverse	JJ	O	adverse	amod	4	SENT_146	[p8l1710t1217r1953b1277],
3	drug	NN	O	drug	nn	4	SENT_146	[p8l1996t1217r2153b1292],
4	events	NNS	O	event	nsubj	5	SENT_146	[p8l11t1326r214b1373],
5	reported	VBD	O	report	_	0	SENT_146	[p8l255t1313r538b1388],
6	to	TO	O	to	_	0	SENT_146	[p8l578t1325r640b1372],
7	the	DT	O	the	det	11	SENT_146	[p8l681t1313r783b1371],
8	Food	NNP	ORGANIZATION	Food	nn	11	SENT_146	[p8l822t1313r986b1372],
9	and	CC	ORGANIZATION	and	_	0	SENT_146	[p8l1025t1313r1146b1372],
10	Drug	NNP	ORGANIZATION	Drug	nn	11	SENT_146	[p8l1184t1318r1354b1388],
11	Administration	NNP	ORGANIZATION	Administration	prep_to	5	SENT_146	[p8l1388t1313r1922b1384],
12	,	,	O	,	_	0	SENT_146	[p8l1388t1313r1922b1384],
13	19982005	CD	NUMBER	19982005	appos	11	SENT_146	[p8l1967t1317r2149b1372, p8l11t1413r185b1468],
14	.	.	O	.	_	0	SENT_146	[p8l1967t1317r2149b1372, p8l11t1413r185b1468],

1	Arch	NNP	O	Arch	nn	3	SENT_147	[p8l213t1409r372b1468],
2	Intern	NNP	O	Intern	nn	3	SENT_147	[p8l397t1414r601b1468],
3	Med	NNP	O	Med	_	0	SENT_147	[p8l625t1409r769b1468],
4	2007	CD	DATE	2007	num	3	SENT_147	[p8l794t1413r1337b1479],
5	;	:	O	;	_	0	SENT_147	[p8l794t1413r1337b1479],
6	167:1752	CD	NUMBER	167:1752	number	7	SENT_147	[p8l794t1413r1337b1479],
7	—	CD	NUMBER	—	dep	3	SENT_147	[p8l794t1413r1337b1479],
8	9	CD	NUMBER	9	dep	7	SENT_147	[p8l794t1413r1337b1479],
9	.	.	O	.	_	0	SENT_147	[p8l794t1413r1337b1479],

1	3	LS	NUMBER	3	_	0	SENT_148	[p8l10t1512r60b1564],
2	.	.	O	.	_	0	SENT_148	[p8l10t1512r60b1564],

1	Need	VBN	O	need	_	0	SENT_149	[p8l137t1506r308b1565],
2	AC	NN	O	ac	dobj	1	SENT_149	[p8l334t1510r449b1577],
3	,	,	O	,	_	0	SENT_149	[p8l334t1510r449b1577],
4	Motulsky	NNP	ORGANIZATION	Motulsky	nn	5	SENT_149	[p8l479t1506r799b1581],
5	AG	NNP	ORGANIZATION	AG	appos	2	SENT_149	[p8l822t1510r944b1577],
6	,	,	O	,	_	0	SENT_149	[p8l822t1510r944b1577],
7	Goldstein	NNP	PERSON	Goldstein	nn	8	SENT_149	[p8l976t1506r1305b1564],
8	DB	NNP	O	DB	appos	5	SENT_149	[p8l1332t1511r1450b1564],
9	.	.	O	.	_	0	SENT_149	[p8l1332t1511r1450b1564],

1	Priorities	NNS	O	priority	_	0	SENT_150	[p8l1481t1506r1791b1564],
2	and	CC	O	and	_	0	SENT_150	[p8l1820t1506r1942b1564],
3	standards	NNS	O	standard	conj_and	1	SENT_150	[p8l1972t1518r2138b1564, p8l10t1602r194b1660],
4	in	IN	O	in	_	0	SENT_150	[p8l237t1602r301b1659],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_150	[p8l342t1602r929b1677],
6	research	NN	O	research	prep_in	1	SENT_150	[p8l971t1602r1274b1660],
7	.	.	O	.	_	0	SENT_150	[p8l971t1602r1274b1660],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_151	[p8l1318t1607r1438b1661],
2	Genet	NNP	PERSON	Genet	_	0	SENT_151	[p8l1476t1606r1676b1660],
3	2005	CD	DATE	2005	num	2	SENT_151	[p8l1714t1606r2138b1673, p8l10t1679r103b1733],
4	;	:	O	;	_	0	SENT_151	[p8l1714t1606r2138b1673, p8l10t1679r103b1733],
5	37:67181	CD	NUMBER	37:67181	dep	2	SENT_151	[p8l1714t1606r2138b1673, p8l10t1679r103b1733],
6	.	.	O	.	_	0	SENT_151	[p8l1714t1606r2138b1673, p8l10t1679r103b1733],

1	4	LS	NUMBER	4	_	0	SENT_152	[p8l7t1777r60b1828],
2	.	.	O	.	_	0	SENT_152	[p8l7t1777r60b1828],

1	Goldstein	NNP	PERSON	Goldstein	nn	2	SENT_153	[p8l139t1770r460b1828],
2	DB	NNP	O	DB	_	0	SENT_153	[p8l483t1775r599b1841],
3	,	,	O	,	_	0	SENT_153	[p8l483t1775r599b1841],
4	Tate	NNP	ORGANIZATION	Tate	nn	5	SENT_153	[p8l624t1774r763b1828],
5	SK	NNP	ORGANIZATION	SK	appos	2	SENT_153	[p8l788t1774r891b1841],
6	,	,	O	,	_	0	SENT_153	[p8l788t1774r891b1841],
7	Sisodiya	NNP	O	Sisodiya	nn	8	SENT_153	[p8l920t1770r1190b1845],
8	SM	NNP	O	SM	appos	5	SENT_153	[p8l1214t1774r1332b1828],
9	.	.	O	.	_	0	SENT_153	[p8l1214t1774r1332b1828],

1	Pharmacogenetics	NNS	MISC	pharmacogenetic	nsubj	2	SENT_154	[p8l1358t1770r1964b1845],
2	goes	VBZ	O	go	_	0	SENT_154	[p8l1989t1789r2137b1845],
3	genomic	JJ	O	genomic	acomp	2	SENT_154	[p8l9t1866r310b1941],
4	.	.	O	.	_	0	SENT_154	[p8l9t1866r310b1941],

1	Nat	NNP	PERSON	Nat	nn	3	SENT_155	[p8l335t1871r454b1925],
2	Rev	NN	PERSON	rev	nn	3	SENT_155	[p8l471t1871r592b1928],
3	Genet	NNP	PERSON	Genet	_	0	SENT_155	[p8l611t1870r808b1924],
4	2003	CD	DATE	2003	dep	3	SENT_155	[p8l827t1870r1296b1937],
5	;	:	O	;	_	0	SENT_155	[p8l827t1870r1296b1937],
6	4:937	CD	NUMBER	4:937	number	7	SENT_155	[p8l827t1870r1296b1937],
7	—	CD	NUMBER	—	dep	3	SENT_155	[p8l827t1870r1296b1937],
8	47	CD	NUMBER	47	dep	7	SENT_155	[p8l827t1870r1296b1937],
9	.	.	O	.	_	0	SENT_155	[p8l827t1870r1296b1937],

1	[	NN	O	[	_	0	SENT_156	[p8l1329t1871r1644b1937],
2	Erratum	NN	O	erratum	dep	1	SENT_156	[p8l1329t1871r1644b1937],
3	,	,	O	,	_	0	SENT_156	[p8l1329t1871r1644b1937],
4	Nat	NNP	PERSON	Nat	nn	6	SENT_156	[p8l1669t1871r1787b1925],
5	Rev	NN	PERSON	rev	nn	6	SENT_156	[p8l1805t1871r1926b1928],
6	Genet	NNP	PERSON	Genet	appos	2	SENT_156	[p8l1946t1870r2143b1924],
7	2004	CD	DATE	2004	rcmod	6	SENT_156	[p8l9t1966r364b2033],
8	;	:	O	;	_	0	SENT_156	[p8l9t1966r364b2033],
9	5:76	CD	NUMBER	5:76	dep	7	SENT_156	[p8l9t1966r364b2033],
10	.	.	O	.	_	0	SENT_156	[p8l9t1966r364b2033],
11	]	SYM	O	]	dep	7	SENT_156	[p8l9t1966r364b2033],

1	5	CD	NUMBER	5	_	0	SENT_157	[p8l10t2065r60b2116],
2	.	.	O	.	_	0	SENT_157	[p8l10t2065r60b2116],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_158	[p8l138t2058r388b2133],
2	E	NNP	O	E	_	0	SENT_158	[p8l412t2063r472b2129],
3	,	,	O	,	_	0	SENT_158	[p8l412t2063r472b2129],
4	Mallal	NNP	O	Mallal	nn	7	SENT_158	[p8l497t2058r708b2116],
5	S.	NNP	O	S.	nn	7	SENT_158	[p8l733t2062r785b2116],
6	Drug	NNP	O	Drug	nn	7	SENT_158	[p8l812t2063r981b2133],
7	hypersensitivity	NN	O	hypersensitivity	appos	2	SENT_158	[p8l1002t2058r1527b2133],
8	in	IN	O	in	_	0	SENT_158	[p8l1547t2058r1611b2115],
9	HIV	NN	O	hiv	prep_in	7	SENT_158	[p8l1634t2063r1777b2116],
10	.	.	O	.	_	0	SENT_158	[p8l1634t2063r1777b2116],

1	Curr	NNP	O	Curr	nn	5	SENT_159	[p8l1805t2062r1955b2117],
2	Opin	NNP	O	Opin	nn	5	SENT_159	[p8l1976t2058r2139b2133],
3	Allergy	NNP	O	Allergy	nn	5	SENT_159	[p8l6t2154r249b2229],
4	Clin	NNP	O	Clin	nn	5	SENT_159	[p8l271t2154r407b2212],
5	Immunol	NNP	O	Immunol	_	0	SENT_159	[p8l431t2154r740b2213],
6	2007	CD	DATE	2007	num	5	SENT_159	[p8l765t2158r1234b2225],
7	;	:	O	;	_	0	SENT_159	[p8l765t2158r1234b2225],
8	7:324	CD	NUMBER	7:324	number	9	SENT_159	[p8l765t2158r1234b2225],
9	—	CD	NUMBER	—	dep	5	SENT_159	[p8l765t2158r1234b2225],
10	30	CD	NUMBER	30	dep	9	SENT_159	[p8l765t2158r1234b2225],
11	.	.	O	.	_	0	SENT_159	[p8l765t2158r1234b2225],

1	6	CD	NUMBER	6	_	0	SENT_160	[p8l9t2256r60b2308],
2	.	.	O	.	_	0	SENT_160	[p8l9t2256r60b2308],

1	Mallal	JJ	O	mallal	amod	2	SENT_161	[p8l136t2250r348b2308],
2	S	NN	O	s	_	0	SENT_161	[p8l378t2254r430b2321],
3	,	,	O	,	_	0	SENT_161	[p8l378t2254r430b2321],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_161	[p8l463t2250r663b2309],
5	D	NNP	PERSON	D	appos	2	SENT_161	[p8l692t2255r760b2321],
6	,	,	O	,	_	0	SENT_161	[p8l692t2255r760b2321],
7	Witt	NNP	PERSON	Witt	nn	8	SENT_161	[p8l792t2250r938b2308],
8	C	NNP	O	C	appos	2	SENT_161	[p8l964t2254r1028b2321],
9	,	,	O	,	_	0	SENT_161	[p8l964t2254r1028b2321],
10	et	FW	O	et	nn	11	SENT_161	[p8l1063t2262r1121b2308],
11	al.	FW	O	al.	appos	2	SENT_161	[p8l1148t2250r1222b2308],
12	.	.	O	.	_	0	SENT_161	[p8l1148t2250r1222b2308],

1	Association	NNP	O	Association	_	0	SENT_162	[p8l1254t2250r1642b2308],
2	between	IN	O	between	_	0	SENT_162	[p8l1672t2250r1946b2310],
3	presence	NN	O	presence	prep_between	1	SENT_162	[p8l1975t2269r2138b2325, p8l10t2365r155b2404],
4	of	IN	O	of	_	0	SENT_162	[p8l187t2345r262b2404],
5	HLA	NN	O	hlum	prep_of	1	SENT_162	[p8l279t2346r709b2417],
6	.	.	O	.	_	0	SENT_162	[p8l279t2346r709b2417],

1	—	NN	O	—	_	0	SENT_163	[p8l279t2346r709b2417],
2	.	.	O	.	_	0	SENT_163	[p8l279t2346r709b2417],

1	B	NN	O	b	_	0	SENT_164	[p8l279t2346r709b2417],
2	*	CD	NUMBER	*	num	3	SENT_164	[p8l279t2346r709b2417],
3	5701	CD	NUMBER	5701	dep	1	SENT_164	[p8l279t2346r709b2417],
4	,	,	O	,	_	0	SENT_164	[p8l279t2346r709b2417],
5	HLA	NN	O	hlum	appos	3	SENT_164	[p8l744t2351r1071b2417],
6	.	.	O	.	_	0	SENT_164	[p8l744t2351r1071b2417],

1	—	NN	O	—	_	0	SENT_165	[p8l744t2351r1071b2417],
2	.	.	O	.	_	0	SENT_165	[p8l744t2351r1071b2417],

1	DR7	NN	O	dr7	_	0	SENT_166	[p8l744t2351r1071b2417],
2	,	,	O	,	_	0	SENT_166	[p8l744t2351r1071b2417],
3	and	CC	O	and	_	0	SENT_166	[p8l1106t2346r1226b2404],
4	HLA	NN	O	hlum	conj_and	1	SENT_166	[p8l1256t2350r1575b2419],
5	.	.	O	.	_	0	SENT_166	[p8l1256t2350r1575b2419],

1	—	NN	O	—	_	0	SENT_167	[p8l1256t2350r1575b2419],
2	.	.	O	.	_	0	SENT_167	[p8l1256t2350r1575b2419],

1	DQ3	NN	O	dq3	_	0	SENT_168	[p8l1256t2350r1575b2419],
2	and	CC	O	and	_	0	SENT_168	[p8l1608t2346r1729b2404],
3	hypersensi	NN	O	hypersensus	conj_and	1	SENT_168	[p8l1760t2346r2138b2421],
4	—	CD	NUMBER	—	num	5	SENT_168	[p8l1760t2346r2138b2421],
5	tivity	NN	O	tivity	dep	1	SENT_168	[p8l10t2442r177b2517],
6	to	TO	O	to	_	0	SENT_168	[p8l210t2454r273b2500],
7	HIV-1	NN	MISC	hiv-1	prep_to	5	SENT_168	[p8l310t2446r498b2500],
8	reverse	JJ	O	reverse	amod	10	SENT_168	[p8l535t2442r1228b2517],
9	—	NN	O	—	nn	10	SENT_168	[p8l535t2442r1228b2517],
10	transcriptase	NN	O	transcriptase	dep	1	SENT_168	[p8l535t2442r1228b2517],
11	inhibitor	NN	O	inhibitor	nn	12	SENT_168	[p8l1265t2442r1559b2500],
12	abacavir	NN	O	abacavir	dep	10	SENT_168	[p8l1594t2442r1883b2501],
13	.	.	O	.	_	0	SENT_168	[p8l1594t2442r1883b2501],

1	Lancet	NNP	O	Lancet	_	0	SENT_169	[p8l1922t2447r2143b2500],
2	2002	CD	DATE	2002	num	1	SENT_169	[p8l9t2542r557b2609],
3	;	:	O	;	_	0	SENT_169	[p8l9t2542r557b2609],
4	359:727	CD	NUMBER	359:727	number	5	SENT_169	[p8l9t2542r557b2609],
5	—	CD	NUMBER	—	dep	1	SENT_169	[p8l9t2542r557b2609],
6	32	CD	NUMBER	32	dep	5	SENT_169	[p8l9t2542r557b2609],
7	.	.	O	.	_	0	SENT_169	[p8l9t2542r557b2609],

1	7	CD	NUMBER	7	_	0	SENT_170	[p8l11t2641r60b2692],
2	.	.	O	.	_	0	SENT_170	[p8l11t2641r60b2692],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_171	[p8l138t2634r588b2709],
2	S	NNP	O	S	_	0	SENT_171	[p8l632t2638r684b2705],
3	,	,	O	,	_	0	SENT_171	[p8l632t2638r684b2705],
4	Hughes	NNP	ORGANIZATION	Hughes	nn	5	SENT_171	[p8l731t2634r980b2709],
5	AR	NNS	ORGANIZATION	ar	appos	2	SENT_171	[p8l1022t2639r1142b2705],
6	,	,	O	,	_	0	SENT_171	[p8l1022t2639r1142b2705],
7	Mosteller	NNP	PERSON	Mosteller	nn	8	SENT_171	[p8l1186t2634r1499b2692],
8	M	NNP	O	M	appos	2	SENT_171	[p8l1537t2639r1619b2705],
9	,	,	O	,	_	0	SENT_171	[p8l1537t2639r1619b2705],
10	et	FW	O	et	nn	11	SENT_171	[p8l1667t2646r1726b2692],
11	al.	FW	O	al.	appos	2	SENT_171	[p8l1765t2634r1839b2692],
12	.	.	O	.	_	0	SENT_171	[p8l1765t2634r1839b2692],

1	Genetic	JJ	O	genetic	amod	2	SENT_172	[p8l1886t2634r2139b2692],
2	variations	NNS	O	variation	_	0	SENT_172	[p8l6t2730r333b2789],
3	in	IN	O	in	_	0	SENT_172	[p8l378t2730r442b2787],
4	HLA	NN	O	hlum	prep_in	2	SENT_172	[p8l484t2735r701b2788],
5	.	.	O	.	_	0	SENT_172	[p8l484t2735r701b2788],

1	—	NN	O	—	_	0	SENT_173	[p8l484t2735r701b2788],
2	.	.	O	.	_	0	SENT_173	[p8l484t2735r701b2788],

1	B	NN	O	b	nn	2	SENT_174	[p8l484t2735r701b2788],
2	region	NN	O	region	_	0	SENT_174	[p8l746t2730r958b2805],
3	and	CC	O	and	_	0	SENT_174	[p8l1001t2730r1121b2788],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_174	[p8l1165t2730r1690b2805],
5	reactions	NNS	O	reaction	conj_and	2	SENT_174	[p8l1730t2730r2030b2788],
6	to	TO	O	to	_	0	SENT_174	[p8l2075t2742r2138b2788],
7	abacavir	NN	O	abacavir	prep_to	2	SENT_174	[p8l9t2826r297b2885],
8	.	.	O	.	_	0	SENT_174	[p8l9t2826r297b2885],

1	Lancet	NNP	O	Lancet	_	0	SENT_175	[p8l327t2831r547b2884],
2	2002	CD	DATE	2002	num	1	SENT_175	[p8l569t2830r1120b2897],
3	;	:	O	;	_	0	SENT_175	[p8l569t2830r1120b2897],
4	359:1121	CD	NUMBER	359:1121	num	5	SENT_175	[p8l569t2830r1120b2897],
5	—	NN	O	—	dep	1	SENT_175	[p8l569t2830r1120b2897],
6	2	CD	NUMBER	2	dep	5	SENT_175	[p8l569t2830r1120b2897],
7	.	.	O	.	_	0	SENT_175	[p8l569t2830r1120b2897],

1	8	CD	NUMBER	8	_	0	SENT_176	[p8l8t2927r60b2981],
2	.	.	O	.	_	0	SENT_176	[p8l8t2927r60b2981],

1	Rauch	NNP	PERSON	Rauch	nn	2	SENT_177	[p8l138t2922r344b2984],
2	A	NNP	O	A	nsubj	21	SENT_177	[p8l367t2927r434b2993],
3	,	,	O	,	_	0	SENT_177	[p8l367t2927r434b2993],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_177	[p8l462t2922r663b2980],
5	D	NNP	PERSON	D	appos	2	SENT_177	[p8l688t2927r756b2993],
6	,	,	O	,	_	0	SENT_177	[p8l688t2927r756b2993],
7	Martin	NNP	PERSON	Martin	nn	8	SENT_177	[p8l784t2922r1014b2980],
8	A	NNP	O	A	appos	2	SENT_177	[p8l1037t2927r1104b2993],
9	,	,	O	,	_	0	SENT_177	[p8l1037t2927r1104b2993],
10	McKinnon	NNP	PERSON	McKinnon	nn	11	SENT_177	[p8l1132t2922r1482b2982],
11	E	NNP	O	E	appos	2	SENT_177	[p8l1507t2927r1567b2993],
12	,	,	O	,	_	0	SENT_177	[p8l1507t2927r1567b2993],
13	Almeida	NNP	ORGANIZATION	Almeida	nn	14	SENT_177	[p8l1594t2922r1872b2980],
14	C	NNP	ORGANIZATION	C	appos	2	SENT_177	[p8l1897t2926r1961b2993],
15	,	,	O	,	_	0	SENT_177	[p8l1897t2926r1961b2993],
16	Mallal	NNP	O	Mallal	nn	17	SENT_177	[p8l1989t2922r2138b2980, p8l8t3018r89b3076],
17	S.	NNP	O	S.	appos	2	SENT_177	[p8l123t3022r176b3076],
18	Prospective	JJ	O	prospective	amod	20	SENT_177	[p8l212t3018r588b3093],
19	genetic	JJ	O	genetic	amod	20	SENT_177	[p8l622t3018r860b3093],
20	screening	NN	O	screening	dep	17	SENT_177	[p8l893t3018r1215b3093],
21	decreases	VBZ	O	decrease	_	0	SENT_177	[p8l1246t3018r1560b3076],
22	the	DT	O	the	det	23	SENT_177	[p8l1596t3018r1697b3076],
23	incidence	NN	O	incidence	dobj	21	SENT_177	[p8l1730t3018r2042b3076],
24	of	IN	O	of	_	0	SENT_177	[p8l2077t3017r2153b3076],
25	abacavir	NN	O	abacavir	nn	27	SENT_177	[p8l9t3114r283b3173],
26	hypersensitivity	NN	O	hypersensitivity	nn	27	SENT_177	[p8l323t3114r848b3189],
27	reactions	NNS	O	reaction	prep_of	23	SENT_177	[p8l887t3114r1187b3172],
28	in	IN	O	in	_	0	SENT_177	[p8l1231t3114r1295b3171],
29	the	DT	O	the	det	34	SENT_177	[p8l1338t3114r1439b3172],
30	Western	JJ	MISC	western	amod	34	SENT_177	[p8l1479t3119r1751b3172],
31	Australian	JJ	MISC	australian	amod	34	SENT_177	[p8l1791t3114r2139b3173],
32	HIV	NN	O	hiv	nn	34	SENT_177	[p8l8t3215r142b3268],
33	cohort	NN	O	cohort	nn	34	SENT_177	[p8l165t3210r381b3268],
34	study	NN	O	study	prep_in	27	SENT_177	[p8l405t3210r592b3285],
35	.	.	O	.	_	0	SENT_177	[p8l405t3210r592b3285],

1	Clin	NNP	O	Clin	nn	3	SENT_178	[p8l623t3210r758b3268],
2	Infect	NNP	O	Infect	nn	3	SENT_178	[p8l783t3209r978b3268],
3	Dis	NNP	O	Dis	_	0	SENT_178	[p8l999t3210r1105b3268],
4	2006	CD	DATE	2006	num	3	SENT_178	[p8l1133t3214r1651b3281],
5	;	:	O	;	_	0	SENT_178	[p8l1133t3214r1651b3281],
6	43:99	CD	NUMBER	43:99	num	7	SENT_178	[p8l1133t3214r1651b3281],
7	—	NN	O	—	dep	3	SENT_178	[p8l1133t3214r1651b3281],
8	102	CD	NUMBER	102	dep	7	SENT_178	[p8l1133t3214r1651b3281],
9	.	.	O	.	_	0	SENT_178	[p8l1133t3214r1651b3281],

1	9	CD	NUMBER	9	_	0	SENT_179	[p8l9t3313r60b3364],
2	.	.	O	.	_	0	SENT_179	[p8l9t3313r60b3364],

1	Hughes	NNP	ORGANIZATION	Hughes	nn	2	SENT_180	[p8l138t3306r388b3381],
2	AR	NNS	ORGANIZATION	ar	_	0	SENT_180	[p8l423t3311r542b3377],
3	,	,	O	,	_	0	SENT_180	[p8l423t3311r542b3377],
4	Mosteller	NNP	PERSON	Mosteller	nn	5	SENT_180	[p8l580t3306r893b3364],
5	M	NNP	O	M	appos	2	SENT_180	[p8l924t3311r1007b3377],
6	,	,	O	,	_	0	SENT_180	[p8l924t3311r1007b3377],
7	Bansal	NNP	PERSON	Bansal	nn	8	SENT_180	[p8l1046t3306r1268b3364],
8	AT	NNP	O	AT	appos	2	SENT_180	[p8l1301t3310r1407b3377],
9	,	,	O	,	_	0	SENT_180	[p8l1301t3310r1407b3377],
10	et	FW	O	et	nn	11	SENT_180	[p8l1448t3318r1507b3364],
11	al.	FW	O	al.	appos	2	SENT_180	[p8l1540t3306r1614b3364],
12	.	.	O	.	_	0	SENT_180	[p8l1540t3306r1614b3364],

1	Association	NNP	O	Association	_	0	SENT_181	[p8l1651t3306r2040b3364],
2	of	IN	O	of	_	0	SENT_181	[p8l2076t3305r2152b3364],
3	genetic	JJ	O	genetic	amod	4	SENT_181	[p8l9t3402r246b3477],
4	variations	NNS	O	variation	prep_of	1	SENT_181	[p8l264t3402r591b3461],
5	in	IN	O	in	_	0	SENT_181	[p8l614t3402r677b3459],
6	HLA	NN	O	hlum	prep_in	1	SENT_181	[p8l699t3407r915b3460],
7	.	.	O	.	_	0	SENT_181	[p8l699t3407r915b3460],

1	—	NN	O	—	_	0	SENT_182	[p8l699t3407r915b3460],
2	.	.	O	.	_	0	SENT_182	[p8l699t3407r915b3460],

1	B	NN	O	b	nn	2	SENT_183	[p8l699t3407r915b3460],
2	region	NN	O	region	_	0	SENT_183	[p8l938t3402r1150b3477],
3	with	IN	O	with	_	0	SENT_183	[p8l1168t3402r1318b3461],
4	hypersensitivity	NN	O	hypersensitivity	prep_with	2	SENT_183	[p8l1339t3402r1864b3477],
5	to	TO	O	to	_	0	SENT_183	[p8l1882t3414r1945b3460],
6	abacavir	NN	O	abacavir	prep_to	2	SENT_183	[p8l1967t3402r2138b3460, p8l9t3498r131b3557],
7	in	IN	O	in	_	0	SENT_183	[p8l152t3498r216b3555],
8	some	DT	O	some	prep_in	6	SENT_183	[p8l240t3517r430b3569],
9	,	,	O	,	_	0	SENT_183	[p8l240t3517r430b3569],
10	but	CC	O	but	_	0	SENT_183	[p8l458t3498r565b3557],
11	not	RB	O	not	_	0	SENT_183	[p8l585t3510r694b3556],
12	all	DT	O	all	conj_negcc	6	SENT_183	[p8l713t3498r812b3569],
13	,	,	O	,	_	0	SENT_183	[p8l713t3498r812b3569],
14	populations	NNS	O	population	appos	12	SENT_183	[p8l839t3498r1253b3573],
15	.	.	O	.	_	0	SENT_183	[p8l839t3498r1253b3573],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_184	[p8l1280t3498r1932b3573],
2	2004	CD	DATE	2004	num	1	SENT_184	[p8l1957t3502r2136b3569],
3	;	:	O	;	_	0	SENT_184	[p8l1957t3502r2136b3569],
4	5:203	CD	NUMBER	5:203	number	5	SENT_184	[p8l11t3598r304b3652],
5	—	CD	NUMBER	—	dep	1	SENT_184	[p8l11t3598r304b3652],
6	11	CD	NUMBER	11	dep	5	SENT_184	[p8l11t3598r304b3652],
7	.	.	O	.	_	0	SENT_184	[p8l11t3598r304b3652],

1	10	CD	NUMBER	10	_	0	SENT_185	[p8l12t3694r98b3747],
2	.	.	O	.	_	0	SENT_185	[p8l12t3694r98b3747],

1	Walsh	NNP	PERSON	Walsh	nsubj	6	SENT_186	[p8l136t3689r340b3747],
2	IS	VBZ	O	be	cop	6	SENT_186	[p8l354t3693r438b3760],
3	,	,	O	,	_	0	SENT_186	[p8l354t3693r438b3760],
4	Reese	NNP	PERSON	Reese	nn	6	SENT_186	[p8l464t3694r652b3751],
5	M	NNP	O	M	nn	6	SENT_186	[p8l672t3694r777b3760],
6	]	NN	O	]	_	0	SENT_186	[p8l672t3694r777b3760],
7	,	,	O	,	_	0	SENT_186	[p8l672t3694r777b3760],
8	Thurmond	NNP	PERSON	Thurmond	nn	9	SENT_186	[p8l800t3689r1156b3748],
9	LM	NNP	O	LM	appos	6	SENT_186	[p8l1177t3694r1301b3747],
10	.	.	O	.	_	0	SENT_186	[p8l1177t3694r1301b3747],

1	The	DT	O	the	det	3	SENT_187	[p8l1324t3689r1447b3747],
2	metabolic	JJ	O	metabolic	amod	3	SENT_187	[p8l1470t3689r1796b3747],
3	activation	NN	O	activation	_	0	SENT_187	[p8l1817t3689r2139b3748],
4	of	IN	O	of	_	0	SENT_187	[p9l10t19r86b78],
5	abacavir	NN	O	abacavir	prep_of	3	SENT_187	[p9l94t20r368b79],
6	by	IN	O	by	dep	3	SENT_187	[p9l390t20r464b95],
7	human	JJ	O	human	amod	9	SENT_187	[p9l483t20r715b79],
8	liver	NN	O	liver	nn	9	SENT_187	[p9l737t20r879b79],
9	cytosol	NN	O	cytosol	pobj	6	SENT_187	[p9l900t20r1134b95],
10	and	CC	O	and	_	0	SENT_187	[p9l1156t20r1276b78],
11	expressed	VBN	O	express	dep	3	SENT_187	[p9l1299t20r1623b95],
12	human	JJ	O	human	amod	15	SENT_187	[p9l1645t20r1878b79],
13	alcohol	NN	O	alcohol	nn	15	SENT_187	[p9l1899t20r2140b78],
14	dehydrogenase	NN	O	dehydrogenase	nn	15	SENT_187	[p9l10t116r503b191],
15	isozymes	NNS	O	isozyme	dobj	11	SENT_187	[p9l529t116r852b191],
16	.	.	O	.	_	0	SENT_187	[p9l529t116r852b191],

1	Chem	NNP	O	Chem	nn	3	SENT_188	[p9l882t116r1072b174],
2	Biol	NNP	O	Biol	nn	3	SENT_188	[p9l1097t116r1224b174],
3	Interact	NNP	O	Interact	_	0	SENT_188	[p9l1249t121r1508b174],
4	2002	CD	DATE	2002	num	3	SENT_188	[p9l1529t120r2083b187],
5	;	:	O	;	_	0	SENT_188	[p9l1529t120r2083b187],
6	142:135	CD	NUMBER	142:135	number	7	SENT_188	[p9l1529t120r2083b187],
7	—	CD	NUMBER	—	dep	3	SENT_188	[p9l1529t120r2083b187],
8	54	CD	NUMBER	54	dep	7	SENT_188	[p9l1529t120r2083b187],
9	.	.	O	.	_	0	SENT_188	[p9l1529t120r2083b187],

1	11	CD	NUMBER	11	_	0	SENT_189	[p9l12t219r98b270],
2	.	.	O	.	_	0	SENT_189	[p9l12t219r98b270],

1	Martin	NNP	PERSON	Martin	nn	2	SENT_190	[p9l136t212r362b270],
2	AM	NNP	O	AM	_	0	SENT_190	[p9l380t217r513b283],
3	,	,	O	,	_	0	SENT_190	[p9l380t217r513b283],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_190	[p9l536t212r734b271],
5	D	NNP	PERSON	D	appos	2	SENT_190	[p9l754t217r821b283],
6	,	,	O	,	_	0	SENT_190	[p9l754t217r821b283],
7	Gaudieri	NNP	PERSON	Gaudieri	nn	8	SENT_190	[p9l846t212r1126b271],
8	S	NNP	O	S	appos	2	SENT_190	[p9l1148t216r1199b283],
9	,	,	O	,	_	0	SENT_190	[p9l1148t216r1199b283],
10	et	FW	O	et	nn	11	SENT_190	[p9l1225t224r1283b270],
11	al.	FW	O	al.	appos	2	SENT_190	[p9l1300t212r1373b270],
12	.	.	O	.	_	0	SENT_190	[p9l1300t212r1373b270],

1	Predisposition	NN	O	predisposition	nsubj	5	SENT_191	[p9l1397t212r1866b287],
2	to	TO	O	to	_	0	SENT_191	[p9l1887t224r1949b270],
3	abacavir	NN	O	abacavir	nn	4	SENT_191	[p9l1970t212r2138b270, p9l9t308r129b367],
4	hypersensitivity	NN	O	hypersensitivity	prep_to	1	SENT_191	[p9l158t308r672b383],
5	conferred	VBD	O	confer	_	0	SENT_191	[p9l701t307r1013b366],
6	by	IN	O	by	_	0	SENT_191	[p9l1046t308r1119b383],
7	HLA	NN	O	hlum	prep_by	5	SENT_191	[p9l1148t308r1553b366],
8	.	.	O	.	_	0	SENT_191	[p9l1148t308r1553b366],

1	—	NN	O	—	_	0	SENT_192	[p9l1148t308r1553b366],
2	.	.	O	.	_	0	SENT_192	[p9l1148t308r1553b366],

1	B	NN	O	b	_	0	SENT_193	[p9l1148t308r1553b366],
2	*	CD	NUMBER	*	num	3	SENT_193	[p9l1148t308r1553b366],
3	5701	CD	DATE	5701	dep	1	SENT_193	[p9l1148t308r1553b366],
4	and	CC	O	and	_	0	SENT_193	[p9l1585t308r1704b366],
5	a	DT	O	a	det	7	SENT_193	[p9l1736t327r1769b366],
6	haplotypic	JJ	O	haplotypic	amod	7	SENT_193	[p9l1801t308r2140b383],
7	Hsp70	NN	O	hsp70	conj_and	3	SENT_193	[p9l8t408r400b479],
8	.	.	O	.	_	0	SENT_193	[p9l8t408r400b479],

1	—	NN	O	—	_	0	SENT_194	[p9l8t408r400b479],
2	.	.	O	.	_	0	SENT_194	[p9l8t408r400b479],

1	Hom	NN	PERSON	hom	_	0	SENT_195	[p9l8t408r400b479],
2	variant	NN	O	variant	dep	1	SENT_195	[p9l421t404r666b463],
3	.	.	O	.	_	0	SENT_195	[p9l421t404r666b463],

1	Proc	NNP	O	Proc	nn	7	SENT_196	[p9l693t409r836b462],
2	Natl	NNP	O	Natl	nn	7	SENT_196	[p9l858t404r996b462],
3	Acad	NNP	O	Acad	nn	7	SENT_196	[p9l1017t404r1177b462],
4	Sci	NNP	O	Sci	nn	7	SENT_196	[p9l1202t404r1292b462],
5	U	NNP	O	U	nn	7	SENT_196	[p9l1316t409r1368b462],
6	S	NNP	O	S	nn	7	SENT_196	[p9l1392t408r1424b462],
7	A	NNP	O	A	_	0	SENT_196	[p9l1448t409r1498b461],
8	2004	CD	DATE	2004	num	7	SENT_196	[p9l1520t408r2067b475],
9	;	:	O	;	_	0	SENT_196	[p9l1520t408r2067b475],
10	101:4180	CD	NUMBER	101:4180	number	11	SENT_196	[p9l1520t408r2067b475],
11	—	CD	NUMBER	—	dep	7	SENT_196	[p9l1520t408r2067b475],
12	5	CD	NUMBER	5	dep	11	SENT_196	[p9l1520t408r2067b475],
13	.	.	O	.	_	0	SENT_196	[p9l1520t408r2067b475],

1	12	CD	NUMBER	12	_	0	SENT_197	[p9l12t507r98b558],
2	.	.	O	.	_	0	SENT_197	[p9l12t507r98b558],

1	Chessman	NNP	PERSON	Chessman	nn	2	SENT_198	[p9l139t500r480b558],
2	D	NNP	PERSON	D	_	0	SENT_198	[p9l504t505r571b571],
3	,	,	O	,	_	0	SENT_198	[p9l504t505r571b571],
4	Lethborg	NNP	ORGANIZATION	Lethborg	nn	5	SENT_198	[p9l600t500r904b575],
5	T	NN	ORGANIZATION	t	appos	2	SENT_198	[p9l924t504r983b571],
6	,	,	O	,	_	0	SENT_198	[p9l924t504r983b571],
7	Kostenko	NNP	PERSON	Kostenko	nn	8	SENT_198	[p9l1012t500r1323b560],
8	L	NNP	O	L	appos	2	SENT_198	[p9l1348t505r1406b571],
9	,	,	O	,	_	0	SENT_198	[p9l1348t505r1406b571],
10	et	FW	O	et	nn	11	SENT_198	[p9l1435t512r1495b558],
11	al.	FW	O	al.	appos	2	SENT_198	[p9l1515t500r1590b558],
12	.	.	O	.	_	0	SENT_198	[p9l1515t500r1590b558],

1	Abacavir	NNP	O	Abacavir	nn	2	SENT_199	[p9l1617t500r1906b559],
2	hypersensitivity	NN	O	hypersensitivity	_	0	SENT_199	[p9l1929t500r2138b575, p9l10t596r345b671],
3	in	IN	O	in	_	0	SENT_199	[p9l365t596r429b653],
4	HLA	NN	O	hlum	prep_in	2	SENT_199	[p9l452t596r1027b671],
5	.	.	O	.	_	0	SENT_199	[p9l452t596r1027b671],

1	—	NN	O	—	_	0	SENT_200	[p9l452t596r1027b671],
2	.	.	O	.	_	0	SENT_200	[p9l452t596r1027b671],

1	B57	NN	O	b57	_	0	SENT_201	[p9l452t596r1027b671],
2	.	.	O	.	_	0	SENT_201	[p9l452t596r1027b671],

1	—	NN	O	—	_	0	SENT_202	[p9l452t596r1027b671],
2	.	.	O	.	_	0	SENT_202	[p9l452t596r1027b671],

1	positive	JJ	O	positive	amod	2	SENT_203	[p9l452t596r1027b671],
2	individuals	NNS	O	individual	nsubj	7	SENT_203	[p9l1051t596r1416b655],
3	with	IN	O	with	_	0	SENT_203	[p9l1438t596r1588b655],
4	HIV	NN	MISC	hiv	nn	5	SENT_203	[p9l1611t601r1744b654],
5	infection	NN	O	infection	prep_with	2	SENT_203	[p9l1765t595r2063b654],
6	is	VBZ	O	be	cop	7	SENT_203	[p9l2087t596r2137b654],
7	dependent	JJ	O	dependent	_	0	SENT_203	[p9l10t692r355b767],
8	upon	IN	O	upon	_	0	SENT_203	[p9l381t711r547b767],
9	the	DT	O	the	det	11	SENT_203	[p9l575t692r677b750],
10	conventional	JJ	O	conventional	amod	11	SENT_203	[p9l707t692r1131b751],
11	MHC	NN	O	mhc	prep_upon	7	SENT_203	[p9l1157t696r1381b750],
12	.	.	O	.	_	0	SENT_203	[p9l1157t696r1381b750],

1	—	NN	O	—	_	0	SENT_204	[p9l1157t696r1381b750],
2	.	.	O	.	_	0	SENT_204	[p9l1157t696r1381b750],

1	I	PRP	O	I	_	0	SENT_205	[p9l1157t696r1381b750],
2	Ag	NN	O	ag	nn	4	SENT_205	[p9l1405t697r1497b767],
3	presentation	NN	O	presentation	nn	4	SENT_205	[p9l1523t692r1939b767],
4	pathway	NN	O	pathway	dep	1	SENT_205	[p9l1966t692r2138b767, p9l6t807r145b863],
5	.	.	O	.	_	0	SENT_205	[p9l1966t692r2138b767, p9l6t807r145b863],

1	Tissue	NN	O	tissue	nn	2	SENT_206	[p9l172t788r382b847],
2	Antigens	NNS	O	antigen	_	0	SENT_206	[p9l406t788r702b863],
3	2007	CD	DATE	2007	num	5	SENT_206	[p9l729t788r1349b863],
4	;	:	O	;	_	0	SENT_206	[p9l729t788r1349b863],
5	69	CD	NUMBER	69	dep	2	SENT_206	[p9l729t788r1349b863],
6	:	:	O	:	_	0	SENT_206	[p9l729t788r1349b863],
7	Suppl	NNP	O	Suppl	dep	2	SENT_206	[p9l729t788r1349b863],
8	:373	CD	NUMBER	:373	num	7	SENT_206	[p9l729t788r1349b863],
9	.	.	O	.	_	0	SENT_206	[p9l729t788r1349b863],

1	abstract	JJ	O	abstract	_	0	SENT_207	[p9l1378t788r1660b846],
2	.	.	O	.	_	0	SENT_207	[p9l1378t788r1660b846],

1	13	CD	NUMBER	13	_	0	SENT_208	[p9l12t890r98b942],
2	.	.	O	.	_	0	SENT_208	[p9l12t890r98b942],

1	Mallal	JJ	O	mallal	amod	2	SENT_209	[p9l136t884r348b942],
2	S	NN	O	s	_	0	SENT_209	[p9l378t888r430b955],
3	,	,	O	,	_	0	SENT_209	[p9l378t888r430b955],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_209	[p9l464t884r714b959],
5	E	NNP	O	E	appos	2	SENT_209	[p9l744t889r803b955],
6	,	,	O	,	_	0	SENT_209	[p9l744t889r803b955],
7	Carosi	NNP	PERSON	Carosi	nn	8	SENT_209	[p9l838t884r1048b942],
8	G	NNP	PERSON	G	appos	2	SENT_209	[p9l1077t888r1148b955],
9	,	,	O	,	_	0	SENT_209	[p9l1077t888r1148b955],
10	et	FW	O	et	nn	11	SENT_209	[p9l1183t896r1241b942],
11	al.	FW	O	al.	appos	2	SENT_209	[p9l1267t884r1342b942],
12	.	.	O	.	_	0	SENT_209	[p9l1267t884r1342b942],

1	HLA	NN	O	hlum	_	0	SENT_210	[p9l1376t884r1788b942],
2	.	.	O	.	_	0	SENT_210	[p9l1376t884r1788b942],

1	—	NN	O	—	_	0	SENT_211	[p9l1376t884r1788b942],
2	.	.	O	.	_	0	SENT_211	[p9l1376t884r1788b942],

1	B	NN	O	b	_	0	SENT_212	[p9l1376t884r1788b942],
2	*	CD	NUMBER	*	number	3	SENT_212	[p9l1376t884r1788b942],
3	5701	CD	NUMBER	5701	num	4	SENT_212	[p9l1376t884r1788b942],
4	screening	NN	O	screening	dep	1	SENT_212	[p9l1820t884r2141b959],
5	for	IN	O	for	_	0	SENT_212	[p9l9t979r105b1038],
6	hypersensitivity	NN	O	hypersensitivity	prep_for	4	SENT_212	[p9l140t980r678b1055],
7	to	TO	O	to	_	0	SENT_212	[p9l712t992r775b1038],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_212	[p9l813t980r1108b1039],
9	.	.	O	.	_	0	SENT_212	[p9l813t980r1108b1039],

1	N	NN	O	n	nn	3	SENT_213	[p9l1148t985r1204b1039],
2	Engl	NNP	O	Engl	nn	3	SENT_213	[p9l1240t980r1391b1055],
3	J	NNP	O	J	nsubj	4	SENT_213	[p9l1421t985r1449b1048],
4	Med	VBD	O	med	_	0	SENT_213	[p9l1483t980r1626b1038],
5	2008	CD	DATE	2008	dobj	4	SENT_213	[p9l1664t984r2138b1051],
6	;	:	O	;	_	0	SENT_213	[p9l1664t984r2138b1051],
7	358:568	CD	NUMBER	358:568	number	8	SENT_213	[p9l1664t984r2138b1051],
8	—	CD	NUMBER	—	dep	5	SENT_213	[p9l1664t984r2138b1051],
9	79	CD	NUMBER	79	dep	8	SENT_213	[p9l10t1080r102b1134],
10	.	.	O	.	_	0	SENT_213	[p9l10t1080r102b1134],

1	14	CD	NUMBER	14	_	0	SENT_214	[p9l12t1178r98b1229],
2	.	.	O	.	_	0	SENT_214	[p9l12t1178r98b1229],

1	Hughes	NNP	ORGANIZATION	Hughes	nn	2	SENT_215	[p9l138t1171r388b1246],
2	DA	NNP	ORGANIZATION	DA	dep	24	SENT_215	[p9l414t1176r532b1242],
3	,	,	O	,	_	0	SENT_215	[p9l414t1176r532b1242],
4	Vilar	NNP	PERSON	Vilar	nn	6	SENT_215	[p9l560t1171r720b1229],
5	F	NN	O	f	nn	6	SENT_215	[p9l743t1176r822b1242],
6	]	NN	O	]	appos	2	SENT_215	[p9l743t1176r822b1242],
7	,	,	O	,	_	0	SENT_215	[p9l743t1176r822b1242],
8	Ward	NNP	ORGANIZATION	Ward	nn	9	SENT_215	[p9l850t1171r1025b1229],
9	CC	NN	ORGANIZATION	cc	appos	2	SENT_215	[p9l1051t1175r1164b1242],
10	,	,	O	,	_	0	SENT_215	[p9l1051t1175r1164b1242],
11	Alfirevic	NNP	O	Alfirevic	nn	12	SENT_215	[p9l1192t1170r1478b1230],
12	A	NNP	O	A	appos	2	SENT_215	[p9l1501t1176r1568b1242],
13	,	,	O	,	_	0	SENT_215	[p9l1501t1176r1568b1242],
14	Park	NNP	O	Park	nn	15	SENT_215	[p9l1597t1171r1747b1231],
15	BK	NNP	O	BK	appos	2	SENT_215	[p9l1769t1176r1880b1242],
16	,	,	O	,	_	0	SENT_215	[p9l1769t1176r1880b1242],
17	Pirmo	NNP	O	Pirmo	nn	20	SENT_215	[p9l1910t1171r2138b1229],
18	—	CD	NUMBER	—	num	20	SENT_215	[p9l1910t1171r2138b1229],
19	hamed	NNP	O	hamed	nn	20	SENT_215	[p9l9t1267r233b1326],
20	M.	NNP	O	M.	appos	2	SENT_215	[p9l262t1272r345b1325],
21	Cost	NN	O	cost	dep	24	SENT_215	[p9l380t1266r977b1326],
22	—	CD	NUMBER	—	num	21	SENT_215	[p9l380t1266r977b1326],
23	effectiveness	NN	O	effectiveness	nn	24	SENT_215	[p9l380t1266r977b1326],
24	analysis	NN	O	analysis	dep	27	SENT_215	[p9l1009t1267r1271b1342],
25	of	IN	O	of	_	0	SENT_215	[p9l1304t1266r1381b1325],
26	HLA	NN	O	hlum	prep_of	24	SENT_215	[p9l1397t1272r1548b1324],
27	B	NN	O	b	dep	30	SENT_215	[p9l1576t1267r1813b1325],
28	*	CD	NUMBER	*	num	27	SENT_215	[p9l1576t1267r1813b1325],
29	5701	CD	NUMBER	5701	num	30	SENT_215	[p9l1576t1267r1813b1325],
30	genotyp	NN	O	genotyp	dep	32	SENT_215	[p9l1845t1279r2138b1342],
31	—	CD	NUMBER	—	num	32	SENT_215	[p9l1845t1279r2138b1342],
32	ing	NN	O	ing	dep	33	SENT_215	[p9l8t1363r116b1438],
33	in	IN	O	in	_	0	SENT_215	[p9l151t1363r215b1420],
34	preventing	VBG	O	prevent	pcomp	33	SENT_215	[p9l253t1363r609b1438],
35	abacavir	NN	O	abacavir	nn	36	SENT_215	[p9l644t1363r918b1422],
36	hypersensitivity	NN	O	hypersensitivity	dobj	34	SENT_215	[p9l954t1363r1490b1438],
37	.	.	O	.	_	0	SENT_215	[p9l954t1363r1490b1438],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_216	[p9l1531t1363r2138b1438],
2	2004	CD	DATE	2004	num	1	SENT_216	[p9l9t1463r530b1530],
3	;	:	O	;	_	0	SENT_216	[p9l9t1463r530b1530],
4	14:335	CD	NUMBER	14:335	number	5	SENT_216	[p9l9t1463r530b1530],
5	—	CD	NUMBER	—	dep	1	SENT_216	[p9l9t1463r530b1530],
6	42	CD	NUMBER	42	dep	5	SENT_216	[p9l9t1463r530b1530],
7	.	.	O	.	_	0	SENT_216	[p9l9t1463r530b1530],

1	Copyright	NN	O	copyright	_	0	SENT_217	[p9l11t1565r265b1630],
2	©	CD	NUMBER	©	num	6	SENT_217	[p9l289t1570r342b1625],
3	2008	CD	DATE	2008	num	6	SENT_217	[p9l369t1569r504b1615],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_217	[p9l526t1565r909b1615],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_217	[p9l933t1565r1141b1615],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_217	[p9l1162t1567r1359b1629],
7	.	.	O	.	_	0	SENT_217	[p9l1162t1567r1359b1629],

1	JOURNAL	NN	O	journal	_	0	SENT_218	[p9l660t1747r793b1774],
2	EDITORIAL	NN	O	editorial	nn	3	SENT_218	[p9l809t1747r954b1768],
3	FELLOW	NN	O	fellow	dep	1	SENT_218	[p9l970t1747r1079b1768],

1	The	DT	O	the	det	2	SENT_219	[p9l428t1790r482b1816],
2	]	NN	O	]	poss	6	SENT_219	[p9l487t1790r607b1823],
3	oumal	JJ	O	oumal	amod	2	SENT_219	[p9l487t1790r607b1823],
4	’s	POS	O	’s	_	0	SENT_219	[p9l487t1790r607b1823],
5	editorial	NN	O	editorial	nn	6	SENT_219	[p9l618t1790r736b1816],
6	office	NN	O	office	nsubj	7	SENT_219	[p9l746t1789r825b1816],
7	invites	VBZ	O	invite	_	0	SENT_219	[p9l834t1790r926b1816],
8	applications	NNS	O	application	dobj	7	SENT_219	[p9l936t1790r1110b1823],
9	for	IN	O	for	_	0	SENT_219	[p9l1120t1789r1162b1816],
10	a	DT	O	a	det	16	SENT_219	[p9l1170t1798r1185b1816],
11	one	CD	NUMBER	one	number	12	SENT_219	[p9l1195t1798r1317b1823],
12	—	CD	NUMBER	—	num	16	SENT_219	[p9l1195t1798r1317b1823],
13	year	NN	NUMBER	year	nn	16	SENT_219	[p9l1195t1798r1317b1823],
14	research	NN	O	research	nn	16	SENT_219	[p9l399t1833r518b1859],
15	fellowship	NN	O	fellowship	nn	16	SENT_219	[p9l528t1833r676b1867],
16	beginning	NN	DATE	beginning	prep_for	8	SENT_219	[p9l687t1833r834b1867],
17	in	IN	DATE	in	_	0	SENT_219	[p9l842t1834r869b1859],
18	July	NNP	DATE	July	prep_in	16	SENT_219	[p9l876t1833r931b1867],
19	2009	CD	DATE	2009	num	18	SENT_219	[p9l940t1835r1009b1860],
20	from	IN	O	from	_	0	SENT_219	[p9l1019t1833r1088b1860],
21	individuals	NNS	O	individual	prep_from	7	SENT_219	[p9l1098t1834r1254b1860],
22	at	IN	O	at	_	0	SENT_219	[p9l1264t1839r1290b1859],
23	any	DT	O	any	det	24	SENT_219	[p9l1298t1842r1348b1867],
24	stage	NN	O	stage	prep_at	21	SENT_219	[p9l402t1883r474b1911],
25	of	IN	O	of	_	0	SENT_219	[p9l484t1877r518b1903],
26	training	NN	O	training	prep_of	24	SENT_219	[p9l522t1878r643b1911],
27	.	.	O	.	_	0	SENT_219	[p9l522t1878r643b1911],

1	The	DT	O	the	det	3	SENT_220	[p9l654t1877r708b1903],
2	editorial	NN	O	editorial	nn	3	SENT_220	[p9l718t1877r836b1903],
3	fellow	NN	O	fellow	nsubjpass	24	SENT_220	[p9l846t1877r934b1903],
4	will	MD	O	will	aux	5	SENT_220	[p9l941t1877r994b1904],
5	work	VB	O	work	_	0	SENT_220	[p9l1002t1877r1076b1904],
6	on	IN	O	on	_	0	SENT_220	[p9l1085t1886r1120b1903],
7	Joumal	JJ	O	joumal	amod	8	SENT_220	[p9l1125t1877r1222b1910],
8	projects	NNS	O	project	prep_on	5	SENT_220	[p9l1231t1878r1343b1910],
9	and	CC	O	and	_	0	SENT_220	[p9l384t1921r436b1947],
10	will	MD	O	will	aux	11	SENT_220	[p9l445t1921r497b1947],
11	participate	VB	O	participate	conj_and	5	SENT_220	[p9l507t1921r658b1954],
12	in	IN	O	in	_	0	SENT_220	[p9l668t1921r695b1947],
13	the	DT	DATE	the	det	14	SENT_220	[p9l705t1921r749b1947],
14	day	NN	DATE	day	prep_in	11	SENT_220	[p9l759t1921r908b1954],
15	—	CD	NUMBER	—	num	18	SENT_220	[p9l759t1921r908b1954],
16	to-day	JJ	O	to-day	amod	18	SENT_220	[p9l759t1921r908b1954],
17	editorial	NN	O	editorial	nn	18	SENT_220	[p9l917t1921r1035b1947],
18	activities	NNS	O	activity	dobj	11	SENT_220	[p9l1044t1921r1167b1947],
19	of	IN	O	of	_	0	SENT_220	[p9l1178t1921r1212b1947],
20	the	DT	O	the	det	21	SENT_220	[p9l1216t1921r1259b1947],
21	journal	NN	O	journal	prep_of	18	SENT_220	[p9l1264t1921r1361b1954],
22	but	CC	O	but	_	0	SENT_220	[p9l427t1965r474b1991],
23	is	VBZ	O	be	auxpass	24	SENT_220	[p9l482t1965r504b1991],
24	expected	VBN	O	expect	conj_but	5	SENT_220	[p9l515t1965r639b1998],
25	in	IN	O	in	_	0	SENT_220	[p9l648t1965r675b1991],
26	addition	NN	O	addition	prep_in	24	SENT_220	[p9l685t1965r804b1991],
27	to	TO	O	to	aux	28	SENT_220	[p9l814t1970r840b1991],
28	have	VB	O	have	xcomp	24	SENT_220	[p9l850t1965r914b1991],
29	his	PRP$	O	he	amod	34	SENT_220	[p9l923t1965r964b1991],
30	or	CC	O	or	_	0	SENT_220	[p9l975t1973r1005b1991],
31	her	PRP$	O	she	amod	34	SENT_220	[p9l1014t1965r1060b1991],
32	own	JJ	O	own	amod	34	SENT_220	[p9l1070t1973r1130b1991],
33	independent	JJ	O	independent	amod	34	SENT_220	[p9l1139t1965r1320b1998],
34	projects	NNS	O	project	dobj	28	SENT_220	[p9l443t2009r564b2042],
35	.	.	O	.	_	0	SENT_220	[p9l443t2009r564b2042],

1	Please	VB	O	please	dep	2	SENT_221	[p9l575t2009r662b2035],
2	send	VB	O	send	_	0	SENT_221	[p9l673t2009r739b2035],
3	curriculum	NN	O	curriculum	nn	4	SENT_221	[p9l749t2009r906b2035],
4	vitae	NNS	O	vita	dobj	2	SENT_221	[p9l914t2009r980b2035],
5	and	CC	O	and	_	0	SENT_221	[p9l989t2009r1041b2035],
6	research	NN	O	research	nn	7	SENT_221	[p9l1051t2009r1171b2035],
7	interests	NNS	O	interest	dobj	2	SENT_221	[p9l1180t2009r1301b2035],
8	to	TO	O	to	_	0	SENT_221	[p9l460t2058r486b2079],
9	the	DT	O	the	det	10	SENT_221	[p9l497t2052r540b2078],
10	Editor	NNP	O	Editor	prep_to	2	SENT_221	[p9l550t2052r775b2084],
11	.	.	O	.	_	0	SENT_221	[p9l550t2052r775b2084],

1	—	NN	O	—	_	0	SENT_222	[p9l550t2052r775b2084],
2	.	.	O	.	_	0	SENT_222	[p9l550t2052r775b2084],

1	in	IN	O	in	_	0	SENT_223	[p9l550t2052r775b2084],
2	.	.	O	.	_	0	SENT_223	[p9l550t2052r775b2084],

1	—	NN	O	—	_	0	SENT_224	[p9l550t2052r775b2084],
2	.	.	O	.	_	0	SENT_224	[p9l550t2052r775b2084],

1	Chief	NNP	O	Chief	_	0	SENT_225	[p9l550t2052r775b2084],
2	,	,	O	,	_	0	SENT_225	[p9l550t2052r775b2084],
3	10	CD	NUMBER	10	appos	1	SENT_225	[p9l788t2054r820b2078],
4	Shattuck	NNP	PERSON	Shattuck	nn	9	SENT_225	[p9l831t2052r955b2079],
5	St.	NNP	PERSON	St.	nn	9	SENT_225	[p9l964t2054r1008b2084],
6	,	,	O	,	_	0	SENT_225	[p9l964t2054r1008b2084],
7	Boston	NNP	LOCATION	Boston	appos	9	SENT_225	[p9l1019t2055r1128b2084],
8	,	,	O	,	_	0	SENT_225	[p9l1019t2055r1128b2084],
9	MA	NNP	O	MA	dep	1	SENT_225	[p9l1138t2055r1189b2078],
10	02115	CD	DATE	02115	num	9	SENT_225	[p9l1198t2054r1284b2079],

1	(	NN	O	(	nn	2	SENT_226	[p9l554t2096r614b2128],
2	fax	NN	O	fax	_	0	SENT_226	[p9l554t2096r614b2128],
3	,	,	O	,	_	0	SENT_226	[p9l554t2096r614b2128],
4	617-739-9864	CD	NUMBER	617-739-9864	num	5	SENT_226	[p9l626t2098r845b2128],
5	)	NN	O	)	appos	2	SENT_226	[p9l626t2098r845b2128],
6	,	,	O	,	_	0	SENT_226	[p9l626t2098r845b2128],
7	by	IN	O	by	_	0	SENT_226	[p9l857t2096r889b2129],
8	September	NNP	DATE	September	prep_by	2	SENT_226	[p9l898t2096r1051b2130],
9	30	CD	DATE	30	num	8	SENT_226	[p9l1060t2098r1101b2128],
10	,	,	DATE	,	_	0	SENT_226	[p9l1060t2098r1101b2128],
11	2008	CD	DATE	2008	num	8	SENT_226	[p9l1113t2098r1190b2122],
12	.	.	O	.	_	0	SENT_226	[p9l1113t2098r1190b2122],

1	NENGLJ	NN	O	nenglj	nn	2	SENT_227	[p9l516t2257r622b2279],
2	MED358	NN	O	med358	_	0	SENT_227	[p9l637t2251r762b2279],
3	;	:	O	;	_	0	SENT_227	[p9l637t2251r762b2279],
4	6	CD	NUMBER	6	num	6	SENT_227	[p9l637t2251r762b2279],
5	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	6	SENT_227	[p9l796t2257r997b2279],
6	FEBRUARY7	NN	O	february7	dep	2	SENT_227	[p9l1034t2257r1184b2278],
7	,	,	O	,	_	0	SENT_227	[p9l1034t2257r1184b2278],
8	2008	CD	DATE	2008	num	9	SENT_227	[p9l1195t2251r1258b2273],
9	639	CD	NUMBER	639	appos	6	SENT_227	[p9l1959t2246r2016b2270],

1	The	DT	O	the	det	5	SENT_228	[p9l702t2314r753b2338],
2	New	NNP	O	New	nn	5	SENT_228	[p9l762t2315r824b2338],
3	England	NNP	O	England	nn	5	SENT_228	[p9l833t2314r944b2345],
4	J	NNP	O	J	nn	5	SENT_228	[p9l952t2315r965b2338],
5	oumal	NN	O	oumal	_	0	SENT_228	[p9l966t2314r1050b2338],
6	of	IN	O	of	_	0	SENT_228	[p9l1059t2314r1088b2338],
7	Medicine	NN	O	medicine	prep_of	5	SENT_228	[p9l1095t2314r1220b2338],

